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Breast cancer is one of the most common types of cancer affecting women in the world 
today. To better understand breast cancer initiation and progression modeling biological tissue 
under physiological conditions is essential. Indeed, breast cancer involves complex interactions 
between mammary epithelial cells and the stroma, both extracellular matrix (ECM) and cells 
including adipocytes (fat tissue) and fibroblasts (connective tissue). Therefore, the engineering of 
in vitro three-dimensional (3D) systems of breast tissues allows a deeper understanding of the 
 xvii 
complex cell-cell and cell-ECM interactions involved during breast tissue development and 
cancer initiation and progression. Furthermore, such 3D systems may provide a viable alternative 
to investigate new drug or drug regimen and to model and monitor concurrent cellular processes 
during tumor growth and invasion. The development of suitable 3D in vitro models relies on the 
ability to mimic the microenvironment, the structure, and the functions of the breast tissue. 
Different approaches to develop a novel 3D breast model have been investigated. Most models 
use gel scaffolds, including Matrigel
®
 and collagen to generate breast tissue-like structures. 
However, the physicochemical, mechanical, and geometrical properties of these scaffolds only 
partially meet the mechanical, physical, and chemical parameters of the breast tissue matrix.  
In the present studies, we investigated the overall hypothesis that electrospun SF-derived 
scaffolds promote mammary cell growth and the formation of mammary-like structures 
depending on the composition and/or coating of the scaffolds with ECM proteins. Through an 
extensive literature search (1) the importance of 3D modeling of tissues and organs in vivo, (2) 
3D modeling of the mammary tissue and currently available models, (3) the properties and 
applications of SF in tissue modeling and regeneration were reviewed (Chapter 1). Our studies 
provide evidence of the effects of various concentrations (Chapter 2) of SF along with different 
electrospinning techniques (Chapter 3) on the structure of electrospun scaffolds and whether 
those scaffolds provide suitable microenvironments for mammary epithelial cells as determined 
by MCF10A cell attachment, viability, and structure formation. Further, we investigated the 
effects of the key ECM proteins collagen I (Chapter 4) and laminin (Chapter 5) used to blend or 
coat, respectively, SF scaffolds on the attachment, viability and structure formation of mammary 
epithelial cells.   
 xviii 
Our studies first highlight the mechanical and physical properties of the different SF-derived 
scaffolds through various SF concentrations and electrospinning techniques. Second, the 
biocompatibility of these SF electrospun scaffolds was defined based on MCF10A cell survival 
and adhesion. Third, our data indicate that scaffolds derived from blended and/or coated SF with 
collagen I also promoted human mammary cell survival and adhesion. Lastly, our observations 
suggest that on laminin-coated SF scaffolds MCF10A mammary cells, in the presence of 
lactogenic hormones, differentiated forming acinus-like structures. 
Overall, these studies provide evidence that SF electrospun scaffolds closely mimic the 
structure of the ECM fibers and allow many advantages such as; physical and chemical 
modification of the microenvironment by varying electrospinning parameters and addition of 
various proteins, hormones, and growth factors, respectively. Further, coating these SF scaffolds 
with essential ECM proteins, in particular laminin, promote cell-ECM interactions necessary for 
cell differentiation and formation of growth-arrested structures, through providing cell integrin 
binding sites and appropriate chemical cues. 
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CHAPTER 1: INTRODUCTION 
 
Bioengineered Silk Scaffolds in 3D Modeling of Mammary Tissues 
1.1. Abstract 
In vitro generation of three-dimensional (3D) biological tissues as organ-like structures is a 
promising strategy to study and closely model complex aspects of the molecular, cellular and 
physiological interactions of tissue in both healthy and disease states. In particular, in vitro 3D 
tissue modeling holds promises to further our understanding of breast development, and breast 
cancer initiation and progression. Indeed, the generation of biologically relevant 3D structures 
that combine mammary cells and engineered matrices have improved our knowledge of 
mammary tissue growth, organization, and differentiation. Several polymeric biomaterials have 
been used as scaffolds to engineer 3D mammary tissues. Among those, silk fibroin-based 
biomaterials have many biologically relevant properties and have been successfully used in 
multiple medical applications. Here, we review the recent advances in engineered scaffolds with 
an emphasis on breast-like tissue generation and the benefits of modified silk-based scaffolds. 
1.2. Introduction 
Many diseases including cancer involve complex processes and interactions between cells 
and their surrounding microenvironment. Understanding and unraveling these processes are 
crucial in disease prevention and treatment [1]. Over the years, biological research has 
contributed tremendously to the understanding of processes involved in human diseases. 
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However, these studies have been dependent on the use of animal models, humans, and two-
dimensional (2D) monolayer cell culture systems, all of which have limitations and can pose 
ethical concerns [2,3]. Indeed, human experimentations are limited by ethics; and when possible 
may cause discomfort or have side effects and risks for the subjects [2]. The use of animal 
models is often limited by their availability and feasibility of the test procedures. Furthermore, 
for human-specific diseases animal models are not always adequate [4] and their responses to 
therapeutics may be drastically different, limiting the usefulness of such animal modeling in the 
investigations of therapeutics for human diseases [2,5]. Conventional 2D cell culture models 
have contributed significantly to our biological understanding, however, they lack the 3D 
microenvironment of tissues that has been shown to play a critical role in tissue morphogenesis 
and function [2,3,6,7].  
Tissue engineering is an interdisciplinary field that combines principles of biological, 
chemical, and engineering sciences towards the goal of tissue regeneration [8]. Tissue 
engineering aims to generate tissues and organs mimicking the physiological properties of 
original targeted tissues [8,9].  In vitro 3D models, which strive to more closely mimic the 
biological microenvironment and physiological cell-extracellular matrix (ECM) interactions than 
2D cultures, are created by combining cells with 3D structures (scaffolds) to generate functional 
3D tissues that allow normal cell growth, organization, and differentiation [8,9]. In vitro 
engineered 3D tissues provide excellent models to investigate human tissue physiology and 
pathophysiology, therefore, bridging the gap between the conventional 2D models and animal 
model systems [2,3,5-7,9,10]. The key promises of in vitro engineered 3D organ and tissue 
models are (1) the improvement of the development, testing, and delivery of new drugs, (2) the 
substitution for animal and/or human studies that may raise ethical concerns [2,3,5], (3) the 
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furthering of our understanding of the complex interactions between cells and the stromal 
components during complex biological processes including cancer [3,5,10-12], and (4) the 
reduction of the need for organ replacement by engineering potential tissue and organ substitutes.   
3D cell culture models generated using different forms of biodegradable and biocompatible 
natural or synthetic polymeric scaffolds have been used in a broad range of studies, including 
organ development [13], analyses of disease including cancer [3,14,15], drug testing [2], and 
functional tissue repair and implantation [13,16]. Specific ECM proteins including collagen, 
elastin, elastin-like-peptides, albumin and fibrin have been used as tissue scaffolds, hemostatic 
agents, and drug delivery vehicles [17]. 3D culture systems have been used towards the 
regeneration of many tissues and organs such as skin, bone, cardiac tissue, cartilage, tendon, 
ligament, lung, nerve, mammary gland, and vascular grafts (Table 1.1).  
Recently, ex vivo regenerated tissues have shown clinical promise. For example, in 2006 ex-
vivo engineered bladders, using urothelial and muscle cells grown on collagen or the 
combination collagen and polyglycolic acid (PGA), were implanted into patients by Atala et al. 
[13]. The patients were monitored for up to five years. Post-operation, renal function was 
preserved and the engineered bladder biopsies showed an adequate structural architecture and 
phenotype [13]. Also, in 2008, Macchiarini et al. replaced the left main bronchus of a patient 
with a decellularized donor trachea [16].  Within 96 hours of bioreactor culture, the donor 
trachea was colonized by the recipient’s epithelial cells and mesenchymal stem-cell-derived 
chondrocytes. The graft provided the recipient with a functional airway immediately after 
implantation. Lung-function tests performed at 2 months were within the normal range for the 
age and sex of the recipient, and after 4 months the graft showed normal appearance and 
mechanical properties [16].  
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Table 1.1. Synthetic or natural polymers 3D culture scaffolds for the regeneration of biological 
tissues. 
Target Tissue ECM Materials References 
Bone 
Chitosan and its composites 
Poly(3-hydroxybutyrate)/nano-hydroxyapatite (PHB/nHA) 
Poly(ɛ-caprolactone) (PCL) and its composites 
Poly(L-lactic acid) (PLLA) and its composites 
Poly(D,L-lactic acid-co-glycolic acid) (PLGA) and its composites 
Regenerated silk fibroin and its composites 
Collagen and its composites 
[18-25] 
Heart 
Collagen and its composites 
Poly(lactic acid) (PLA)/PCL 
Alginate 
[26-29] 
Cartilage 
Collagen and its composites 
Regenerated Silk Fibroin 
Alginate, Polyglycolic acid (PGA) 
PLLA 
PGA and PLLA copolymers 
PCL 
poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) (PHBV) 
[30-40] 
Ligament 
Regenerated silk fibroin 
Collagen 
Alginate 
Chitosan 
PLGA 
[41-45] 
Lung 
Collagen and its composites 
decellularized lung ECM 
poly-DL-lactic acid (PDLLA) 
[46-49] 
Breast 
Matrigel 
Collagen and its composites 
Regenerated silk fibroin 
PLGA/Poly(lactic acid) (PLA) 
[14,50-58] 
Nerve 
Poly(glycerol sebacate) (PGS) 
Poly(phosphoester) (PPE) 
PLLA 
[59-62] 
Skin 
Collagen and its composites 
Chitosan 
PCL and its composites 
Poly(lactic acid-co-glycolic acid) 
[63-67] 
Tendon 
Alginate 
Chitosan 
PLGA 
Collagen and its composites 
PGA 
[44,45,68-71] 
Vessels 
PLLA 
Collagen and its composites 
PCL 
Chitosan 
Poly(ethylene glycol) (PEG) 
Poly(lactic acid) PLA/PCL 
Regenerated silk fibroin 
[72-78] 
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1.3. Biological Features of the Breast Tissue 
1.3.1. Anatomy and Structure of the Breast Tissue 
Breast tissue is composed of glandular, ductal, and stromal tissue containing epithelial cells, 
adipocytes and various stromal cell types (e.g., mesenchymal stem cells/pre-adipocytes, 
endothelial cells, fibroblasts, myofibroblasts, and leukocytes) [12,79,80]. In the mammary 
tubulo-alveolar gland, secretory acini and ducts are lined by an outer myoepithelial (MEP) cell 
layer and an inner luminal epithelial (LEP) cell layer [54,80]. These structures are well organized 
and have an apical-basal polarity, which is required in the directional secretion of milk [10]. 
Within the human breast there are 15-20 lobes of glands, which are embedded in fibrous and 
adipose tissue [1,12]. The primary ducts reach the nipple and give rise to a complex branching 
pattern of secondary ducts. Further branching into smaller ducts leads to terminal ducts that give 
rise to blind-ended ductules called acini. A collection of acini arising from one terminal duct 
embedded in a layer of contractile epithelial cells and intralobular stroma is referred to as a 
terminal duct lobular unit (TDLU), which is considered the functional unit of the breast 
[1,12,81]. The breast is primarily composed of adipose tissue dispersed between glandular and 
fibrous components of the breast. The adipose tissue determines the bulk and contour of the 
breast mound [12,79]. Growth of the adipose stroma occurs normally in the absence of the ductal 
network, also known as parenchyma, and can fully support subsequent mammary parenchyma 
development [82]. The ECM of the mammary gland is mainly composed of type I collagen 
[54,83]; however, fibronectin and several glycosaminoglycans are also present. The basement 
membrane (BM) of the breast acinus and ductal epithelium contains various proteins including 
laminin and type IV collagen [54]. Complex interactions between the multiple cell types within 
the breast tissue are required for the proper development and functioning of the organ [80]. Cell-
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cell and cell-microenvironment interactions modify the proliferation, survival, polarity, 
differentiation, and invasive capacity of mammary epithelial cells suggesting the active role of 
breast stroma in mammary gland development and function. Further knowledge of stromal-
epithelial interactions will enhance the understanding of mammary gland function [80,82,84,85]. 
The cellular components of the mammary tissue microenvironment are depicted in Figure 1.1.  
 
Figure 1.1. Mammary tissue microenvironment. Adapted and modified from [86,87] 
 
1.3.2. Mechanical Properties of the Breast Tissue 
Mechanical properties of the breast tissue have been investigated using various methods such 
as; indentation or compressive force [88,89], sonography, sonoelastography [90], and magnetic 
resonance (MR) elastography [91]. Using these techniques the elastic modulus of normal breast 
tissue was measured and ranged from 3 to 20 kPa within the fat regions and from 3 to 44 kPa 
within the fibroglandular regions, respectively. Many factors such as age, hormonal status, and 
menstrual cycle effect breast tissue’s elastic modulus [90]. It has also been demonstrated that the 
proper organization of breast tissue is disrupted in cancer and is associated with increased breast 
density and stiffness [88-91]. 
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1.3.3. Breast Development 
Breasts arise as the result of reciprocal epithelial and mesenchymal interactions [81]. The 
breast development is divided into four phases: fetal, postnatal, post-pubertal, and adult [82]. The 
mammary epithelium is specified in the embryo and most of the branching morphogenesis 
required to develop the ductal tree occurs post-partum during puberty [10]. The mammary bud 
develops as a down-growth of a group of cells from the overlying ectoderm followed by the 
development of the primary ducts as a result of cell death in the lumen. Generally lined by two 
layers of epithelial cells, the primary duct, branches to form secondary ducts lined by a single 
layer of epithelial cells. This ductal network is connected to the nipple [82]. At birth, the 
parenchyma attains only a few orders of branching. The number of primary ducts per nipple is 
species dependent, with humans having approximately 20. In humans, the growth of the 
mammary parenchyma from birth until puberty involves ductal elongation and branching at a 
slow rate [82]. During puberty, as the levels of ovarian steroid increase, changes occur in both 
the epithelium and the stroma [82]. In the stroma, the amount of fibrous and fatty tissue increases 
[82]. The glandular epithelium increases in size while the mammary ducts elongate and branch 
through terminal end bud mitotic activity. Mitotic activity remains high until the mammary fat 
pad is filled with a system of ducts and side branches. Subsequently, mitotic activity regresses 
resulting in single layered luminal epithelial cell lobular structures with low mitotic activity and 
formation of terminal ductal lobular units [81,82,92]. The fourth phase of growth, further 
branching of the ductal network and full functional differentiation of the gland, is initiated by the 
hormones of pregnancy and involves a rapid and intense proliferative activity followed by 
alveolar differentiation [82]. This creates a system of ducts that collect the milk produced by the 
alveoli [10]. After pregnancy and lactation, significant reduction of milk in the breast results in 
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post-lactation involution, during which the mammary gland transitions to a resting non-lactating 
state [93]. During involution, the mammary epithelium cells are lost through apoptosis and are 
replaced by adipose tissue and mesenchyme that support the lobules in the non-pregnant adult. 
This regression of the breast leads to a resting (non-lactating) state until the next pregnancy.  
[10,82,93].  The structure and morphology of the post-pregnancy gland differs from that of the 
pre-pregnancy state [93]. Declining circulatory concentrations of sex-steroid hormones 
(estrogen, progesterone) triggered by decreased ovarian function result in post-menopausal 
involution [93]. 
1.3.4. Cancer Development & Progression 
Breast cancer is a complex disease that requires interconnection of several signaling 
pathways [94]. Our current understanding of breast cancer highlights each breast cancer as 
unique. Thus, for each patient the development of personalized medicine could play a crucial 
role in the treatment of the disease [94]. The development of breast cancer is characterized by the 
loss of epithelial polarity and tissue organization, and almost all breast malignancies arise from 
TDLU [1,95]. The progression from normal mammary gland to invasive carcinoma is 
accompanied by enhanced vascularization, the loss of myoepithelial cells, and increases in myo-
fibroblasts and immune cells in the stroma [1]. Early breast cancer tumors or benign in situ 
carcinomas, are defined by confinement of tumor cells within the basement membrane of the 
mammary ductal-lobular system. Once tumor cells invade the adjacent stroma, breast cancers are 
defined as malignant [1]. In addition to tumor size, malignant breast cancers are also defined 
based on the presence of specific molecular markers by the American Joint Committee on 
Cancer (AJCC) staging. Indeed, breast cancers are divided into major groups based on whether 
or not the tumor cells express the estrogen receptor-α (ER) [1], and are further divided into 
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subtypes. The ER-negative carcinomas are divided into three cell and molecular subtypes: basal-
like, HER2+, and normal breast-like. The ER-positive breast carcinomas are divided into either 
luminal A or luminal B subtypes [1,96] both associated with the expression of genes expressed 
by lumen cells lining the mammary ducts [94]. Breast cancers of the luminal A subtype are the 
most common subtype (50% - 60%) and are Her2+ [94,96]. Breast cancers of luminal B subtype 
are Her2- and account for 10% - 20% of all breast cancers. The luminal B breast cancers have a 
more aggressive phenotype, higher histological grade, increased proliferative index, and worse 
prognosis than luminal A breast cancers [94,96]. The invasive breast cancer tumor mass is 
composed of cancer cells, stromal cells such as fibroblast and immune cells, and a different ECM 
composition and density [1]. The interactions between and amounts of these components varies 
amongst tumors and within each breast tumor mass. Therefore, modeling the specific 
characteristics of the breast cancer stroma will likely provide useful data in cancer prognosis and 
prediction [1]. 
1.4. Breast Tissue Modeling 
1.4.1. Clinical Potential and Other Uses 
As most (~90%) of human mammary carcinoma arises from ductal epithelium [10,97,98], 3D 
engineered mammary tissues may serve as models to deepen our understanding of cancer 
progression and to screen drug candidates for cancer treatments [10]. Additionally, 3D 
engineered mammary tissues may potentially be used to reconstruct breast tissues following 
various traumas including surgical removal of mammary tissue due to cancer. Based on cohort 
studies of women with breast cancer, as many as 34 to 40% of women with this disease undergo 
full mastectomy [99-101]. Different surgical approaches such as the use of autologous, implant-
based materials, or a combination of these two are available to reconstruct breast tissues 
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[12,79,102]. Most patients opt for either autologous or silicone implants based reconstruction 
[12,79]. In the former, the autologous tissue used is the patient’s own fat tissue from abdomen or 
buttocks. In the latter, silicone implants are implanted in place of the surgically removed 
mammary tissue. Silicone implants have been shown to result in local complications including 
bleeding [12], fluid collection [12] and most commonly capsular contracture due to scarring and 
fibrosis [12,79]. Furthermore, the implants themselves are subject to rupture [79], leakage [79], 
displacement [79], deflation [79] and/or deformation [79]. Autologous breast reconstruction has 
also been associated with poor results. In particular, a 50-70% graft volume reduction due to fat 
cell/tissue resorption has been observed [103,104]. Moreover, this fat resorption leads to calcium 
deposits that hinder mammographic examination and tumor detection [105]. The fat cells used in 
autologous reconstruction are mostly composed of mature adipocytes that are resistant to current 
ex vivo expansion attempts [79]. The inability to graft adipocytes capable of dividing and 
differentiating in large part explains the tissue defect associated with autologous reconstruction 
[79]. The limitations associated with either the silicon implants or autologous reconstructions 
highlight the need for better approaches. Thus, significant research efforts have been directed 
toward the generation of biocompatible, bioresorbable 3D scaffolds/tissues that would permit, 
following implantation, the regeneration of the patient breast tissue [14,50-58]. As a key step 
toward those 3D scaffolds/tissues, in vitro 3D scaffolds mimicking the structure and function of 
the mammary gland have been developed and studied. Those 3D scaffolds have been used as 
experimental model systems to investigate steps of breast development and cancer progression 
[14,50-58].   
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1.4.2. 2D vs. 3D In Vitro Models 
Modeling the structure and function of normal tissue allows for a better understanding of the 
normal tissue and of disruptions occurring in diseased tissue [10]. Mammary cells cultured in 2D 
monolayers have been used to investigate cellular events in mammary morphogenesis and 
carcinogenesis; however, these models only poorly reflect the function and structure of breast 
tissue [10,106,107]. Indeed, culture of mammary epithelial cells in 2D monolayer in vitro failed 
to generate acini and produce milk proteins even after stimulation with lactogenic hormones 
[10]. In contrast, 3D models of mammary tissues led to the formation of acinus- and duct-like 
structures similar to those observed in vivo with the ability to produce basement membrane and 
secrete milk proteins [10,51,52,55,108]. Moreover, distinction of normal and cancer-derived 
cells in 2D cultures is difficult. In 3D, however, normal mammary epithelial cells form polarized 
acini with central lumina as they growth-arrest. These observations contrast sharply with 
mammary epithelial cancer cells that do not organize and form disordered highly proliferative 
colonies [10]. Furthermore, in mammary tissue 3D models pathways deregulated or upregulated 
during the tumorigenic progression can be mimicked [10]. Overall, the use of 3D mammary 
tissue constructs can increase understanding of the complex processes that dictate organization 
and structure of mammary epithelial cells, and how disruption of those signals in cancer can alter 
the development, function, and physiology of mammary tissue [10,51,55,109,110].  
1.4.3. Biomaterial Properties and Suitability for Tissue Regeneration 
Early on, artificial scaffolds were engineered to provide cells with an environment that 
promoted their survival [111]. However, it is now understood that mimicking the native 
microenvironment and the host tissue’s physiochemical and mechanical properties are essential 
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to the maintenance and regulation of cell behavior and tissue function [111].  In tissue 
regeneration applications, an ideal biomaterial scaffold should: 
 Be biocompatible and not evoke a sustained inflammatory or toxic response in vivo 
[17,111] 
 Have physiochemical and mechanical properties similar to the native host tissue [17,111]. 
 Enable the fabrication of 3D constructs that can incorporate cells [111]. 
 Be able to incorporate growth factors and cell adhesion functional groups [111].  
 Be bio-degradable and the degradation products should be non-toxic, metabolized and 
cleared from the body [17,111]. 
 Synthetic and natural polymers have been utilized in the engineering of biological tissues 
extensively (Table 1.1). Each of these polymer types possesses several advantages and 
disadvantages [17]. Synthetic polymers are easy to process and modify, have more predictable 
properties, batch-to-batch uniformity [17], good mechanical properties and thermal stability; 
however, they often have associated disadvantages such as; cell toxicity, immunogenicity, and 
poor biocompatibility [111-114]. For example, Poly(ɛ-caprolactone) (PCL) and polyurethanes 
(PU) are two of the typical synthetic polymers used in tissue engineering [115]. The biologically 
relevant properties of PCL are its high elasticity at room or body temperature and its 
degradability. However, the slow degradation rate of PCL makes it less attractive for some tissue 
engineering applications [115]. A major limitation of PU for biomedical applications is the 
presence of traces of toxic precursors (such as toluene disocyanates) used in the synthesis of PU 
[115]. 
Natural polymers such as structural proteins offer improved biocompatibility and possess 
diverse features, which mimic natural ECM [112-114,116]. They have the ability to present 
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receptor-binding ligands to cells, and they are susceptible to cell-triggered proteolytic 
degradation and natural remodeling [17]. However, they may trigger strong immunogenic 
response, their purification process is often complex, and they may be a vector of disease 
transmission [17]. Further, their rapid degradation, and poor mechanical strength and thermal 
properties limit their use [112-114,116]. Nair et al. [17] have recently reviewed most of the 
promising synthetic and natural biomaterials.  
To overcome the limitations of currently available polymers, approaches that blend synthetic 
and natural polymers or natural and natural polymers have been developed [113]. Blending 
natural polymers such as collagen, gelatin, or elastin with a variety of other polymers improves 
their biocompatibility [25,63,117-119]. Recently, Sionkowska et al. [113] reviewed the blends of 
natural and synthetic polymers. 
1.4.4. Early 3D Breast Models 
Following the pioneering work of the Bissell group [6,10,84,86,106,107,120-124], 3D 
mammary models have been developed and refined mostly using gel-based scaffolds, such as 
Matrigel
®
, collagen, Matrigel
®
/collagen mix, or laminin [50,51,54,56,83,122,125-127]. In these 
models mammary epithelial cells exibit low proliferation rate, form polarized growth-arrested 
structures, and secrete basement membrane [51]. The key roles of cell-ECM interactions in the 
growth and differentiation of the mammary gland in this model have been highlighted by Bissell 
et al., Roskelley et al., and Wicha et al. [84,106,124,128]. It has been demonstrated that the 
mechanical density and stiffness of the ECM plays an important role in the organization of the 
polarized growth-arrested structures and that the polarized organization of these acinar and 
ductal structures is disrupted by increased ECM stiffness [129,130]. The role of stromal cell 
types, especially fibroblasts, in epithelial-stromal interactions and the generation of acini were 
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also demonstrated in 3D gel cultures [50]. Formation of acinar and ductal structures have been 
observed in co-cultures of human mammary fibroblasts and epithelial cells on either 3D collagen 
type I or mixed Matrigel
®
-collagen matrices [54,110]. More recently, Wang et al. [55] 
demonstrated that mammary epithelial cells co-cultured with stromal cells, within mixed 
Matrigel
®
-collagen matrices and maintained on 3D silk sponges led to the formation of ductal 
and acinar structures. These Matrigel
®
-based gel scaffolds, however, only partially meet the 
physicochemical and mechanical properties of the breast tissue ECM [131] and their spontaneous 
gel contraction, limited mass transport, and rapid degradation after transplantation limit their 
applications in the field of mammary tissue engineering [55]. Furthermore, Matrigel
®
 contains 
unknown concentrations of growth factors that vary substantially between batches making the 
reproduction of the experimental findings and understanding the role of each specific factor 
challenging. Also, Matrigel
®
 is a mouse sarcoma secretion and not clinically appropriate for in 
vivo studies and human use [132-134]. Due to these challenges there is a renewed interest for 
other sources of natural polymers such as silk protein for use in tissue engineering/biomedical 
applications [112-114,116]. 
1.4.5. Epithelial Cell Interactions with ECM Proteins 
The ECM plays an important role in the differentiation and organization of the epithelium. 
Epithelial cells attach to the ECM in order to establish cell polarity [135]. This cell-ECM 
attachment is mediated by cell integrins which are transmembrane receptors and bind to a variety 
of ECM components including collagen, laminin, and fibronectin [135,136]. Mammary epithelial 
cells attach to laminin and collagen through α2β1 integrin subunits [136]. β1-integrin-cell 
interactions have been shown to be crucial in differentiation of mammary epithelial cells and 
secretion of milk protein, β-casein, by these cells [106]. Inhibiting these β1-integrin-cell 
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interactions results in disruption of the polarized and differentiated structures [106]. The BM 
component that interacts with β1-integrin has been shown to be laminin-1 [106,137]. Polarized 
structures resulting from interactions with laminin, but not other ECM proteins such as collagen 
I, are resistant to apoptosis through β4 integrin interactions [138]. Interactions of β4 integrin with 
laminin initiate signals for cell growth, viability, and functional differentiation; it also directs 
tissue polarity and promotes resistance to apoptosis in both nonmalignant and malignant breast 
epithelial structures [138].  
 These findings highlight the importance of laminin in 3D modeling of the beast tissue in 
vitro.  
1.4.6. Silk in Biomedical Applications 
Silk fibroin (SF) is the major component of a large subset of non-bioabsorbable biomedical 
sutures and has been used extensively in the medical field [114,139]. Due to their easy handling 
and tying capacities, silk sutures are used in eye and lip surgeries, intraoral surgeries, and skin 
wounds [140]. More recently, silk has been used as a biomaterial scaffold due to its excellent 
mechanical properties [141], and thermal stability over a wide range of temperatures up to about 
250°C without loss of functional integrity [142]. In addition, the biocompatibility, controlled 
slow degradation rate [139,143,144], hemostatic properties, low antigenicity, non-inflammatory 
characteristics [142,145], high oxygen permeability, high drug permeability, resistance against 
enzymatic cleavage [146] of silk-derived products has made it a viable option in biological 
environments. Different forms of SF-derived biomaterial have been assessed including films 
[143,145], membranes [143,145], gels [145,147], sponges [143,145], powders, scaffolds 
[145,147], fibers, nets, meshes, yarn [143], and nano-particles [147]. Specific biological 
applications encompass burn-wound dressing, enzyme immobilization matrices, vascular 
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prostheses and structural implants [145]. Furthermore, different forms of SF-derived biomaterials 
have been investigated for multiple biomedical applications such as tissue engineering, disease 
modeling, drug delivery, implant devices, and wound healing (Table 1.2).  
As both processing and understanding of biologically relevant properties improved, SF-
derived biomaterials have become an attractive option to develop bio-resorbable scaffolds 
[114,140]. Variations in the processing procedures employed during material formation generate 
SF with degradation rate ranging from months to years [142]. Further, the presence of easy 
accessible chemical groups offers the ability for functional modification [148]. The wide range 
of extensibility, elasticity, good strength, and strain hardening from different varieties of silk 
provide advantages to developing a range of silk-based biomaterials based on needed application 
[148]. These properties of silk fibroin are particularly useful for tissue engineering applications 
[140]. 
As mentioned previously, 3D models of the mammary gland have been investigated during 
the past three decades many of which have utilized mostly gel scaffolds, such as Matrigel
®
 and 
collagen [50,51,54,56,83,122,125-127] to reconstruct the mammary tissue microenvironment. 
However, these scaffolds only partially meet the physicochemical and mechanical properties of 
the breast tissue ECM [131] and their spontaneous gel contraction, limited mass transport, and 
rapid degradation after transplantation limit their applications in the field of mammary tissue 
engineering [55]. Furthermore, the use of Matrigel
®
 is associated with several disadvantages 
mentioned previously in section 1.4.4.  Considering the advantages of SF biomaterials and their 
wide range of processing, they offer significant benefits in maintaining long-term 3D mammary 
culture models in vitro and as potential in vivo transplants [55]. 
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Table 1.2. Current applications of silk fibroin as biomaterial. 
Applications Target Tissues Sources Silk Fibroin Forms 
Tissue Engineering Anterior cruciate ligament 
 B. mori silk fibroin 
 B. mori silk fibroin 
 Silk fiber wire-rope [42] 
 Knitted silk mesh [149] 
 Adipose-like tissue  B. mori silk fibroin  Sponges [150] 
 Bone 
 B. mori silk fibroin  
 B. mori silk fibroin  
 B. mori silk fibroin 
 Films [151] 
 Sponges [152-156] 
 Electrospun fibers [23] 
 Cardiac Tissue 
 Not specified 
 Antheraea mylitta and 
B. mori silk fibroin 
 Microparticle patches [157] 
 Sponges [158] 
 
Cartilage 
 B. mori silk fibroin 
 B. mori silk fibroin 
 B. mori silk fibroin 
 Sponges [33-35] 
 Films [34,35] 
 Electrospun fibers [159] 
 Corneal Tissue  B. mori silk fibroin  Films [160,161] 
 Cervical Tissue  B. mori silk fibroin  Sponges [162] 
 
Liver 
 B. mori silk fibroin 
 Antheraea mylitta  silk 
fibroin 
 Films [163,164] 
 Micro/nano fibrous nonwoven 
scaffold [165] 
 
Nerve Tissue 
 B. mori silk fibroin 
 B. mori silk fibroin 
 Fibers [166,167] 
 Film [168] 
 Soft Tissue  B. mori silk fibroin  Gels [169] 
 
Skin 
 B. mori silk fibroin 
 Not specified 
 Films [170]  
 Electrospun fibers [171] 
 
Tendon 
 Antheraea pernyi silk 
fibroin 
 Braided fibers [172] 
 
Vascular Tissue 
 B. mori silk fibroin 
 B. mori silk fibroin 
 Electrospun fibers [78,173] 
 Tubes [174] 
Disease Models Mammary Gland 
 B. mori silk fibroin 
 B. mori silk fibroin 
 Sponges [55,56] 
 Electrospun Fibers [58] 
 Kidney  B. mori silk fibroin  Sponges [175,176] 
 
Tumor Model 
 Antheraea mylitta and 
B. mori silk fibroin 
 Films and Sponges [139] 
Drug Delivery  
 B. mori silk fibroin 
 B. mori silk fibroin 
 Spheres [177-179] 
 Films [180] 
Implants Femur  B. mori silk fibroin  Sponges [181] 
Wound Healing   B. mori silk fibroin  Electrospun fibers [182,183] 
 
1.5. Silk Bioengineered Scaffolds  
1.5.1. Source, Type, Physical and Chemical Properties 
Naturally, silks are polymeric fibrous proteins present in the glands of silk producing 
arthropods such as silkworms, spiders, scorpions, mites, and bees [143,148,184]. Despite some 
variations in the primary organization and structural features at the nanometer scale between silk 
types, all silkworm silk fibers follow similar hierarchical structural arrangements [148]. Silks 
consist of two types of proteins: a filament core protein, SF, and a glue-like coating family of 
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hydrophilic proteins holding two fibroin fibers together, the sericins [143,145,185]. These two 
silk proteins are self-assembling proteins and both contain the same 18 amino acids such as 
glycine, alanine and serine in different amounts [145]. Depending on the organism, the 
secondary structure of silk can be helical, β-sheet, or cross-β-sheet [184]. Structurally, SF is 
composed of hydrophobic blocks with highly preserved repetitive sequence consisting of short 
side-chain amino acids such as glycine and alanine, and hydrophilic blocks with more complex 
sequences that consist of larger side-chain amino acids as well as charged amino acids [143]. The 
hydrophobic blocks, also referred to as crystalline portions, contain highly repetitive amino acid 
sequences (-Gly-Ala-Gly-Ala-Gly-Ser-), forming an antiparallel β-sheet structure 
[143,145,186,187]. The physiochemical and mechanical properties of SF, resistance to 
dissolution, thermal and enzymatic degradation strongly depends on its conformational transition 
of α-helix and random coil to highly stable β-sheets [143,145,148,171,186,188].  
The most widely studied silks are silkworm cocoon silk from Bombyx mori (B. mori, also 
known as mulberry silk) and dragline silk from the spider Nephila clavipes [143,148]. However, 
compared to silkworm silk, there are no commercial supply chains available for spider silks 
mainly due to the more aggressive nature of spiders and the more complex and smaller quantity 
of silk generated [140]. The yield of silk fiber from a single silkworm cocoon is 600-1500 
meters, compared to only ~12 meters from the spider web [148]. Thus, silk-based biomaterials 
are commonly prepared from B. mori SF [114,143,148]. B. mori SF is composed of a heavy (H) 
and a light (L) chain linked together by a disulfide bond, as well as, a 25 kDa glycoprotein (P25) 
which is non-covalently linked to these chains [148,189]. The hydrophobic domains of H chains 
contain Gly-X (X being Ala, Ser, Thr, Val) repeats and can form anti-parallel β-sheets. The L-
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chain is hydrophilic in nature and relatively elastic. P25 protein is thought to play a significant 
role in maintaining the integrity of the complex [148]. 
1.5.2. Mechanical Properties 
Mechanically, silks exhibit toughness, elasticity, high strength, and are lightweight [143]. 
The toughness of silk fibers is greater than Kevlar 49, which is the benchmark in high-
performance synthetic fiber technology [140]. The strength-to-density of silk is ten times higher 
than that of steel [148]. Silk fibroin possesses an anti-thrombotic surface with good resistance to 
high shear stress and blood flow pressure [148]. It must be noted that despite high mechanical 
strength of native silk fibers, the strength of materials prepared from regenerated silk fibroin 
solution are weak [148]. The tensile strength of native fibers are in the 0.5-0.6 GPa range 
whereas the tensile strength of a regenerated silk material, such as silk films, is about 0.02 GPa 
in its dry state [190]. This is due the loss of secondary structure in the processed silk. Various 
investigations are ongoing to improve the strength of regenerated silk materials [148]. 
Mechanical properties of silks and other materials are listed in Table 1.3. 
 
Table 1.3. Mechanical properties of silks and other materials. Adapted from [140] 
Material 
Stiffness, Einit 
(GPa) 
Strength, 
Gmax (GPa) 
Extensibility 
ɛmax 
Toughness 
(MJ m
-3
) 
Araneus MA silk 10 1.1 0.27 160 
Araneus viscid silk 0.003 0.5 2.7 150.65 
Bombyx mori cocoon 
silk 
7 0.6 0.18 70 
Tendon collagen 1.5 0.15 0.12 7.5 
Bone 20 0.16 0.03 4 
Breast tissue  
(fat regions) 
3 – 20 x 10-6 - - - 
Breast tissue 
(fibroglanular region)  
3 – 44 x 10-6 - - - 
Kevlar 49 fiber 130 3.6 0.027 50 
High-tensile steel 200 1.5 0.008 6 
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1.5.3. Biocompatibility 
Sericins, the gum/glue-like proteins present in silk have been shown to cause decreased 
biocompatibility and increased hypersensitivity to non-purified silk. However, properly 
degummed and sterilized silk (purified silk) has good biocompatibility comparable to other 
commonly used biomaterials such as collagen [191,192]. The successful use of silk as medical 
sutures over the years has demonstrated the biocompatibility of this material [114,148,193]. 
Indeed, several studies have demonstrated minimal or no inflammation during subcutaneous 
implantation and in vivo testing of SF biomaterials for up to one year [144,149,194,195]. Despite 
these positive findings, mild pro-inflammatory cytokine production [192] and possible 
amyloidogenesis due to the presence of silk fibroin and degraded products of silk fibroin, 
respectively, have been observed [196]. Consequently, it is of great importance to extensively 
investigate the safety of SF biomaterials and their degraded products for long-term use in vivo.  
In vitro studies have demonstrated the ability of SF to support the adhesion, growth and 
function of a variety of cell types including fibroblasts, keratinocytes [143,146,197], 
mesenchymal stem cells, chondrocytes, hepatocytes [139,148], neurons, macrophages, 
endothelial cells [139,197], epithelial cells, glial cells, osteoblasts [139,197], dorsal root ganglia, 
and Schwann cells [166] without affecting their normal phenotype or functionality, suggesting 
their biocompatibility for in vitro tissue modeling. 
1.5.4. Biodegradation 
The United States Pharmacopeia defines an absorbable biomaterial as a material that “loses 
most of its tensile strength within 60 days” post implantation in vivo [191]. Since silk has 
negligible tensile strength loss in vivo it is thus classified as a non-degradable biomaterial. 
Nevertheless, silk has been shown to be biodegradable over periods of time greater than 60 days 
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[191]. The degradation rate of SF biomaterials is dependent upon several processing factors such 
as preparation of SF scaffolds using aqueous or organic solvents, concentration of SF solution, 
and pore size [144]. Through in vivo subcutaneous implantations of SF porous scaffolds in Lewis 
rats, Wang et al. [144] demonstrated that aqueous-derived SF scaffolds degraded at a faster rate 
than SF scaffolds prepared using the organic solvent 1,1,1,3,3,3 hexafluoro-2-propanol (HFIP). It 
was observed that the aqueous-derived scaffolds held their structural integrity no longer than 6 
months while remains of the HFIP-derived scaffolds were still present after 12 months. The 
increasing concentration of SF used in preparation of the scaffolds resulted in a slower 
degradation rate. Reduced tissue ingrowth and, therefore, a slower degradation rate was observed 
in scaffolds with smaller pore size. The degradation of 3D SF porous scaffolds is significantly 
affected by the activities of the host immune system [144,148]. Indeed, the resorption of these 
scaffolds was mediated by macrophages, suggesting that silk is not only biodegradable but also 
bio-resorbable [144,148].   
In vitro treatment of B. mori SF fibers and films with proteolytic enzymes (collagenase Type 
F, α-chymotrypsin Type I-S, and protease Type XXI from Streptomyces griseus) demonstrated 
that degradation of these materials was dependent upon the type of enzyme, treatment time, and 
ratio of enzyme-to-substrate [198].  Protease treatment caused a higher weight loss in SF films 
and higher loss of tensile strength in SF fibers than treatment with collagenase or α-
chymotrypsin [198]. Treatment of aqueous-derived SF electrospun scaffolds with Protease XIV 
confirmed the positive effects of this enzyme on SF degradation [195]. Although, the in vitro 
studies suggest that silk degradation is mediated by enzymatic digestion, Wang et al. [144] 
demonstrated that, in vitro, the effect of cytokines, enzymes, and other non-immune system-
related factors on the degradation of SF was moderate compared to immune system-related 
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cellular components including macrophages. The degradation rate of SF biomaterials can be 
further hindered through incorporation of proteinase inhibiting agents such as ethylenediamine 
tetraacetic acid (EDTA) [199]. Given the factors and parameters involved in SF degradation, it is 
likely that the biodegradation rate of SF biomaterials can be controlled for extended time periods 
(from weeks to years) to meet the requirements associated with the regeneration of a target tissue 
or of drug delivery systems.   
1.5.5. Binding sites 
Amino acid sequences of SF determined from cDNA sequencing of B.mori domestic 
silkworm contains a large number of basic amino acids, including arginine, in their non-
repetitive region near the C-terminus. On the other hand, the sequences of Antheraea pernyi wild 
silkworm contain not only the basic amino acids but also the tripeptide sequence arginine-
glycine-aspartic acid (RGD) [146], a recognition site for integrin-mediated cell adhesion [200-
202]. Fibroblast cell adhesion tested on both silk types demonstrated a higher cell adhesion on 
films formed by SF from A. pernyi than those from B. mori [146]. This difference in adhesion 
was attributed to the presence of the tripeptide RGD in the SF sequence from the wild 
silkworms. Minoura et al. [146] also demonstrated that removing the C-terminus region of the 
B.mori silk, which contains arginine amino acids, resulted in even less cell adhesion than 
adhesion on the non-modified B.mori silk. Thus, cell attachment onto B. mori SF biomaterial is 
likely due to alternative low-affinity cell binding domains [41] including arginine residues 
present in the non-repetitive region [139,146], and/or electrostatic interactions between cells and 
silk [41,139]. The effect of the RGD sequence on the attachment of mammalian cells to SF has 
been confirmed through various studies [41,143,171,186,203,204]. The cell attachment and early 
stages of cell-matrix interactions to B. mori SF are enhanced by modifying the SF biomaterial 
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surface through coating or chemical coupling with the integrin recognition sequence RGD or 
specific growth factors [41,143,186,203,204]. Introducing the fibronectin cell-adhesive 
sequence, RGD, onto the SF biomaterial enhanced cell attachment to this material [204,205]. 
Increased attachment and growth of endothelial cells were obtained when SF nets were coated 
with gelatin, fibronectin, or collagen type I [204]. Human bone marrow stromal cells (BMSCs) 
and human ACL fibroblasts showed increased cell attachment, spreading, and proliferation on 
RGD-modified SF matrices and silk films [41]. Moreover, human keratinocyte cell spreading, 
but not attachment, stimulated by laminin coating on SF microfibers, nanofibers, and films was 
increased [206]. Altman et al. [191] demonstrated that when SF films were decorated with RGD 
tripeptide the induction of bone formation in vitro was significantly enhanced due to increased 
integrin interaction for cell adhesion. 
1.6. Engineered Silk-based Constructs 
1.6.1. Preparations  
Prior to constructing 3D SF scaffolds B. mori silk fibroin is extracted from silk cocoons as 
described by Rockwood et al. [207]. Although the purification process used in extraction of SF 
from the B. mori silk cocoons disrupts the β-sheet crystalline domains [208], treatments with 
organic solvents such as methanol, ethanol, or alcohol, water vapor annealing, mechanical 
stretching, or ultrasonic treatments lead to conformational change and self-organization of 
random coils into natural β-sheet structures [139,142,148,171,187,193,208].  This 
conformational change in SF and the formation of polymer crystallites upon these treatments 
makes the SF insoluble in aqueous environment and therefore suitable for in vivo implantation 
and in vitro manipulation [41,192].   
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Three-dimensional silk scaffolds have been used in different forms such as; films, hydrogels, 
microspheres, tubes, sponges, and nanofibers. The processing methods for generation of these 
constructs are summarized in Table 1.4. 
Table 1.4. Preparation methods and properties of 3D SF biomaterials in various forms. 
3D Form Properties Preparation Method 
Films 
 Biocompatible 
 Water and oxygen permeable 
 Surface modification availability   
 Controlled morphological a structural features  
 Can be made patterned or non-patterned 
 Stable 
 Casting [207] 
 Layer by layer deposition [209] 
Hydrogels 
 Biocompatible 
 Injectable 
 High water content 
 Controlled gelation 
sol-gel transition of aqueous SF 
solution by: 
 Sonication [207,210,211] 
 Vortexing [207,212] 
 Presence of acids [213,214] 
 Presence of ions [213] 
 Application of direct electrical 
current [207,215]. 
Microspheres 
 Biocompatible 
 Controllable size and shape 
 Tunable drug loading 
 Tunable drug release 
 Phase separation [178,207] 
 Encapsulation in fatty acid lipid 
[177,207] 
Tubes 
 Biocompatible 
 Surface modification availability   
 Diameter variability 
 Surface can be texturized 
 Can be made porous if needed 
 Dip method [174,207] 
 Gel-spun method [207,216] 
Sponges 
 Biocompatible 
 Porous structure 
 Controlled porosity 
 High strength 
 Surface modification availability 
 Mimic the in vivo physiological micro 
environment  
 High strength 
 Rough and hydrophilic surfaces 
 Salt leaching [207,217] 
 Gas foaming [217] 
 Use of organic solvents [218] 
 Freeze-drying [217] 
Nanofibers 
 Biocompatible 
 Nano/micro fibrous structure  
 Controlled fiber size 
 Porous structure 
 Controlled porosity 
 High strength 
 Surface modification availability 
 Mimic the in vivo physiological micro 
environment  
 High strength and structural stability 
 Electrospinning [58,141,188] 
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1.6.2. Nanofibrous SF Scaffolds 
The nano-fibrous structures within the ECM, mainly composed of structural proteins 
collagens types I, II, and III have diameters varying from 50 to 500 nm. These nano-fibrous 
structures provide the cells with the appropriate biological environment for embryologic 
development, organogenesis, cell growth, and wound repair [115,219,220]. These nanofibers are 
one to two orders of magnitude smaller than the cells allowing cell interaction with multiple 
fibers simultaneously and maintaining a 3D orientation [221]. This organization of the ECM in 
the form of nanofibers provides steady anchorage to cells, through integrin binding, and also 
activates intracellular signaling pathways affecting almost all aspects of cell behavior [222]. 
 Recent advances in nanotechnology have led to a variety of approaches for the development 
of engineered scaffolds to create biomimetic ECM analogues [10,220]. More recently, the 
electrospinning process, a unique and versatile technique, enabled the development of nanofiber-
based biomaterial scaffolds. The electrospinning technique is simple, efficient, inexpensive, and 
can be scaled-up for large-scale production [141,142]. With this technique a diverse set of 
polymers can be used to produce fibers from a few micrometers down to the tens of nanometers 
in diameter [131,141,142,223]. The generated scaffolds are useful for tissue engineering and 
regenerative medicine in part due to the similarity of the nanoscale properties of fibrous 
components to the native ECM [8,142,171]. Electrospinning offers the ability to tailor and 
control several aspects of ECM-like scaffolds such as the thickness and composition of 
nanofibers as well as fiber diameters and porosity [8,141,224,225].  The high surface area and 
porosity of electrospun nanofiber scaffolds allow favorable cell interactions [8]. The similarity of 
their 3D structure to natural ECM provides an excellent micro/nano environment for cell growth 
and natural function [8,171]. Further, electrospinning allows for the incorporation of growth 
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factors into the electrospun matrix for improved culture conditions [23]. As a result, electrospun 
nanofibrous structures have been extensively investigated as scaffolds for tissue engineering 
applications [8]. Table 1.5 summarizes the investigations of nanofibrous electrospun scaffolds in 
tissue engineering applications.  
 
Table 1.5. Nanofibrous electrospun scaffolds and their tissue-engineering applications.   
Target Tissue Material References 
Bone 
 Regenerated SF 
 PCL 
[23,226-228] 
[21,229] 
Bladder 
 Fibrinogen 
 PCL and its composites 
[230] 
[231] 
Cardiac tissue 
 Chitosan 
 Gelatin and its composites 
[232] 
[233] 
Cartilage 
 Regenerated SF 
 PCL 
[234] 
[39] 
Mammary gland  Regenerated SF [58] 
Nerve 
 PCL and its composites 
 Gelatin and its composites 
 Chitosan 
 PLLA 
[235,236] 
[235] 
[237] 
[238,239] 
Skin tissue / Wound healing 
 Collagen and its composites 
 PCL and its composites 
 Gelatin and its composites 
 Regenerated SF 
 poly(lactic acid-co-glycolic acid) (PLAGA) 
 Polyurethane (PU) 
[65,240] 
[65,241] 
[241,242] 
[171,243] 
[67] 
[244] 
Vascular grafts 
 Regenerated SF 
 Collagen and its composites 
 PCL and its composites 
 Elastin and its composites 
 Gelatin and its composites 
 PLGA and its composites 
[78,173] 
[119,245-251] 
[119,246-248] 
[117,249-253] 
[117] 
[117] 
 
1.7. Conclusion and Rationale 
Tissue engineering provides the medical field with approaches/tools to generate improved in 
vitro 3D culture models mimicking the physiological microenvironment of various biological 
tissues including normal and diseased breast tissues. Additionally, those approaches are also 
focused towards the goal of tissue and organ regeneration as an alternative to autologous and 
allogeneic tissue repairs. One of the major challenges of tissue engineering i.e., mimicking the 
nano-structures of ECM can be approached using electrospun nanofibrous polymeric scaffolds. 
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Data available underline the potential of nanofiber-based scaffolds for a variety of tissue 
engineering applications and their mimicry of ECM properties. In particular, SF-based 
electrospun nanofibrous scaffolds have led to the regeneration of biocompatible tissue culture 
conditions. SF is an attractive polymeric biomaterial for design, engineering, and processing into 
scaffolds for applications in controlled drug delivery, tissue repair and functional tissue 
engineering as highlighted by its successful applications.  
Engineered 3D models of mammary tissue have been great tools for studying breast 
development and cancer initiation over the past three decades. Based on these studies, the 
importance of physical and chemical characteristics of the ECM, cell-cell, and cell-ECM 
interactions in the function and organization of the breast tissue have been highlighted. Although 
these 3D models have contributed tremendously to our knowledge of physiological activities in 
the normal or diseased mammary tissue, they can be improved upon to more accurately mimic 
not only the chemical characteristics of the biological tissue but also the physical environment  to 
increase their appropriateness for in vivo testing and as potential implants.     
SF nonofibrous scaffolds hold promise in developing appropriate 3D breast models and 
potential implants. Although the use of SF in modeling of mammary tissues is recent, proper 
physical and chemical SF nanofibrous scaffold modifications along with the incorporation of 
stromal cells likely will favor the development of functional mammary models as well as 
resorbable breast implants.     
Our overall rationale for developing 3D breast models using laminin coated SF electrospun 
scaffolds is that constructing a 3D breast model system through the use of tissue engineered 
biocompatible nanofibrous scaffolds may prove to be more beneficial to the understanding of 
cancer development and the regeneration of a functional breast tissue than the current models 
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due to its structural properties closely mimicking the breast tissue ECM and the potential to 
allow direct control of the microenvironment at multiple levels and scales. Silk, which exhibits 
excellent biocompatibility and slow degradability will generate a tissue-engineered scaffold with 
great potential for use in breast tissue engineering. The formation of electrospun SF scaffolds 
composed of nanofibers will exhibit a structure similar to that of the ECM. The similarities 
between such a structure and the microenvironment of the breast tissue likely will result in cell-
matrix interactions that are similar to those observed between cells and the ECM in vivo.  The 
slow degradation time and excellent mechanical properties of SF will provide a stable structure 
for MCF10A cell attachment and survival. Air-flow electrospinning of SF scaffolds will result in 
formation of large pores resulting in MCF10A cell adhesion, survival, and infiltration. In 
addition to this structural support, MCF10A cells require integrin-mediated interactions with 
ECM protein laminin to organize into polarized growth-arrested structures that are resistant to 
apoptosis. Therefore, the coating of the nanofibers with the ECM protein laminin will enhance 
initial cell attachment and will promote MCF10A cell differentiation and structure formation.  
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CHAPTER 2: PHYSICAL PROPERTIES AND MAMMARY EPITHELIAL 
BIOCOMPATIBILITY OF SILK FIBROIN ELECTROSPUN NANOFIBER 
SCAFFOLDS 
 
2.1. Abstract 
In the present study, the effects of various silk fibroin (SF) concentrations used in the 
generation of electrospun fiber scaffolds were investigated. First, the physical and mechanical 
properties of scaffolds obtained from 7%, 12%, and 17% silk concentrations were defined. In 
addition, attachment and viability of MCF10A mammary epithelial cells cultured onto these 
scaffolds were used to assess the biological suitability of these nanostructures. Results indicate 
that both fiber diameters and pore sizes significantly increased as SF concentration increased. 
The largest fibers (5.4 ± 0.22 µm) and pores (12.96 ± 0.87 µm) were formed following the 
electrospining of 17% SF. Scaffolds with the largest fiber diameters exhibited the smallest 
specific surface areas. The average specific surface area (SSA) for 7, 12, and 17% scaffolds was 
2.54 ± 0.04, 0.90 ± 0.04, and 0.64 ± 0.02 µm
2
, respectively. Additionally, following a 2-hour 
incubation, the highest cell attachment (66 ± 7%) was observed on 7% SF electrospun scaffolds. 
MCF10A cell attachment on 7% scaffolds was significantly higher than MCF10A cell 
attachment on two-dimensional (2D) SF-coated cell culture vessels.  MCF10A cell viability 
measured after 14 days in culture was similar on all electrospun scaffolds. In contrast, 
significantly higher MCF10A cell numbers were recorded in 2D SF-coated cell culture vessels. 
Taken together, these results highlight the biocompatibility of SF-based electrospun nanofiber 
scaffolds supporting MCF10A cell attachment and survival. 
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2.2. Introduction 
Breast cancer involves complex set of interactions between mammary epithelial cells and the 
stroma, both extracellular matrix (ECM) and cells including adipocytes (fat cells) and fibroblasts 
(an abundant stromal cell within the connective tissue) [125]. Tools allowing modeling of the 
biological tissue including mammary tissue under physiological and pathophysiological 
conditions in vitro are becoming essential to better understand cancer initiation and progression 
[10]. The engineering of in vitro three-dimensional (3D) systems of mammary gland potentially 
allows a deeper understanding of the complex cell-cell and cell-ECM interactions involved 
during breast tissue development and cancer initiation and progression [10,107,254]. 
Furthermore, such 3D systems may provide a viable alternative for the investigation and testing 
of new drug or drug regimen [10]. The 3D engineered models of breast tissue also allow detailed 
monitoring of multiple concurrent cellular processes involved in tumor growth and invasion [12].  
Suitable 3D in vitro mammary tissue models must have features of the native tissue 
microenvironment and ideally mimic the function and structure of the breast tissue [254]. The 
recent progress in tissue engineering support a tailored control of the microenvironment 
properties currently not possible using ECM based 3D approaches [10]. Within tissue 
engineering, electrospun nanofiber scaffolds in particular hold those promises. Electrospinning is 
a simple, efficient, and inexpensive technique that can be scaled-up for large-scale production 
[141,142]. Electrospinning allows the formation of fibers with diameters from a few micrometers 
to the tens of nanometers [131,141,142,223]. Non-woven nanofiber scaffolds electrospun from 
natural or synthetic polymers have been and are considered in tissue engineering and 
regenerative medicine in part because they have nanoscale properties similar to those of the 
fibrous components of biological ECM [131,142].  
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The potential of SF-based biomaterials in different forms, in particular, in the form of 
electrospun nanofibers in various tissue regeneration and repair applications has been 
investigated [142]. SF-based biomaterials offer significant advantages for tissue engineering 
applications due to their excellent mechanical properties, controllable biodegradability, 
hemostatic properties, low antigenicity and non-inflammatory characteristics [142,145], high 
oxygen permeability, high drug permeability, and resistance against enzymatic cleavage [146]. 
Non-woven micro-fibrous silk nets supported the adhesion and proliferation of a variety of 
human cell types including epithelial cells, endothelial cells, glial cells, osteoblasts, keratinocytes 
and fibroblasts [143,146,197]. Altman et al. [191] demonstrated that fibroin films induced bone 
tissue growth in vitro when seeded with osteoblasts. Moreover, 3D highly porous silk scaffolds 
seeded with chondrocytes supported cartilage tissue engineering and were suitable for 
osteogenesis and chondrogenesis of human bone marrow stem cells (hMSCs) [34].  Human 
adipose-derived stem cells have been grown on aqueous and HFIP-based porous silk sponges 
and chitosan/silk fibroin films for bone, adipose tissue engineering, and nerve regeneration 
applications [150,168,255].  
The negligible tensile strength loss of SF-based scaffolds in vivo may be appropriate for the 
generation of long-term in vitro 3D mammary cell culture models and potentially in vivo 
implants [55].  
In the present study we investigate the effects of increasing SF concentrations from 7% to 
17% on the properties of the nanofibers generated through electrospinning and evaluate the 
attachment and survival of MCF10A human mammary epithelial cells.  
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2.3. Materials & Methods 
2.3.1. Silk Extraction 
Bombyx mori SF was extracted from silk cocoons (Bombyx mori silk cocoons, B quality, The 
Yarn Tree, Asheville, NC) as described by Rockwood et al. [207]. Briefly, after discarding the 
silk worms, 5 grams of cocoons were cut and boiled for 30 minutes in 2 liters of 0.02M Na2CO3 
(Sigma, Saint Louis, MO, USA) aqueous solution then rinsed 3 times (20 minutes each) in 
deionized (DI) water to remove the sericins. Silk fibers were left to dry overnight then dissolved 
in 9.3M LiBr (Fisher Scientific, Fair Lawn, NJ, USA), 12% (w/v), overnight (in 60ºC for the first 
4 hours). Silk solution was then dialyzed against DI water for 48 hours using 3500 MWCO 
dialysis tubes (Fisher Scientific) with repeated water changes after 1, 4, 6, 12, 12, and 12 hours. 
The regenerated dry SF sponge was collected by freezing extracted SF solution in -80°C 
followed by lyophilization (SP Scientific, Gardiner, NY, USA). 
2.3.2. Electrospinning 
The electrospinning techniques described by Barnes et al. [220] on a 6 mm in diameter solid 
stainless steel mandrel (Beverlin Manufacturing Company, Grand Rapids, MI, USA) was used.   
Extracted SF was dissolved in 1,1,1,3,3,3 hexafluoro-2-propanol (HFIP) (TCI America, Portland, 
OR, USA) at concentrations of 7, 12, and 17%. The SF solutions were loaded into 3 ml Becton 
Dickinson syringes with an 18 gauge blunt tip needle. The needle was subjected to +25 kV with 
an air-gap distance of 13 cm between the needle and the mandrel. A volume of 1.8 to 2 ml of the 
SF solution was dispensed at a rate of 5ml/h and electrospun on the target mandrel [58].   
2.3.3. Scaffold Characterization 
Scanning Electron Microscopy (SEM) was performed using a JEOL LV-5610 SEM (JEOL 
Ltd., Tokyo, Japan). Average fiber diameter and pore size of the electrospun structures were 
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measured using 100 random locations on each SEM image using ImageTool 3.0 software 
(Shareware provided by UTHSCSA, San Antonio, TX, USA). 
2.3.4. Specific Surface Area Evaluations 
Statistical fiber diameter distributions in the electrospun scaffolds were determined based on 
the frequency distribution. Scaffold specific surface area (SSA) was evaluated as described 
earlier using the following equation: 
Specific surface area = 
                  
            
 = 
  ∑      
 
   
∑   
  
      
  
Where D is fiber diameter, f is frequency of fiber distribution, and n is the fiber number counted 
[256]. 
2.3.5. Mechanical Testing 
Uniaxial tensile testing was performed on three sets of ‘dog bone’ shape scaffold samples 
(2.75 mm wide at their narrowest point with a gage length of 11 mm) for each silk concentration 
[257]. Two sets of the scaffold samples were soaked in 99.98% ethyl alcohol (PHARMCO-
AAPER) for 1 hour followed by three 10-minute washes in Phosphate-Buffered Saline (PBS) 
(Cellgro, Manassas, VA, USA). One set of the scaffolds per each SF concentration were seeded 
with 40×10
3
 immortalized human mammary epithelial cells, MCF10A (ATCC, Manassas, VA, 
USA) per ‘dog bone’ and maintained in culture for 15 days (noted as “Hydrated With Cells” in 
the results section). A second set (non-cellularized) remained in culture media for 14 days (noted 
as “Hydrated No Cells” in the results section). The third set was soaked in 99.98% ethyl alcohol 
for 1 hour followed by three 10-minute washes in PBS immediately before uniaxial tensile 
testing (noted as “Hydrated in PBS” in the results section).  
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2.3.6. Cell Cultures 
Electrospun scaffolds were disinfected through soaking in 99.98% ethyl alcohol for 1 hour 
followed by three 10-minute washes in PBS. Immortalized human mammary epithelial cells, 
MCF10A were seeded at 40×10
3 
cells per 10-mm diameter biopsy punches of electrospun SF 
scaffolds and maintained for up to 14 days at 37
°
C and 5% CO2. MCF10A cells were cultured in 
growth media containing DMEM/F12 supplemented with 5% horse serum (both from Invitrogen, 
Carlsbad, CA, USA), 1% Penicillin (10,000 units/ml) and Streptomycin (10,000 g/ml) 
(Cellgro), 20 ng/ml Epidermal Growth Factor (EGF) (BD Biosciences, San Jose, CA), 0.5 g/ml 
Hydrocortisone, 100 ng/ml Cholera Toxin, and 10 g/ml Insulin (all from Sigma) [51]. Half of 
the media volume was changed every 2 days. 
2.3.7. Cell Attachment Analyses 
Tissue culture well-plates were coated with 7.5% poly(2-hydrohyethyl methacrylate) 
(PHEMA) (Sigma) to prevent cells from attaching to cell culture plastic [258,259]. Ten-
millimeter SF scaffold disks were disinfected through soaking in 99.98% ethyl alcohol for 1 hour 
followed by three 10-minute washes in PBS. Control 2D SF-coated cell culture vessels were 
prepared through vessel coating with SF (40 mg/ml). To reduce the adhesion of serum proteins, 
both scaffolds and control 2D SF-coated cell culture vessels were coated with 1% bovine serum 
albumin (BSA) (Gemini Bio-Products, West Sacramento, CA) solution for 30 minutes, followed 
by three 5-minute washes in PBS. One 10 mm diameter disinfected and BSA-coated SF scaffold 
disk was used per well. MCF10A cells (4×10
4 
cells / scaffold) were seeded on these scaffold 
disks and the control 2D SF-coated cell culture vessels and incubated for 40 minutes before 
addition of further media to allow for better cell attachment. After 1 or 2 hours in culture the 
plates were gently shaken, each scaffold was taken out and dipped 5 times in a media-containing 
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well to wash off the non-attached cells. The number of non-attached cells suspended in each well 
was counted. The percentage of attached cells on each scaffold disk was calculated based on the 
number of non-attached cells.   
2.3.8. Cell Viability Analyses 
MCF10A cells (1×10
4 
cells / scaffold) were seeded on 6-mm diameter disinfected scaffold 
disks and SF coated cell culture vessels. Cell viability was assessed on day 14 using colorimetric 
MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt] assays (CellTiter 96 ® Aqueous Non-Radioactive Cell Proliferation 
Assay, Promega, Madison, WI, USA), as described by the manufacturer. The metabolically 
active cells react with a tetrazolium salt in the MTS reagent to produce a soluble formazan dye 
with an absorption that can be measured at 490 nm. Numbers of cells per each condition were 
calculated based on standard curves and normalized to the percentages of attached cells.  
2.3.9. Statistical Analysis 
All parameters are expressed as mean ± standard error of the mean (SEM). One-way analysis 
of variance (ANOVA) followed by the post-hoc Dunnett’s Multiple Comparison Test were used 
to assess differences in fiber diameter, pore size, SSA, cell attachment, and cell viability between 
the electrospun scaffolds at different SF concentrations. Two-way ANOVA followed by the 
Benferroni’s Multiple Comparison Test was used to assess the differences in elastic moduli 
between the electrospun scaffolds at different SF concentrations. A priori, p values below 0.05 
were defined as significant.   
 
 
Figure 2. Fiber diameter 
measurements. *, ^, and 
+ indicate a significant 
difference from 50, 300,  
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2.4. Results 
2.4.1. Physical and Mechanical Characteristics of Electrospun SF Scaffolds  
Electrospun scaffolds generated from three SF concentrations of 7, 12, and 17% were 
characterized based on SEM microphotographs (Table 2.1). Both fiber diameters and pore sizes 
of the electrospun SF scaffolds were measured and characterized on a sample of randomly 
selected fibers (Figures 2.1A and 2.1B, respectively). 
Using a higher SF concentration in the generation of SF derived electrospun scaffolds lead 
to scaffolds with increased fiber diameters and pore sizes. The increase in fiber diameters and 
pore sizes was significantly correlated with an increase in SF concentrations (r
2 
= 0.9997, p < 
0.05 and r
2 
= 0.9966, p < 0.05, respectively, Figure 2.1A and B).  
Table 2.1. Scanning electron micrographs of scaffolds derived from 7%, 12%, and 17% SF electrospun 
using a solid mandrel. 
SF 
Concentration 
Scanning Electron Microscopy 
Microphotgraphs 
Average Fiber Diameter 
± SEM (µm) 
Average Pore Size ± 
SEM (µm) 
7% 
 
1.19 ± 0.06 3.2 ± 0.13 
12% 
 
3.36 ± 0.19 8.57 ± 0.41 
17% 
 
5.40 ± 0.22 12.96 ± 0.87 
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Scaffolds electrospun using 7% SF concentration resulted in the formation of significantly 
smaller fiber diameters and pore sizes than scaffolds electrospun using 12 and 17% SF 
concentrations (fiber diameter = 1.19 ± 0.06 and pore size = 3.2 ± 0.13 µm, p < 0.001). The 
average scaffold fiber diameter and pore size generated following electrospinning of 12% SF 
were significantly smaller than the fiber diameter and pore size of scaffolds generated by 
electrospinning of 17% SF (p < 0.001).  
                     
Figure 2.1. Diameter and pore size in SF derived electrospun scaffolds. A) Fiber diameter. *** 
indicates a significant difference from 7% SF (p<0.001). # indicates a significant difference from 12% SF 
(p<0.001). B) Pore size. *** indicates a significant difference from 7% SF (p<0.001). # indicates a 
significant difference from 12% SF (p<0.001).   
 
 
To account for scaffold geometry, the SSAs of electrospun scaffolds derived from SF were 
calculated. Scaffolds derived from 7% SF concentration exhibited the highest SSA (2.54 ± 0.04 
µm
-1
, Figure 2.2). This area was significantly higher than the SSA of the scaffolds derived from 
12 and 17% SF (p < 0.001). Similarly the SSA of 12% SF derived scaffolds was significantly 
higher than SSA of 17% SF derived scaffolds (p < 0.01).   
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Figure 2.2. Specific surface area (SSA in µm
-1
) of electrospun SF-derived scaffolds. *** indicates 
significantly higher SSA in 7% SF derived scaffolds than 12 and 17% scaffolds (p < 0.001). ** indicates 
significant difference between 12% and 17% SF derived scaffolds (p < 0.01). 
 
 
2.4.2. Mechanical Strength of SF-derived Electrospun Scaffolds  
The uniaxial tensile modulus of each scaffold hydrated with either PBS (HPBS), culture 
media no cells (HNC), or culture media with cells (HWC) was determined. Scaffold moduli were 
not different between the different hydration conditions tested (n.s., Figure 2.3). Moreover, no 
significant difference was observed in the elastic modulus of PBS-hydrated electrospun SF 
scaffolds generated using 7, 12, and 17% SF (n.s., Figure 2.3). Similarly, after an incubation in 
culture media alone (HNC) or with cells (HWC) for 14 days (37°C, humidity >90%), the elastic 
moduli of scaffolds derived from 7, 12, and 17% SF were not significantly different (Figure 2.3).  
    
Figure 2.3. Modulus of elasticity of 7, 12, and 17% SF-derived electrospun scaffolds. No significant 
differences in the elastic moduli of the SF electrospun scaffolds. 
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2.4.3. MCF10A Cell Attachment and Viability on Electrospun SF Scaffolds  
MCF10A cell attachment and viability were tested on electrospun SF scaffolds generated 
using 7, 12, or 17% SF and compared to cultures maintained on control 2D SF-coated culture 
vessels. After 1 hour in culture, 43 ± 7%, 25 ± 7%, and 32 ± 6% of the seeded MCF10A cells 
attached to different scaffolds derived from 7, 12, or 17% SF, respectively. After 2 hours in 
culture, MCF10A cell adhesion onto scaffolds generated using 7, 12, and 17% electrospun SF 
increased to 66 ± 7%, 46 ± 5%, and 51 ± 5%, respectively (Figure 2.4A and B). Following a 1- 
or 2-hour incubation, MCF10A cell attachment was not significantly different amongst the 
electrospun SF scaffolds tested (n.s. Figure 2.4A and B). No correlation between MCF10A cell 
adhesion and fiber diameter or pore size was observed (r
2 
= 0.5371, p > 0.05 and r
2 
= 0.5772, p > 
0.05, respectively, Figure 2.4A and B). Similarly, MCF10A cell adhesion was not significantly 
correlated with the SSAs of the scaffolds tested (r
2 
= 0.9304, p > 0.05, Figure 2.4A and B). 
    
Figure 2.4. MCF10A cell attachment onto 7, 12, and 17% SF-derived electrospun scaffolds 
compared to attachment on control SF coated culture vessels (SCP). A) After 1 hour. No significant 
differences in cell adhesion between 3D and 2D cultures. B) After 2 hours. ** indicates significant 
difference from adhesion on 2D cultures (p < 0.01). 
 
MCF10A cell attachment on 3D electrospun SF-derived scaffolds was similar to MCF10A 
cell attachment to control 2D SF coated cell culture vessels after a 1-hour incubation (n.s. Figure 
2.4A). Following a 2-hours incubation MCF10A cell attachment on 7% SF derived electrospun 
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scaffolds was significantly higher than MCF10A attachment on control SF coated culture vessels 
(p < 0.01, Figure 2.4B).  
After 14 days in culture, numbers of viable MCF10A cells growing onto 7, 12, and 17% SF 
derived electrospun scaffolds were not significantly different (n.s., Figure 2.5). However, the 
numbers of viable MCF10A onto these SF derived scaffolds were significantly lower than the 
number of cells determined in the control 2D SF coated culture vessels (p < 0.001, Figure 2.5), 
Cell viability was not correlated with either fiber diameters, pore sizes, or SSAs of the scaffolds 
(r
2 
= 0.9645, p > 0.05, r
2 
= 0.5577, p > 0.05, and r
2 
= 0.9173, respectively, Figure 2.5).  
   
Figure 2.5. MCF10A cell viability after 14 days in culture. *** indicates significantly lower MCF10A 
cell numbers on 7, 12, and 17% SF derived scaffolds compared to SCP (p < 0.001).  
 
2.5. Discussion 
Breast cancer initiation and progression involves a complex set of interactions between 
mammary epithelial cells and the stromal components including the ECM [125]. The engineering 
of appropriate in vitro mammary epithelial cell models will allow a deeper understanding of the 
complex effects of mammary stroma during breast cancer initiation, progression, and could also 
serve in the development and testing of new drugs [12]. Thus, here we investigated the physical 
and mechanical characteristics of SF electrospun scaffolds at 7, 12, and 17% SF concentrations. 
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The mechanical integrity of the SF scaffolds was tested by incubation in culture media with or 
without cells for 14 days. Biocompatibility of these scaffolds was evaluated through assessment 
of MCF10A cell adhesion and viability.  Our results indicate that although the increasing SF 
concentration led to significant changes in physical properties of the electrospun scaffolds, the 
tensile strength of these scaffolds remained similar. Furthermore, MCF10A cell viability and 
adhesion on these electrospun scaffolds confirmed their biocompatibility. 
As demonstrated with other polymers [220,251,260], our results indicate a linear relationship 
between SF solution concentrations, fiber diameters and pore sizes of SF-derived electrospun 
scaffolds. Specifically, fiber diameters and pore sizes significantly increased as the concentration 
of electrospun SF increased. Indeed, scaffolds generated using electrospun 17% SF had 
significantly larger pore sizes and fiber diameters than scaffolds derived from 12 and 7% SF. 
Furthermore, scaffolds derived from 12% SF had significantly larger pores and fibers than 
scaffolds generated from 7% SF. These results agree with previously demonstrated increases in 
fiber diameter observed when Poly(ethylene oxide) (PEO), Poly(glycolic acid) (PGA), 
Polydioxanone (PDO), or collagen type I were electrospun at higher polymer concentrations 
[220,225].  
Our results also indicate that the scaffolds with smaller fiber diameters exhibited higher 
SSAs. Significantly higher SSAs were recorded in 7% SF derived electrospun scaffolds 
compared to either 12 or 17% SF derived electrospun scaffolds. Moreover, 12% SF scaffolds had 
significantly higher SSAs than 17% SF derived scaffolds. Our data concur with findings by Chen 
et al. [256] that electrospun poly(ε -caprolactone) (PCL) scaffolds with nanometer to micrometer 
fiber diameters demonstrated higher SSAs for scaffolds with smaller fiber diameters.     
 42 
Furthermore, our data demonstrates that there is no significant difference in the elastic 
moduli of the 7, 12, and 17% SF derived electrospun scaffolds when hydrated in PBS. These 
results demonstrate that although higher elastic modulus should be seen due to larger fibers at 
higher concentration of SF, the presence of larger pores within these scaffolds counter balance 
the effects of large fibers, therefore, resulting in no change in the elastic moduli of these 
electrospun scaffolds. These observations and the fact that regardless of hydration condition, the 
electrospun SF-derived scaffolds retained their mechanical strength (after 14 days) underline the 
resilience of the silk mechanical properties essential to form a scaffold for tissue regeneration 
[42,142,186,191]. Our results also are in line with the unchanged mechanical properties of cell-
seeded poly (ε-caprolactone) (PCL) electrospun scaffolds compared with acellular scaffolds 
measured after three weeks in culture [261].  
Non-woven micro-fibrous silk scaffolds have been shown to support the adhesion and 
proliferation of a variety of human cell types including epithelial cells, endothelial cells, glial 
cells, osteoblasts [197], keratinocytes and fibroblasts [143,197].  Our data indicates that SF 
derived scaffolds also provided support for MCF10A cell attachment. Although MCF10A cell 
attachments onto electrospun SF derived scaffolds all with SSAs below 7 µm
-1
 were not 
significantly different, our results mimicked observations by Chen et al. [256] that although 
scaffolds with higher SSA promoted higher cell attachment, within SSA below 7.13 µm
-1
, cell 
attachment remained unchanged.  As shown by Chehroudi et al. [262], our data comparing the 
adhesion of mammary epithelial cells to the fibrous scaffolds to their adhesion to the 2D SF-
coated tissue culture vessels also demonstrated that epithelial cell attachment was higher onto 
grooved textured surfaces than flat smooth surfaces. 
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Although the numbers of viable cells on electrospun SF derived scaffolds were significantly 
lower in comparison to 2D cultures maintained on SF coated cell culture vessels, MCF10A cell 
viability amongst 7, 12, and 17% SF derived scaffolds were similar. This observation is 
comparable to observations by Xu et al. [263] of higher smooth muscle cell proliferation on 2D 
tissue culture vessels than on poly(l-lactid-co-ɛ-caprolactone) [P(LLA-CL)] nanofiber scaffolds.   
2.6. Conclusion 
Taken together the observations presented here suggest that electrospinning of SF leads to 
the formation of scaffolds with biocompatible properties. Moreover, the MCF10A cell 
attachment and viability on SF derived electrospun scaffolds detailed here suggest that this 
biomaterial will support human mammary epithelial cells and has the potential to be used in 3D 
modeling of the mammary tissue. The results specifically demonstrate that the ECM-like, porous 
nanofiber structure of electrospun SF scaffolds promoted MCF10A cell attachment. The low cell 
proliferation on these scaffolds is a feature that is essential in 3D modeling of breast tissue as 
mammary epithelial cells have low proliferation levels as they form growth-arrested 
differentiated structures. In further work, the generation of mammary epithelial structures will 
require the identification and addition of specific chemical cues to improve nanofiber electrospun 
SF scaffolds based mammary tissues.  
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CHAPTER 3: EFFECTS OF AIR-FLOW ELECTROSPINNING ON 
PHYSICAL, MECHANICAL, AND BIOCOMPATIBILITY OF 
ELECTROSPUN SILK-BASED SCAFFOLDS 
 
Preface: The following manuscript has been published in the Journal of Tissue Engineering and 
Regenerative Medicine, 2013. The included work investigates the potential for incorporation of 
highly porous regions within silk fibroin electrospun scaffolds to enhance cellular infiltration 
and scaffold bioactivity through cellular adhesion and survival. 
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3.1. Abstract 
In the present study, the effects of air-flow impedance electrospinning and air-flow rates on 
silk-based scaffolds for biological tissues were investigated. First, the properties of scaffolds 
obtained from 7% and 12% silk concentrations were defined. In addition, cell infiltration and 
viability of MCF-10A breast epithelial cells cultured onto these scaffolds were used to determine 
the biological suitability of these nanostructures. Air-flow impedance electrospun scaffolds 
resulted in an overall higher pore size than scaffolds electrospun on a solid mandrel with the 
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largest pores in 7% silk electrospun with an air pressure of 100 kPa and in 12% silk electrospun 
with an air-pressure of 400 kPa (13.4 ± 0.67 and 26.03 ± 1.19 µm, respectively). After 14 days in 
culture, the deepest MCF-10A cell infiltration (36.58 ± 2.28 µm) was observed into 7% silk air-
flow impedance electrospun scaffolds subjected to an air pressure of 100 kPa. In those scaffolds 
MCF-10A cell viability was also highest after 14 days in culture. Taken together these results 
strongly support the use of 7% silk-based scaffolds electrosun with a 100 kPa air-flow as the 
most suitable microenvironment for MCF-10A infiltration and viability. 
Keywords: Breast tissue engineering; Epithelial cells; Electrospinning; Porosity; Scaffold; Silk.  
3.2. Introduction 
Development of an appropriate in vitro breast epithelial cell model and a functional in vitro 
breast tissue depends on the ability to recreate the native tissue microenvironment. A suitable 
three dimensional (3D) in vitro microenvironment must account for the natural function and 
structure of the breast tissue. Indeed, the breast tissue extracellular matrix (ECM) plays an 
important role in the control of luminal epithelial cell gene expression and the induction and 
maintenance of their tissue specific function [254], and is crucial for proper patterning and 
function of the normal mammary gland [125]. The dominant components of the ECM are 
structural proteins: collagen, elastin, and reticular fibers. These proteins are synthesized as 
peptide monomers, which form polymers after covalent crosslinking. These polymers self-
assemble to form fibrils, which then organize into fibers. These fibrous structures have diameters 
on the nanometer or submicrometer scales varying from 50 to 500 nm [115,219]. The structural 
ECM proteins are one to two orders of magnitude smaller than the cells, allowing cell interaction 
with multiple fibers simultaneously and maintaining a 3D orientation [221]. This organization of 
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the ECM in the form of nanofibers provides steady anchorage to cells, through integrin bindings, 
and activates intracellular signaling pathways affecting almost all aspects of cell behavior [222]. 
Within the past three decades multiple approaches have been used to develop in vitro 3D 
mammary gland models. Most of these 3D models use gel scaffolds, such as Matrigel
® 
(BD 
Biosciences, San Jose, CA), collagen, or aqueous-derived porous silk scaffolds to mimic breast 
tissue micoenvironment [50,51,54,56,83,122,125-127,185,186]. However, these gel scaffolds 
have different geometrical, mechanical, and physico-chemical properties from those of breast 
tissue ECM [131]. Furthermore, these scaffolds can contain residual growth factors and other 
unquantified substances, rendering their use challenging [264]. Nanofibers from natural or 
synthetic polymers electrospun into non-woven scaffolds have also been used to engineer ECM-
like structures that closely resemble the microenvironments of various tissues, including breast 
[131]. Because they allow more control and further definition of the microenvironment 
parameters, nanofibers may lead to replicable in vitro 3D breast-like tissues that would be 
extremely useful tools to further our understanding of breast and other gland biology [10].  
Porosity is a key parameter in the engineering of scaffolds for biomedical tissues and a 
highly porous scaffold is critical to control tissue formation in 3D [115]. To improve electrospun 
non-woven nanostructures, McClure et al. (2012) have introduced an air-flow impedance 
electrospinning technique, leading to the formation of nanofiber scaffolds that demonstrate 
higher porosity and greater cell infiltration without loss of mechanical property and structural 
integrity [221].     
Natural biodegradable polymers such as collagen, gelatin, chitosan and silk fibroin (SF) have 
promising advantages over synthetic polymers because of their biocompatibility, 
biodegradability, bioresorbability [145], and high affinity for cell attachment [146]. Among these 
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natural polymers, silk-based biomaterials offer significant advantages for tissue engineering 
applications. They possess excellent mechanical properties, controllable biodegradability, 
hemostatic properties, low antigenicity and non-inflammatory characteristics [145], high oxygen 
permeability, high drug permeability, and resistance against enzymatic cleavage [146]. 
Naturally, silk consists of two types of proteins: a filament core protein, SF, and a glue-like 
coating family of hydrophilic proteins holding two fibroin fibers together, the sericins [143,145]. 
Sericins have been shown to decrease biocompatibility and increase hypersensitivity to silk 
[191]. However, when sericins are removed from silk, the biocompatibility of SF was 
comparable to other biomaterials [191]. Silk fibroin has been used as a biomaterial in various 
forms such as films [143,145], membranes [143,145], gels [145], sponges [143,145], powders, 
scaffolds [145], fibers, nets, meshes, and yarn [143]. Native Bombyx mori SF proteins do not 
contain arginine-glycine-aspartic acid (RGD) tripeptide binding domains associated with cell 
attachment [41]. Therefore, cell attachment on this biomaterial most likely results from 
alternative low-affinity cell binding domains [41] such as arginine residues present in the non-
repetitive region near the carboxy-terminus [146], or electrostatic interactions between cells and 
silk [41]. Regardless of the scaffold type, B. mori SF supports the adhesion, growth and 
functions of a variety of cell types including fibroblasts, keratinocytes, mesenchymal stem cells, 
chondrocytes, hepatocytes, osteoblasts, neurons, macrophages, and endothelial cells [139,148]. 
Further non-woven micro-fibrous silk nets supported the adhesion and proliferation of a variety 
of human cell types including epithelial cells, endothelial cells, glial cells, osteoblasts, 
keratinocytes and fibroblasts [143,146,197]. Human adipose-derived stem cells have been grown 
on aqueous and 1,1,1,3,3,3 hexafluoro-2-propanol (HFIP)-based porous silk sponges and 
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chitosan/SF films for bone, adipose tissue engineering, and nerve regeneration applications 
[150,168,255].  
Silk fibroin is the major component of a large subset of non-bioabsorbable biomedical 
sutures. The United States Pharmacopeia defines a biomaterial absorbable as a material that 
“loses most of its tensile strength within 60 days” post implantation in vivo [191]. Since silk has 
negligible tensile strength loss in vivo it is thus classified as a non-degradable biomaterial. 
Nevertheless, silk has been shown to be biodegradable over periods of time greater than 60 days 
[191]. 
The present study investigates the effects of air-flow electrospinning using increasing applied 
air pressure (AP) on the structure of silk scaffolds at 7% and 12% concentrations [143] and 
whether those scaffolds are a suitable microenvironment for breast epithelial cells as determined 
by MCF-10A cell infiltration and viability. This is an essential early step in the optimization of 
an air-flow impedance electrospun silk-based 3D nanofiber scaffold to generate functional 
breast-tissue 3D systems.  
3.3. Materials & Methods 
3.3.1. Silk Extraction 
Bombyx mori SF was extracted from silk cocoons (B. mori silk cocoons, B quality; The Yarn 
Tree, Asheville, NC,USA) as described by Rockwood et al. (2011) and Sofia et al. (2001) with 
minor modifications. Briefly, after discarding the silk worms, 5 grams of cocoons were cut and 
boiled for 30 minutes in 2 liters of 0.02M Na2CO3 (Sigma, Saint Louis, MO,USA) aqueous 
solution then rinsed three times (20 min each) in deionized water to remove the sericins. Silk 
fibers were left to dry overnight then dissolved in 9.3M LiBr (Fisher Scientific, Fair Lawn, NJ), 
12% (w/v), overnight (in 60ºC for the first 4 hours). Silk solution was then dialyzed against 
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deionized water for 48 hours using 3500 MWCO dialysis tubes (Fisher Scientific) with repeated 
water changes after 1, 4, 6, 12, 12, and 12 hours. The regenerated dry SF sponge was collected 
by freezing extracted silk solution in -80°C followed by lyophilization (SP Scientific, Gardiner, 
NY). 
3.3.2. Electrospinning 
The electrospinning techniques, as described by Barnes et al. (2007), on a solid mandrel and 
with air-flow impedance on a perforated mandrel, as described by McClure et al. (2012), were 
used. In the air-flow technique electrospinning the solid mandrel (Custom Design & Fabrication, 
Richmond, VA, USA) was replaced with a perforated mandrel connected to the air line (Figure 
1). Pressurized air travelled through the lumen of this mandrel and exited through the pores 
impeding fiber deposition [221]. This air-flow impedance electrospinning leads to the formation 
of both highly porous regions (perforation regions), which allow cell infiltration, and dense fiber 
regions (flat regions), which provide structural stability [221]. 
Both mandrels were stainless steel and 6 mm in diameter. The perforated mandrel (Beverlin 
Manufacturing Company, Grand Rapids, MI, USA) is a hollow mandrel that contains 0.75 mm 
holes spaced 2.0 mm center to center, laterally. The center-to-center longitudinal distance was 
1.5 mm. A lure lock (Becton Dickinson, Franklin Lakes, NJ, USA) was fitted and taped to one 
end of the perforated mandrel using Tartan electric tape (3M Company, St. Paul, MN, USA). A 
3mm diameter solid mandrel was inserted into the opposite end of the perforated mandrel and 
secured in place using electric tape (3M Company) (Figure 3.1) [221]. The perforated mandrel 
was subjected to an applied AP of 0, 50, 100, 200, 300, and 400 kPa.  
Extracted SF was dissolved in HFIP (TCI America, Portland, OR, USA) at concentrations of 
7 and 12%. The silk solutions were loaded into Becton Dickinson syringes with an 18 gauge 
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blunt tip needle. The needle was subjected to +25 kV with an air-gap distance of 13 cm between 
the needle and the mandrel. A volume of 1.8 ml of the silk solution was dispensed at a rate of 
5ml/h and electrospun on the target mandrel.   
 
Figure 3.1. Air-flow and perforated mandrel. A) Air-flow connection and direction (arrows). B) 
Dimensions of the perforated mandrel used in air-flow electrospinning. Figure adapted from [221]. 
 
3.3.3. Scaffold Characterization 
Scanning Electron Microscopy (SEM) was performed using a JEOL LV-5610 SEM (JEOL 
Ltd., Tokyo, Japan). Inner surface measurements were taken randomly for the solid mandrel and 
within the site of perforation and outside the site of perforation for the air-flow mandrel samples.  
Average fiber diameter and pore size of the electrospun structures were measured using 100 
random locations on each SEM image using ImageTool 3.0 software (Shareware provided by 
UTHSCSA, San Antonio, TX, USA).  
3.3.4. Cell Culture and Staining 
Electrospun scaffolds were disinfected through soaking in 99.98% ethyl alcohol 
(PHARMCO-AAPER) for 1 hour followed by three 10-minute washes in Phosphate-Buffered 
Saline (PBS) (Cellgro, Manassas, VA, USA). Immortalized human mammary epithelial cells, 
MCF-10A (ATCC, Manassas, VA, USA) were seeded at 15×10
3 
cells per 10-mm diameter 
biopsy punch of electrospun silk scaffolds and maintained for up to 14 days at 37
°
C and 5% CO2. 
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MCF-10A cells were cultured in growth media containing DMEM/F12 (Invitrogen; Invitrogen 
Life Technologies, Grand Island, NY) supplemented with 5% horse serum (Invitrogen), 1% 
Penicillin (10,000 units/ml) and Streptomycin (10,000 g/ml) (Cellgro), 20 ng/ml epidermal 
growth factor (EGF) (BD Biosciences, San Jose, CA, USA), 0.5 g/ml hydrocortisone, 100 
ng/ml cholera toxin, and 10 g/ml Insulin (all from Sigma) [51]. Half of the media volume was 
changed every 2 days. 
Following cell culture on electrospun silk scaffolds, scaffolds and cells were fixed in 4% 
formaldehyde for 20 min then rinsed in PBS at room temperature. Samples were permeabilized 
in 1:1000 Triton (MP Biomedicals, Solon, OH) and equilibrated briefly in 2X saline sodium 
citrate (SSC) (0.3 M NaCl, 0.03 M sodium citrate, pH 7.0; Kirkegard and Perry Laboratories, 
Gaithersburg, MD, USA) then treated with 100 g/ml DNAse-free RNAse (ABgene, Surrey, 
U.K.) in 2X SSC for 20 minutes at 37°C. Samples were then incubated for 5 min with the 
fluorochrome base-intercalator propidium iodide (500nM; MP Biomedicals), which dyes the 
nuclei, then rinsed in 2X SSC. 
3.3.5. Cell Viability Analysis 
MCF-10A cells (1×10
4 
cells per scaffold) were seeded on 6-mm diameter disinfected scaffold 
disks and cell viability was examined on day 14. Cell viability (number of living cells) was 
assessed using MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt] assays (CellTiter 96 ® Aqueous Non-Radioactive Cell 
Proliferation Assay; Promega, Madison, WI, USA), as described by the manufacturer. The 
number of viable cells was calculated based on a standard curve defining the relationship 
between absorbance and cell number.  
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3.3.6. Cell Infiltration Measurements and Analyses 
Fixed and stained scaffold-cell samples were soaked in 30% sucrose solution for 2 hours at 
4
°
C. The samples were then embedded in Tissue-Tek® Optimal Cutting Temperature (OCT) 
compound (Ted Pella, Redding, CA, USA) and stored at -80
°
C. Frozen samples were cross-
sectioned (20-m thick sections) using a cryostat (MICROM GmbH, Walldorf, Germany). For 
each sample, 10 cross-sections were imaged using an Olympus IX71 fluorescent microscope 
equipped with a DP70 digital camera, using the 10X objective (Olympus, Tokyo, Japan). The 
distance from the surface of the scaffold to the center of 16 nuclei was measured at evenly 
spaced points (totaling 160 points per sample) using ImageTool 3.0 software. 
3.3.7. Statistical Analysis 
All parameters are expressed as mean ± standard error of the mean (SEM). The 
characteristics of the electrospun silk samples, including their abilities to promote cell infiltration 
and cell viability, were analyzed using one-way analyses of variance followed by post-hoc tests 
to determine the differences between each treatment. A priori, p values below 0.05 are defined as 
significant.   
3.4. Results 
3.4.1. Characteristics of Electrospun Silk Scaffolds  
Both fiber diameters and pore sizes of the inner surface of the silk scaffolds were 
characterized randomly for the solid mandrel and within the flat regions (dense fiber regions) and 
perforation regions (highly porous regions) of the perforated mandrel subjected to various AP 
(See Figures 3.2 and 3.3, respectively). Electrospun scaffolds generated from two silk 
concentrations of 7% and 12% were characterized based on SEM images (Table 3.1). 
Figure 2. Fiber diameter 
measurements. *, ^, and 
+ indicate a significant 
difference from 50, 300,  
and 400 kPa respectively 
(*p<0.001, ^p<0.05, and 
+p<0.01). # indicates a 
significant difference from 
all other conditions 
(#p<0.001).    
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3.4.2. Effects of Air-flow Rate on Fiber Diameters and Pore Sizes in 7% Silk Scaffolds 
As shown in Figure 3.2A, in 7% silk scaffolds the decrease in fiber diameter within the flat 
regions was correlated with an increase in the electrospinning AP from 0 to 400 kPa (r
2 
= 0.97, p 
< 0.001). No correlation between the fiber diameter of 7% silk scaffolds and the electrospinning 
AP was observed within the perforation regions (r
2 
= 0.0003, p > 0.05). However, in the flat 
regions, electrospinning with an AP of 0 and 50 kPa promoted significantly higher fiber 
diameters than the Solid Mandrel, electrospinning with AP of 300 kPa or 400 kPa (p < 0.05, 
0.001, and 0.001, respectively). Electrospinning with an AP of 400 kPa promoted the smallest 
fiber diameter (0.99 ± 0.07 µm) in 7% silk scaffolds - a fiber diameter significantly smaller than 
those obtained through electrospinning at AP of either 0, 50, 100, or 200 kPa (p < 0.001, 0.001, 
0.01, and 0.05, respectively).  
In the perforation regions, electrospinning at AP of 50 kPa and 300 kPa promoted the 
smallest fiber diameter (0.92 ± 0.04 and 1.04 ± 0.06 µm, respectively p < 0.05) in 7% silk 
scaffolds. Moreover, electrospinning at an AP of 50 kPa promoted significantly smaller fiber 
diameter than electrospinning on a Solid Mandrel, or at AP of 0, 100, 200, and 400 kPa (p < 
0.05, 0.001, 0.01, and 0.05, respectively; Figure 3.2A). The average fiber diameter generated 
following electrospinning with an AP of 300 kPa was significantly smaller than the fiber 
diameter generated by electrospinning with an AP of 0 kPa (p < 0.05).  
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Table 3.1: Micrographs of 7% and 12% electrospun silk scaffolds spun using a solid mandrel and from 
perforation regions subjected to AP of 0 to 400 kPa.   
 7% Silk 12% Silk 
Mandre 
Condition 
SEM Image, Perforation 
Region 2000X 
Avg. Fiber 
Diameter, 
µm ± SEM 
Avg. Pore 
Size, µm ± 
SEM 
SEM Image, Perforation 
Region 1000X 
Avg. Fiber 
Diameter, 
µm ± SEM 
Avg. Pore 
Size, µm ± 
SEM 
Solid 
Mandrel 
 
1.19 ± 0.06 
 
3.20 ± 0.13 
 
3.36 ± 0.19 8.57 ± 0.41  
d. 
0 kPa 
 
1.28 ± 0.06 7.67 ± 0.35 
 
3.42 ± 0.14 18.99 ± 0.83 
50 kPa 
 
0.92 ± 0.04 
a. 
 
7.12 ± 0.33 
 
3.60 ± 0.21 13.74 ± 0.36 
e. 
100 kPa 
 
1.22 ± 0.09 13.40 ± 0.67 
b. 
 
3.75 ± 0.18 20.36 ± 0.7 
200 kPa 
 
1.26 ± 0.08 5.52 ± 0.33 
 
2.91 ± 0.19 
c. 
17.60 ± 0.52 
300 kPa 
 
1.04 ± 0.06 6.68 ± 0.37 
 
3.84 ± 0.19 21.39 ± 1.22 
400 kPa 
 
1.21 ± 0.07 10.57 ± 0.47 
 
3.6 ± 0.17 26.03 ± 1.19  
f. 
a. Significantly < SM, 0, 100, 200, 400 kPa; p < 0.05, 0.001, 0.01, 0.01, 0.05 
b. Significantly > all conditions; p < 0.001  
c. Significantly < 100 and 300 kPa; p < 0.05 and 0.01 
d. Significantly < 100 and 300 kPa; p < 0.05 and 0.01 
e. Significantly < 0, 100, 200, 300, 400 kPa; p < 0.001, 0.001, 0.01, 0.001, 0.001 
f. Significantly > all conditions; p < 0.001 
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The diameter of silk scaffold fibers in the perforation regions was not significantly different 
from the fiber diameters in the flat regions, except for scaffolds electrospun at an AP of 50 kPa, 
in which fibers had significantly smaller diameters (p < 0.001). Overall, the average fiber 
diameters of 7% silk scaffolds were no different in scaffolds obtained through either air-flow 
electrospinning or electrospinning on a solid mandrel, except in the perforation region of 
scaffolds electrospun with an AP of 50 kPa (p < 0.05; Figure 3.2A).  
Air-flow electrospun scaffolds demonstrated significantly larger pore sizes compared to 
scaffolds spun using a solid mandrel for every condition tested (p < 0.001; Figure 3.3A) except 
within the flat regions of scaffolds spun at an AP of 200 kPa. Air-flow electrospinning at AP of 
0, 100, 200, 300, or 400 kPa promoted significantly larger pore sizes in scaffolds within the 
perforation regions compared to their counterpart flat regions (p < 0.001, 0.001, 0.05, 0.05, 
0.001, respectively, Figure 3.3A). In these perforation regions, pore size increased from 7.12 ± 
0.33 to 13.4 ± 0.67 µm as electrospinning AP increased from 50 to 100 kPa (p < 0.001, Figure 
3.3A). In contrast, an increase in the electrospinning AP from 100 to 200 kPa was associated 
with a 59% decrease in scaffold pore size (Figure 3.3A). A 48% increase in scaffold pore size 
was observed when the electrospinning AP was increased from 200 to 400 kPa (p < 0.001, 
Figure 3.3A). Pore sizes measured following an AP of 100 kPa and 400 kPa, were significantly 
different from each other (p < 0.05; 13.4 ± 0.67 and 10.57 ± 0.47 µm, respectively), and both of 
these conditions were significantly different from all other conditions tested (p < 0.001).  
Within the flat regions, electrospinning at AP of 50 kPa and 100 kPa promoted significantly 
larger pore sizes (6.76 ± 0.37 and 6.93 ± 0.42 µm, respectively), than those obtained in scaffolds 
electrospun on a solid mandrel, or with AP of 0, 200, and 300 kPa (p < 0.001, 0.001, 0.001, 0.01, 
respectively; Figure 3.3A). In either flat or perforation regions, no correlation was observed 
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between the scaffold pore size, and the electrospinning AP used to generate the 7% silk scaffolds 
(r
2
 = 0.022, p > 0.05 and r
2
 = 0.0025, p > 0.05, respectively; Figure 3.3A).     
3.4.3. Effect of Air-flow Rate on Fiber Diameters and Pore Sizes in 12% Silk Scaffolds 
No correlation was detected between the 12% silk scaffold fiber diameters and changes in 
electrospinning AP within flat or perforation regions (r
2
 = 0.53, p > 0.05, and r
2
 = 0.015, p > 
0.05, respectively; Figure 3.2B). In the flat regions, electrospinning with an AP of 300 kPa 
resulted in significantly larger fiber diameters than electrospinning on a solid mandrel, and at AP 
of 50, 100, and 200 kPa (p <0.01, 0.05, 0.05, and 0.01, respectively). Electrospinning with an AP 
of 400 kPa promoted significantly larger fiber diameter than electrospinning on a solid mandrel 
(p < 0.05). 
Within the perforation regions, electrospinning at 200 kPa AP promoted significantly smaller 
fiber diameters than electrospinning at AP of 100 kPa and 300 kPa (p < 0.05 and 0.01, 
respectively; Figure 3.2B). No significant difference was observed in fiber diameters between the 
flat and perforation regions for any of the conditions tested (Figure 3.2B). Overall, there was no 
improvement in the average fiber diameter of 12% silk scaffolds obtained through either air-flow 
electrospinning or spinning on a solid mandrel. 
Pore sizes within the flat regions of 12% silk scaffolds were highly correlated with the 
increase in electrospinning AP from 0 to 400 kPa (r
2
 = 0.97, p < 0.001; Figure 3.3B). However, 
no correlation was observed within the perforation regions of the scaffolds (r
2 
= 0.58, p > 0.05). 
Within the flat regions of the 12% silk scaffolds, electrospinning at AP of 400 promoted a 
significantly larger pore size (21.36 ± 1.11 µm) than all other tested conditions (p < 0.001; 
Figure 3.3B). Electrospinning at AP of 200 kPa and 300 kPa resulted in larger pore sizes in the 
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flat regions (13.98 ± 0.46 and 16.35 ± 0.87, respectively, p < 0.05) than electrospinning with a 
solid mandrel or AP of 0, 50, and 100 kPa (p < 0.001, Figure 3.3B).  
Pore sizes in 12% silk scaffolds were significantly larger within the perforation regions than 
within the flat regions for all conditions tested (p < 0.001), demonstrating the effects of air-flow 
on fiber deposition. In the perforation regions, electrospinning with an AP of 400 kPa promoted 
significantly higher pore size (26.03 ± 1.19 µm, p < 0.001; Figure 3.3B) than all other conditions 
tested. In these perforation regions, electrospinning with an AP of 50 kPa promoted significantly 
smaller pore sizes (13.74 ± 0.36 µm) than electrospinning with AP of 0, 100, 200, 300, and 400 
kPa (p < 0.001, 0.001, 0.01, 0.001, 0.001, respectively). In addition, the pore size obtained 
through electrospinning with an AP of 300 kPa was significantly higher than following 
electrospinning with an AP of 200 kPa (p < 0.05). Overall, scaffolds spun using air-flow 
electrospinning demonstrated significantly larger pore sizes in the perforation regions of all 
conditions tested than scaffolds spun on a solid mandrel (p < 0.001; Figure 3.3B). 
    
Figure 3.2. Randomly measured average fiber diameters for the solid mandrel and within the 
perforation and flat regions of air-flow electrospun 7% and 12% silk scaffolds. A) 7% silk 
scaffolds. * indicates a significant difference from the flat region at AP of 50 kPa (p < 0.001). ^ indicates 
a significant difference from perforation region of SM, AP of 0, 100, 200, 400 kPa (p < 0.05, 0.001, 0.01, 
0.01, and 0.05, respectively). B) 12% silk scaffolds. * indicates a significant difference from the 
perforation region at AP of 100 kPa (p < 0.05). ^ indicates a significant difference from the perforation 
region at AP of 300 kPa (p < 0.01). 
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Figure 3.3. Randomly measured average pore size for the solid mandrel and within the flat and 
perforation regions of the air-flow electrospun 7% and 12% silk scaffolds. A) 7% silk scaffolds. * 
indicates significantly smaller pore size than all conditions tested except the flat region at AP of 200 kPa 
(p < 0.001). ** indicates a significant difference from all conditions tested (p < 0.001). B) 12% silk 
scaffolds. * indicates significantly smaller pore size from the flat regions at AP of 200, 300, and 400 kPa 
and the peroration regions of all conditions tested (p < 0.001). ** indicates significantly higher pore size 
than all conditions tested (p < 0.001). 
 
 
3.4.4. MCF-10A Cell Growth and Viability Seeded on 7% and 12% Electrospun Silk 
Scaffolds  
After 1 day in culture, about half of the seeded MCF-10A cells were attached to the 
electrospun silk scaffolds (Table 3.2). After 14 days in culture, there was a significant increase in 
the number of viable MCF-10A cells onto 7% and 12% silk scaffolds for all conditions tested (p 
< 0.05; Table 3.2). However, this increase was modest compared to the number of viable cells in 
two-dimensional (2D) cultures maintained on positively coated tissue-culture treated vessels.  No 
correlation was observed between the pore size and cell viability in either 7% or 12% silk 
scaffolds (r
2 
= 0.539, p > 0.05 and r
2 
= 0.293, p > 0.05, respectively). Within 12% silk scaffolds, 
no significant difference in MCF-10A cell viability between all the conditions tested was 
observed (Figure 3.4). However, 7% silk scaffolds electrospun at AP of 100 and 400 kPa 
significantly promoted a higher MCF-10A cell viability (62.0 x 10
3 
± 5.0 x 10
3
 cells and 63.0 x 
10
3 
± 1.0 x 10
3 
cells, respectively) than 7% silk scaffolds electrospun at 50 kPa AP and 
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electrospun using a solid mandrel (43.7 x 10
3 
± 5.2 x 10
3
 cells and 44.0 x 10
3 
± 5.8 x 10
3
 cells, 
respectively, p < 0.05; Figure 3.4). Overall, 7% silk scaffolds obtained by electrospinning at AP 
of 100, 200, and 400 kPa promoted significantly higher cell viability than 12% silk scaffolds 
generated in the same conditions (p < 0.05, 0.05, and 0.01, respectively; Figure 3.4). 
S
ol
id
 M
an
dr
el
0 
kP
a
50
 k
P
a
10
0 
kP
a
20
0 
kP
a
30
0 
kP
a
40
0 
kP
a
0
20000
40000
60000
80000
7% Silk
12% Silk
*,^ *,**
^
Mandrel Condition
N
u
m
b
e
r 
o
f 
L
iv
e
 C
e
ll
s
 
Figure 3.4. MCF-10A cell viability on 7% and 12% electrospun silk scaffolds after 14 days in 
culture. * indicates a significant difference from Solid mandrel and 50 kPa (p < 0.05). ^ and ** indicate a 
significant difference from their corresponding values for 12% silk (^ p < 0.05, ** p < 0.01). 
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Table 3.2. MCF-10A cell growth on 7% and 12% electrospun silk scaffolds after 1, 7, and 14 days in 
culture. 
 7% Silk 12% Silk 
Mandrel 
Condition 
Cell Growth 
Number of Viable 
Cells at (Day 14 ± 
SEM) × 103 
Cell Growth 
Number of Viable 
Cells at (Day 14 ± 
SEM) × 103 
Solid 
Mandrel 
Day 1 Day 7 Day 14
0
20000
40000
60000
80000
***, b
***
Time Point
N
u
m
b
e
r 
o
f 
L
iv
e
 C
e
lls
 
44.03 ± 5.81 
Day 1 Day 7 Day 14
0
20000
40000
60000
80000
***
**
Time Point
N
u
m
b
e
r 
o
f 
L
iv
e
 C
e
lls
 
32.01 ± 4.94 
0 kPa 
Day 1 Day 7 Day 14
0
20000
40000
60000
80000
***
**
Time Point
N
u
m
b
e
r 
o
f 
L
iv
e
 C
e
lls
 
50.38 ± 1.92 
Day 1 Day 7 Day 14
0
20000
40000
60000
80000
***, c
Time Point
N
u
m
b
e
r 
o
f 
L
iv
e
 C
e
lls
 
45.37 ± 2.01 
50 kPa 
Day 1 Day 7 Day 14
0
20000
40000
60000
80000
***
***
Time Point
N
u
m
b
e
r 
o
f 
L
iv
e
 C
e
lls
 
43.66 ± 5.18 
Day 1 Day 7 Day 14
0
20000
40000
60000
80000
***, c
*
Time Point
N
u
m
b
e
r 
o
f 
L
iv
e
 C
e
lls
 
41.87 ± 4.0 
100 kPa 
Day 1 Day 7 Day 14
0
20000
40000
60000
80000
***, a
***
Time Point
N
u
m
b
e
r 
o
f 
L
iv
e
 C
e
lls
 
61.97 ± 4.96 
Day 1 Day 7 Day 14
0
20000
40000
60000
80000
***, c
***
Time Point
N
u
m
b
e
r 
o
f 
L
iv
e
 C
e
lls
 
42.33 ± 3.97 
200 kPa 
Day 1 Day 7 Day 14
0
20000
40000
60000
80000
***
*
Time Point
N
u
m
b
e
r 
o
f 
L
iv
e
 C
e
lls
 
56.30 ± 1.05 
Day 1 Day 7 Day 14
0
20000
40000
60000
80000
***
***
Time Point
N
u
m
b
e
r 
o
f 
L
iv
e
 C
e
lls
 
34.84 ± 4.19 
300 kPa 
Day 1 Day 7 Day 14
0
20000
40000
60000
80000
***
***
Time Point
N
u
m
b
e
r 
o
f 
L
iv
e
 C
e
lls
 
57.89 ± 2.19 
Day 1 Day 7 Day 14
0
20000
40000
60000
80000
***, c
**
Time Point
N
u
m
b
e
r 
o
f 
L
iv
e
 C
e
lls
 
43.91 ± 5.80 
400 kPa 
Day 1 Day 7 Day 14
0
20000
40000
60000
80000
***, c
***
Time Point
N
u
m
b
e
r 
o
f 
L
iv
e
 C
e
lls
 
62.97 ± 0.98 
Day 1 Day 7 Day 14
0
20000
40000
60000
80000
***
***
Time Point
N
u
m
b
e
r 
o
f 
L
iv
e
 C
e
lls
 
40.18 ± 0.51 
*, **, and *** indicate significant difference from Day 1. * (p < 0.05), ** (p < 0.01), *** (p < 0.001) 
a, b, and c indicate significant difference from Day 7. a (p < 0.05), b (p < 0.01), c (p < 0.001) 
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3.4.5. MCF-10A Cell Infiltration into 7% and 12% Porous Silk Scaffolds 
Static cultures of MCF-10A cells were maintained for up to 14 days on both 7% and 12% 
silk scaffolds obtained following either electrospinning using air-flow electrospinning or 
electrospinning on a solid mandrel. The ability of MCF-10A cells to migrate and colonize the 
scaffolds (i.e., the MCF-10A cell infiltration within the scaffolds) was assessed by nucleic acid 
staining (Figure 3.5 and Table 3.3). 
In 7% silk scaffolds, no correlation was observed between the electrospinning AP used to 
generate the scaffolds and MCF10A cell infiltration (r
2
 = 0.018, p > 0.05; Figure 3.5A). 
However, the increase in pore size within 7% silk scaffolds significantly correlated with 
increased cell infiltration after 14 days of culture (r
2 
= 0.64, p < 0.05). MCF10A cell infiltration 
into 7% silk scaffolds increased significantly from day 7 to day 14 in all conditions tested (p < 
0.001). The greatest increase in MCF10A cell infiltration between day 7 and day 14 was 
observed in 7% silk scaffolds obtained through electrospinning with an AP of 100 kPa (17.01 ± 
0.84 µm vs. 36.58 ± 2.28 µm; p < 0.001; Figure 3.5A). MCF10A cell infiltration onto 7% silk 
scaffolds obtained through electrospinning with an AP of 100 kPa was significantly higher than 
onto 7% silk scaffolds obtained through electrospinning with an AP of 50 kPa or those 
electrospun on a solid mandrel (p < 0.05) after 7 days of culture, and significantly higher than in 
all other scaffolds tested after 14 days in culture (p < 0.001; Figure 3.5A). On day 14, MCF10A 
cell infiltrations were not different between air-flow electrospun scaffolds at AP of 0, 50, 
200,300, and 400 kPa and scaffolds spun using a solid mandrel (Figure 3.5A).  
From day 7 to day 14, MCF10A cell infiltration in 12% silk scaffolds increased significantly 
only in scaffolds electrospun with 100 kPa AP (23.9 ± 1.57 vs. 33.27 ± 1.71 µm, p < 0.001). The 
AP used during the electrospinning of 7% or 12% silk to generate different scaffolds and the 
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resulting MCF10A cell infiltration were not correlated (r
2
 = 0.0008, p > 0.05). In addition, in 
12% silk scaffolds no correlation was observed between pore size and cell infiltration after 14 
days (r
2 
= 0.256, p > 0.05). After 7 days in culture, 7% or 12% scaffolds electrospun at AP of 50, 
100, 200, and 400 kPa promoted significantly higher MCF10A cell infiltration than scaffolds 
electrospun on a solid mandrel (p < 0.01, 0.001, 0.01, and 0.001, respectively). On day 7, 12% 
silk scaffolds electrospun at AP of 100 kPa and 400 kPa promoted significantly higher MCF-10A 
cell infiltration than scaffolds electrospun at 0 kPa (p < 0.01 and 0.001, respectively). On day 14, 
7% or 12% scaffolds obtained through an AP of 100 kPa promoted significantly higher MCF10A 
cell infiltration (33.27 ± 1.7 µm) than all other conditions tested (p < 0.001; Figure 3.5B). 
Overall, on day 14 of culture 12% silk scaffolds obtained following electrospinning at AP of 50, 
100, 200, 300, and 400 kPa promoted significantly higher MCF10A cell infiltration than 
scaffolds electrospun on a solid mandrel (p < 0.01, 0.05, 0.01, and 0.01, respectively; Figure 
3.5B).  
After 7 days in culture 12% silk scaffolds generated following electrospinning at AP of 50, 
100, 200, and 400 kPa promoted significantly higher MCF-10A cell infiltration than 7% silk 
scaffolds obtained following electrospinning at the same APs (p < 0.001, Figure 3.6). After 14 
days in culture, no difference in MCF-10A cell infiltration was detected between 7% and 12% 
silk scaffolds except for those electrospun using a solid mandrel and those electrospun at AP of 0 
kPa. Under these two conditions, using 12% silk scaffolds promoted significantly lower MCF-
10A cell infiltration than 7% silk scaffolds (p < 0.05; Figure 3.6B).   
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Figure 3.5. MCF-10A cell infiltration through 7% and 12% electrospun silk scaffolds after 7 and 14 
days in culture. A) 7% silk scaffold. * indicates a significant difference from all conditions tested at day 
14 (p < 0.001). + indicates a significant difference from Solid Mandrel and 50 kPa at day 7 (p < 0.05). ^ 
indicates a significant difference between days 7 and 14 for all conditions tested (p < 0.05). B) 12% silk 
scaffolds. * indicates a significant difference from all conditions tested and day 7 at AP of 100 kPa (p < 
0.001). 
 
 
 
Figure 3.6. MCF-10A cell infiltration comparison between 7% and 12% Silk scaffolds after 7 and 
14 days in culture. A) After 7 days in culture. *** indicates a significant difference from 7% silk at AP 
of 50, 100, 200, and 400 kPa (p < 0.001). B) After 14 days in culture. * indicates a significant difference 
form 7% silk at SM and AP of 0 kPa (p < 0.05). 
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Table 3.3. Nucleic acid staining of MCF-10A cell infiltration through 7% and 12% silk scaffolds spun 
using a solid mandrel and a perforated mandrel subjected to air pressure of 0 to 400 kPa. 
 7% Silk 12% Silk 
Mandrel 
Condition 
Day 14 Infiltration,  
10X Objective 
Avg. 
Thickness, 
µm ± SEM 
(Prior to 
seeding) 
Avg. Cell 
Infiltration, 
µm ± SEM 
Day 14 Infiltration,  
10X Objective 
 Avg. 
Thickness, 
µm ± SEM 
(Prior to 
seeding) 
Avg. Cell 
Infiltration, 
µm ± SEM 
Solid 
Mandrel 
 
300 ± 5.77 
 
21.27 ± 1.65 
 
693 ± 11.86 16.82 ± 1.21 
0 kPa 
 
167 ± 14.53 24.70 ± 1.46 
 
807 ± 11.86 19.63 ± 1.35 
50 kPa 
 
463 ± 13.33 20.83 ± 1.25 
 
937 ± 16.56 24.12 ± 1.29 
100 kPa 
 
177 ± 6.67 36.58 ± 2.28 
a. 
 
850 ± 18.86 33.27 ± 1.71 
b. 
200 kPa 
 
330 ± 11.55 23.98 ± 1.48 
 
923 ± 11.86 23.32 ± 1.11 
300 kPa 
 
147 ± 6.67 24.74 ± 1.49 
 
957 ± 28.80 24.29 ± 1.22 
400 kPa 
 
140 ± 5.77 24.02 ± 1.73 
 
930 ± 17 24.12 ± 1.09 
a. Significantly > all conditions; p < 0.001 
b. Significantly > all conditions; p < 0.001 
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3.5. Discussion 
We and others have shown the formation of acinar and ductal structures in 3D cultures of 
mammary epithelial cells maintained on gel matrices and aqueous-derived SF scaffolds, 
respectively [56,265]. Here we investigated the use of electrospun nanofiber silk-based scaffolds 
for similar purposes. To determine which condition provided a more suitable microenvironment 
for MCF-10A cell viability and infiltration, we cultured MCF-10A breast epithelial cells on 7% 
and 12% silk scaffolds generated by electrospinning on a solid mandrel and electrospinning on a 
perforated mandrel using air pressures of 0-400 kPa. The results indicate that air-flow 
electrospinning of 7% and 12% silk scaffolds resulted in formation of larger pore sizes than 
electrospinning on a solid mandrel modulating the MCF-10A cell adhesion and proliferation on 
these electrospun silk scaffolds.  
Electrospinning is a simple process and allows the formation of porous structures with fiber 
diameters from a few nanometers to a few micrometers [219,220]. Tissue engineering scaffolds 
prepared by electrospinning process mimic the characteristics of natural ECM, such as fiber 
diameter, high porosity, and interconnected architecture [266]. Here, we developed scaffolds 
fabricated through air-flow impedance electrospinning containing highly porous regions 
(perforation regions), which allow cell infiltration, and dense fiber regions (flat regions), which 
provide structural stability. Therefore, these scaffolds offer a more porous structure without the 
loss of mechanical performance [221].  
Our data demonstrates the effects of electrostatic forces and air-flow on fiber deposition and 
generation of less dense and more porous structures with larger pore sizes. More specifically, 7% 
silk scaffolds electrospun at 100 kPa AP and 12% silk scaffolds electrospun at 400 kPa AP 
demonstrated significantly larger pore sizes than all the conditions tested. Our observations 
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demonstrating formation of larger pore sizes within scaffolds obtained through air-flow 
electrospinning concur with McClure et al. (2012) observations in which poly (ɛ-caprolactone) 
(PCL) scaffolds electrospun using a perforated mandrel at 50 kPa and 100 kPa AP exhibited 
significantly larger pore sizes than scaffolds spun using a solid mandrel. 
The physical features of the microenvironment present in one of the conditions tested (7% 
silk scaffold obtained following electrospinning at 100 kPa AP) provided improved support for 
MCF-10A cell survival and greatest MCF-10A cell infiltration compared to all other conditions 
tested. The higher level of cell infiltration through 7% silk scaffolds spun at AP of 100 kPa is 
related to the larger pores present on this scaffold. This result mirrors the observations by 
McClure et al. [221]of an increased human dermal fibroblast cell infiltration through air-flow 
electrospun scaffolds subjected to 0-100 kPa AP. The higher cell viability and proliferation 
within 7% silk scaffolds may be related to the smaller fiber diameters. These observations 
support Li et al.’s (2006) demonstration that chondrocyte proliferation was higher in nanofiber 
scaffold cultures than in microfiber scaffold cultures [267]. The limited MCF-10A cell 
attachment to silk scaffolds observed here is remarkably similar to the attachment to B. mori SF 
films of Saos-2 osteoblast-like cells [151]. Others have shown that non-woven microfibrous silk 
nets supported the adhesion and proliferation of a variety of human cell types including epithelial 
cells, endothelial cells, glial cells, osteoblasts [197], keratinocytes and fibroblasts [143,197].  
In the conditions tested, although high MCF-10A cell infiltration through 7% silk scaffolds 
generated through electrospinning at an AP of 100 kPa was observed, the entire scaffold was not 
colonized. To further increase cell infiltration into these structures, we are currently improving 
both the silk scaffold and culture conditions. The observations presented here are a proof-of-
concept demonstration that a perforated mandrel along with air-flow impedance electrospinning 
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leads to the formation of silk scaffolds with biocompatible properties. Moreover, the MCF-10A 
cell growth and viability on electrospun silk fibroin scaffolds detailed here suggest that this 
biomaterial will support human mammary epithelial cell proliferation and has the potential to be 
used to 3D model or regenerate the breast tissue.  
3.6. Conclusion 
These findings further support the use of air-flow impedance technique rather than solid 
mandrel electrospinning to generate silk scaffolds compatible with MCF10A cell growth. The 
results demonstrate that nanofiber electrospun silk scaffolds spun using air-flow impedance 
technique generated a highly porous matrix. In particular, within the conditions tested, 7% silk 
electrospun scaffolds spun at an AP of 100kPa promoted higher cell infiltration and viability 
possibly because of the porous nanofiber structures used here had physical properties closer to 
the breast ECM, providing the most suitable microenvironment for the 3D in vitro culture of the 
human breast epithelial MCF-10A cells.  
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CHAPTER 3S: EFFECTS OF AIR PRESSURE ON MECHANICAL 
PROPERTIES AND BIOCOMPATIBILITY OF SILK FIBROIN DERIVED 
ELECTROSPUN SCAFFOLDS 
 
Preface: The following chapter is supplemental data to Chapter 3.  The included work 
investigates mechanical properties and biocompatibility of silk fibroin electrospun scaffolds 
derived from 7% silk fibroin following air-flow electrospinning at various air pressures. 
 
 
3S.1.  Abstract 
To supplement the data presented in the previous chapter, the effects of air-flow impedance 
electrospinning and air-flow rates on 7% silk fibroin (SF)-based scaffolds were investigated. 
First, the specific surface area (SSA) and mechanical properties of scaffolds obtained from 7% 
SF concentration were defined. Moreover, cell adhesion and viability of MCF10A breast 
epithelial cells cultured onto these scaffolds were used to determine the biological suitability of 
these nanostructures. There were no significant differences between the SSAs of the scaffolds 
derived from SF electrospun on a solid mandrel or using different air pressures (APs). All of the 
scaffolds retained their mechanical strengths after remaining in culture for 14 days, with or 
without cells. No significant difference was observed in the elastic moduli of the scaffolds 
hydrated in PBS. After incubation in culture media for 14 days without cells, scaffolds derived 
from SF electrospun with APs of 100 and 400 kPa exhibited the lowest elastic modulus. After a 
14-day incubation in culture media along with cells, the elastic moduli of scaffolds derived from 
SF electrospun on a solid mandrel were significantly higher than the moduli of scaffolds derived 
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from SF electrospun at APs of 50, 300, and 400 kPa (p<0.05). MCF10A cell attachment was 
significantly higher on scaffolds derived from SF electrospun at an AP of 100 kPa than cell 
attachment onto scaffolds obtained following electrospinning of SF at 200 kPa AP. MCF10A 
viability on scaffolds derived from SF electrospun at an AP of 200 kPa was higher than cell 
viability on scaffolds derived from SF electrospun on a solid mandrel. These results provide 
additional evidence of the suitability of SF-derived scaffolds, prepared using air-flow 
electrospinning technique for MCF10A adhesion and viability. 
3S.2.   Introduction 
Refer to section 3.2. 
3S.3.   Materials & Methods 
3S.3.1.   Silk Extraction 
Refer to section 3.3.1. 
3S.3.2.   Electrospinning 
Refer to section 3.3.2.  
3S.3.3.   Specific Surface Area Evaluations 
Statistical fiber diameter distributions in the electrospun scaffolds were determined based on 
the frequency distribution using fiber diameters in both flat and perforation regions. Scaffold 
specific surface area (SSA) was evaluated as described earlier using the following equation: 
Specific surface area = 
                  
            
 = 
  ∑      
 
   
∑   
  
      
 
Where D is fiber diameter and f is frequency of fiber distribution, and n is the fiber number 
counted [256]. 
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3S.3.4.   Mechanical Testing 
Uniaxial tensile testing was performed on three sets of ‘dog bone’ shape scaffold samples for 
each silk concentration. Two sets of the scaffold samples were soaked in 99.98% ethyl alcohol 
(PHARMCO-AAPER) for 1 hour followed by three 10-minute washes in Phosphate-Buffered 
Saline (PBS) (Cellgro, Manassas, VA, USA). One set of the scaffolds per each SF concentration 
were seeded with 40×10
3
 immortalized human mammary epithelial cells, MCF10A (ATCC, 
Manassas, VA, USA) per ‘dog bone’ and maintained in culture for 15 days (noted as “Hydrated 
With Cells” in the results section). A second set (non-cellularized) remained in culture media for 
15 days (noted as “Hydrated No Cells” in the results section). The third set was soaked in 
99.98% ethyl alcohol for 1 hour followed by three 10-minute washes in PBS immediately before 
uniaxial tensile testing (noted as “Hydrated in PBS” in the results section).  
 3S.3.5.   Cell Culture Media  
Refer to section 3.3.4.  
 3S.3.6.   Cell Adhesion Analyses  
Tissue culture well-plates were coated with 7.5% poly(2-hydrohyethyl methacrylate) 
(PHEMA) (Sigma) to prevent cells from attaching to cell culture plastic [258,259]. Ten-
millimeter SF scaffold disks were disinfected through soaking in 99.98% ethyl alcohol for 1 hour 
followed by three 10-minute washes in PBS. To reduce the adhesion of serum proteins scaffolds 
were coated with 1% bovine serum albumin (BSA) (Gemini Bio-Products, West Sacramento, 
CA) solution for 30 minutes, followed by three 5-minute washes in PBS. One 10 mm diameter 
disinfected and BSA-coated scaffold disk was used per well. MCF10A cells (4×10
4 
cells / 
scaffold) were seeded on these scaffold disks and incubated for 40 minutes before addition of 
further media to allow for better cell attachment. After 1 or 2 hours in culture the plates were 
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gently shaken, each scaffold was taken out and dipped 5 times in a media-containing well to 
wash off the non-attached cells. The number of non-attached cells suspended in each well was 
counted. The percentage of attached cells on each scaffold disk was calculated based on the 
number of non-attached cells. 
3S.3.7.   Cell Viability Analysis 
MCF-10A cells (1×10
4 
cells per scaffold) were seeded on 6-mm diameter disinfected scaffold 
disks and cell viability was examined on day 14. Cell viability (number of living cells) was 
assessed using MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt] assays (CellTiter 96 ® Aqueous Non-Radioactive Cell 
Proliferation Assay; Promega, Madison, WI, USA), as described by the manufacturer. The 
metabolically active cells react with a tetrazolium salt in the MTS reagent to produce a soluble 
formazan dye with an absorption that can be measured at 490 nm. Numbers of cells per each 
condition were calculated based on standard curves and normalized to the percentages of 
attached cells.  
 3S.3.8.   Statistical Analysis 
All parameters are expressed as mean ± standard error of the mean (SEM). One-way analysis 
of variance (ANOVA) followed by the post-hoc Dunnett’s Multiple Comparison Test were used 
to assess differences in SSA, elastic moduli, cell attachment, and cell viability between the 
scaffolds derived from SF electrospun at different air pressures. A priori, p values below 0.05 
were defined as significant.   
 
 
Figure 2. Fiber diameter 
measurements. *, ^, and 
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3S.4   Results 
 3S.4.1.   SSA and Mechanical Strength of SF Electrospun Scaffolds  
The SSAs of scaffolds derived from SF electrospun were calculated, within their flat and 
perforation regions, to more accurately account for scaffold geometry. Scaffolds derived from 
electrospinning with an AP of 50 kPa exhibited the highest SSAs within their perforation regions 
(3.63 ± 0.07 µm
-1
). This SSA was significantly higher than the SSAs within the perforation 
region of scaffolds derived from SF electrospun at APs of 0, 100, 200 (p < 0.001), 400 kPa and 
scaffolds derived from SF electrospun on solid mandrel (p < 0.01, Figure 3S.1). Within the flat 
regions, the SSA of scaffolds derived SF electrospun at AP of 50 kPa was significantly smaller 
than the SSAs of scaffolds derived from electrospun at APs of 300 (p < 0.001) and 400 kPa (p < 
0.01, Figure 3S.1)  
   
Figure 3S.1. Specific surface area (SSA in µm
-1
) of electrospun SF-derived scaffolds. # indicates 
significant difference from flat region of scaffolds derived from SF electrospun at AP of 300 kPa (p < 
0.001). + indicates significant difference from flat region of scaffolds derived from SF electrospun at AP 
of 400 kPa (p < 0.01). ** indicates significant difference from perforation region of scaffolds derived 
from SF electrospun on a solid mandrel and scaffolds derived from SF electrospun at an AP of 400 kPa (p 
< 0.01). *** indicates significant difference from perforation region of scaffolds derived from SF 
electrospun at APs of 0, 100, and 200 kPa (p < 0.001). 
 
The uniaxial tensile modulus of each scaffold hydrated with either PBS (HPBS), culture 
media no cells (HNC), or culture media with cells (HWC) was determined. Scaffold moduli, for 
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each scaffold electrospun at a specific air pressure, were not significantly different regardless of 
the hydration conditions or mandrel conditions (n.s., Table 3S.1). 
Table 3S.1. Elastic moduli of SF derived scaffolds electrospun using a solid mandel or using various air 
pressures on a perforated mandrel.   
Mandrel Condition HPBS HNC HWC 
SM 3.23 ± 0.59 2.76 ± 0.15 3.40 ± 0.62 
0 2.16 ± 0.48 2.45 ± 0.11 2.37 ± 0.13 
50 2.02 ± 0.53 2.24 ± 0.26 1.85 ± 0.21 
100 2.23 ± 0.46 1.42 ± 0.16 2.32 ± 0.08 
200 3.17 ± 0.8 2.44 ± 0.24 2.39 ± 0.07 
300 1.56 ± 0.31 1.77 ± 0.28 1.51 ± 0.07 
400 2.98 ± 0.93 1.45 ± 0.18 1.73 ± 0.19 
 
No significant difference was observed in the elastic modulus of PBS-hydrated scaffolds 
generated using 7% SF electrospun using a solid mandrel or at various APs using a perforated 
mandrel (n.s., Figure 3S.2A). However, in biologically relevant conditions, i.e., incubation in 
culture media alone (HNC) for 14 days (37°C, humidity >90%), the elastic moduli of scaffolds 
derived from SF electrospun at air pressures of 100 and 400 kPa were significantly lower than 
the modulus of scaffolds derived from SF electrospun at 0 and 200 kPa (p < 0.05, Figure 3S.2B) 
and scaffolds derived from SF electrospun on a solid mandrel (p < 0.01, Figure 3S.2B). Scaffolds 
(HWC) derived from electrospun SF on a solid mandrel and seeded with MCF10A cells, 
following a 14-day incubation (37°C, humidity >90%) in media had a significantly higher elastic 
moduli than the moduli of scaffolds derived from SF electrospun at air pressures of 50 and 400 
kPa (p < 0.01, Figure 3S.2C) and 300 kPa (p < 0.001, Figure 3S.2C).  
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Figure 3S.2. Modulus of Elasticity SF-Derived Electrospun Scaffolds. A) HPBS. No significant 
difference observed. B) HNC. * indicated significant differences from scaffolds derived from SF 
electrospun at APs of 0 and 200 kPa (p < 0.05). ** indicates significant difference from SF scaffolds 
electrospun on a solid mandrel (p < 0.01). + indicates a significant difference from SF scaffolds 
electrospun on a solid mandrel (p < 0.05). C) HWC. ** indicates significant differences from SF-derived 
scaffolds electrospun at APs of 50 and 400 kPa (p < 0.01). *** indicates significant difference from SF-
derived scaffolds electrospun at an AP of 300 kPa (p < 0.001). 
 
3S.4.2.   MCF10A Cell Attachment and Viability on SF-derived Scaffolds  
MCF10A cell attachment was tested on SF-derived scaffolds generated on solid mandrel or 
at air pressures ranging from 0 to 400 kPa. Following a 1-hour incubation in culture conditions, 
35 ± 5%, 44 ± 4%, 41 ± 3%, 55 ± 7%, 36 ± 4%, 32 ± 0%, and 34 ± 0% of the seeded MCF10A 
cells attached to scaffolds derived from SF electrospun using solid mandrel, AP of 0, 50, 100, 
200, 300, and 400 kPa, respectively. After a 2-hour incubation in culture conditions, MCF10A 
cell adhesion onto these SF-derived scaffolds increased to 65 ± 5%, 48 ± 2%, 50 ± 4%, 68 ± 5%, 
49 ± 4%, 47 ± 6%, and 65 ± 5% for scaffolds derived from SF electrospun using a solid mandrel, 
AP of 0, 50, 100, 200, 300, and 400 kPa, respectively (Figure 3S.3A and B). Regardless of 
incubation time, MCF10A cell attachment was not significantly different amongst the 
electrospun SF derived scaffolds tested (n.s. Figure 3S.3A and B).  
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Figure 3S.3. MCF10A cell attachment onto SF-derived scaffolds. A) After 1 hour. No significant 
difference in cell adhesion between different conditions tested. B) After 2 hours. No significant 
difference in cell adhesion between different conditions tested.  
 
Moreover, no correlation between MCF10A cell adhesion and fiber diameter, pore size, SSA 
of the flat region, or the SSA of the perforation region was observed (r
2 
= 0.092, p > 0.05 and r
2 
= 
0.186, p > 0.05, r
2 
= 0.012, p > 0.05, r
2 
= 0.049, p > 0.05, respectively, Figure 3S.3A and B) 
regardless of the electrospun SF derived scaffold and the incubation time tested. 
After 14 days in culture, numbers of viable MCF10A cells present on / in SF derived 
scaffolds electrospun using air-flow technique were significantly higher than on / in SF-derived 
scaffolds electrospun using a solid mandrel. (p < 0.05 for 100 and 400 kPa, p < 0.01 for 50 kPa, 
and p <0.001 for 0, 200, and 300 kPa, Figure 3S.4). No significant difference in the number of 
viable cells was recorded between the SF-derived scaffolds electrospun at various APs (n.s., 
Figure 3S.4). MCF10A cell viability was not correlated with either fiber diameters, pore sizes, 
SSA of the flat region, or the SSA of the perforation regions of the scaffolds (r
2 
= 0.017, p > 
0.05, r
2 
= 0.024, p > 0.05, and r
2 
= 0.022, p > 0.05, r
2 
= 0.001, p > 0.05 respectively, Figure 3S.4).  
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Figure 3S.4. MCF10A cell viability following a 14-day incubation in culture conditions. MCF10A 
viability was significantly higher when cultured onto SF-derived scaffolds electrospun using a perforated 
mandrel regardless of the AP used than SF-derived scaffolds developed using solid mandrel (SM) (* p 
<0.05; ** p<0.01; *** p<0.001). 
 
3S.5.   Discussion 
The ability of mammary epithelial cells to form acinar and ductal structures in 3D cultures 
maintained on gel matrices and aqueous-derived SF scaffolds have been demonstrated 
[56,84,122,265]. The data presented here supplement our investigation of electrospun SF-derived 
scaffolds tested as 3D scaffolding for MCF10A mammary epithelial cell growth.  As described 
earlier (section 3.4), scaffolds prepared by electrospinning process mimic the physical features of 
the breast tissue ECM [266]. Further, the scaffolds developed here fabricated through air-flow 
impedance electrospinning containing highly porous regions (perforation regions) and dense 
fiber regions (flat regions), which allow cell infiltration and provide structural stability, 
respectively [221]. In complement to our previous observations [58], here we examined the 
effects of air-flow electrospinning on the physical and mechanical properties of SF-derived 
electrospun scaffolds and whether they provided a more suitable microenvironment for MCF10A 
cell attachment and viability. The results indicate first that SF scaffolds derived from air-flow 
electrospinning had similar mechanical strength as scaffolds electrospun on a solid mandrel. 
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Secondly, our data indicate that MCF10A cell adhesion and viability on SF-derived scaffolds 
generated using the air-flow electrospinning technique were improved compared to scaffolds 
obtained using SF electrospun on a solid mandrel.   
Electrospun poly(ɛ-caprolactone) (PCL) derived scaffolds with nanometer to micrometer 
fiber diameters demonstrated higher SSAs for scaffolds with smaller fiber diameters [256]. 
Concurring with observations by Chen et al. [256], our data demonstrated significant difference 
in the SSAs of scaffolds derived from SF electrospun at an AP of 50 kPa, within both the flat and 
perforation regions compared to the SSA of scaffolds derived from SF electrospun at APs of 0, 
100, 200, and 400 kPa. The SSA of scaffolds derived from SF electrospun at an AP of 50 kPa 
correspond with significantly smaller fiber diameters in their perforation regions and 
significantly larger fiber diameters in their flat regions (For an extended discussion of that point, 
please see section 3.4.2).   
Our data also indicates the absence of difference in the elastic moduli of the SF derived 
electrospun scaffolds when hydrated in PBS. That observation and along with the fact that 
regardless of the hydration conditions tested, the electrospun SF-derived scaffolds retained their 
mechanical strength highlight the resilience of the silk mechanical properties [42,142,186,191]. 
The similar elastic moduli observed here regardless of the hydration condition and the presence 
or absence of cells within the scaffolds supports the unchanged mechanical properties of cell-
seeded poly (ε-caprolactone) (PCL)-derived electrospun scaffolds compared with acellular 
scaffolds [261].  
Moreover, our data demonstrated that regardless of the electrospun SF derived scaffolds 
tested (all with SSAs below 7 µm
2
), MCF10A cell attachment was not significantly altered. 
These results mimicked the observations by Chen et al. [256] that SSAs below 7.13 µm
2 
were 
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associated no changes in cell attachment whereas scaffolds with higher SSAs promoted higher 
cell attachment. Furthermore, the MCF10A cell attachment observed here is comparable to the 
attachment of Saos-2 osteoblast-like cells to B. mori SF films [151].  
The higher cell viability onto and within scaffolds generated from SF electrospun using air-
flow electrospinning technique may be related to the development of larger pore sizes throughout 
these scaffolds compared to scaffolds obtained from SF electrospun on a solid mandrel. Indeed, 
higher MCF10A cell viability associated with larger pores noted here confirms previous 
observations demonstrating increased cell viability through scaffolds with larger pores [58,268]. 
Although, electrospun SF-derived scaffolds supported the MCF10A cell attachment and 
viability, they did not provide the appropriate microenvironment to promote cell differentiation 
and structure formation. This is possibly due to the absence of chemical cues provided by the 
other cell types and the stromal/ECM components present in the breast tissue.   
3S.6.   Conclusion 
These complementary observations support the use of air-flow impedance electrospinning in 
generation of SF-derived scaffolds compatible with MCF10A cell attachment, survival, and 
infiltration. Although, these SF nanofiber scaffolds electrospun using air-flow impedance 
technique formed highly porous matrices that resembled the ECM fibers and provided a 
microenvironment compatible with 3D in vitro culture of the human breast epithelial MCF10A 
cells they did not promote cell differentiation and structure formation. The absence of epithelial 
structures confirms the need for ECM proteins and chemical cues present in the breast tissue 
microenvironment. Therefore, to further improve these culture conditions, inclusion of crucial 
ECM proteins such as collagen and/or laminin is necessary.  
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CHAPTER 4: EFFECTS OF COLLAGEN TYPE I ON SILK-BASED 
ELECTROSPUN SCAFFOLDS 
 
 
Preface: The following chapter has been submitted for review to the Journal of Materials 
Science and Engineering C.  The included work investigates physical and mechanical properties 
and biocompatibility of silk fibroin electrospun scaffolds when blended or coated with collagen 
type I. 
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4.1. Abstract 
Most cellular events depend on the interactions between cells and the extracellular matrix 
(ECM) and play a crucial role in regulating tissue function. Silk biomaterials from Bombyx mori 
(B. mori) silkworm silk are widely used in tissue engineering. As this silk fibroin (SF) contains 
no strong adhesion sites, we assessed whether the blending or coating of SF with collagen would 
further improve SF biocompatibility, in part through the addition of the specific integrin 
recognition sequences. In the present study, electrospun scaffolds were developed by blending 
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7% SF and 7% type I collagen solutions at ratios of 100:0 (pure SF) , 95:5, 90:10, and 85:15 
(SF:collagen , v/v) prior to electrospinning. Pure SF scaffolds were further coated with collagen 
type I. The physical and mechanical properties of these scaffolds and MCF10A mammary 
epithelial cell adhesion, viability, and infiltration into these blended or coated SF-collagen (SF-
C) scaffolds were determined. The blending of SF with collagen decreased average pore sizes 
and fiber diameters of the electrospun scaffolds regardless of the ratio (p < 0.01). The 
mechanical strength of these scaffolds, did not changed in their hydrated state (n.s.), and was 
decreased for 85:15 SF-C blended scaffolds in the dry state (p < 0.05 and 0.01). The adhesion of 
MCF10A cells was significantly increased in SF-C blended or coated scaffolds compared to pure 
SF scaffolds (p < 0.01). MCF10A cell viability and infiltration on SF-C coated scaffolds was 
significantly higher compared to all other conditions tested (p < 0.01, p < 0.001).  
Keywords 
Silk Fibroin, Type I Collagen, Cell Adhesion, Cell Viability, Mechanical Properties, Electrospun 
Scaffolds 
4.2. Introduction 
The activities of biological tissues are dependent on interactions between the cells present 
within the tissue and the cell-ECM interactions [6]. The cell-ECM interactions critically define 
the tissue microenvironment and thus play a crucial role in regulating homeostasis and tissue 
specificity [6]. Fundamental cellular events including proliferation, migration and apoptosis, are 
regulated by the cellular context [269]. In vitro three-dimensional (3D) cell cultures mimicking 
these physiological cell-ECM interactions provide a microenvironment closer to the native tissue 
than the conventional two-dimensional (2D) cell cultures [6,7]. As scaffolds for tissue 
engineering, natural or synthetic polymers electrospun non-woven fibrous structures led to the 
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engineering of tissue-like formations that closely resemble the structure of collagen fibers in the 
ECM [131]. Among the multiple natural biodegradable polymers available such as collagen, 
gelatin, chitosan and silk fibroin, silk-based biomaterials offer significant advantages for tissue 
engineering applications [56,145]. Indeed, silk-based biomaterials have excellent mechanical 
properties, controllable biodegradability, hemostatic properties, low antigenicity and non-
inflammatory characteristics [145], are highly permeable to oxygen and drugs, and resist to 
enzymatic cleavage [146]. 
Silk consists of two types of proteins: SF, which is a filament core protein, and sericins, 
which are a glue-like coating family of hydrophilic proteins holding two fibroin fibers together 
[143,145]. Sericins have been shown to decrease biocompatibility and increase hypersensitivity 
to silk, however, when removed biocompatibility of SF was comparable to other biomaterials 
[191]. SF has been used as a biomaterial in various forms such as films [143,145], membranes 
[143,145], gels [145], sponges [143,145], powders, scaffolds [145], fibers, nets, meshes, and 
yarn [143]. The native B. mori SF protein contain no RGD sequence, a recognized binding site 
for integrin-mediated cell adhesion [41,200-202]. Cell adhesion to this biomaterial has been 
attributed to alternative low-affinity cell binding domains [41] such as arginine residues present 
in the non-repetitive region near the carboxy-terminus [146], or electrostatic interactions between 
cells and silk [41]. The cell attachment and early stages of cell-matrix interactions to B. mori SF 
can be enhanced by modifying the SF biomaterial surface through coating or chemical coupling 
with the RGD peptide sequence or specific growth factors [41,143,186,203,204]. Introducing the 
fibronectin cell-adhesive sequence, RGD, onto the SF biomaterial enhanced cell attachment to 
this material [204,205]. Higher attachment and growth of endothelial cells were obtained when 
SF nets were coated with gelatin, fibronectin, or collagen type I [204]. Human bone marrow 
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stromal cells (BMSCs) and human ACL fibroblasts showed higher cell attachment, spreading, 
and proliferation on RGD-modified SF matrices and silk films [41]. Human keratinocyte cell 
spreading but not attachment was stimulated by laminin coating on SF microfibers, nanofibers, 
and films [206]. Altman et al. [191] demonstrated that when SF films were decorated with the 
RGD peptide the induction of bone formation in vitro was significantly enhanced due to 
increased integrin interaction for cell adhesion.  
In the native ECM, collagen type I serves as a structural protein, an adhesion protein that 
enhances cell attachment, and a signaling protein that promote proliferation through multiple 
binding sites including RGD integrin binding sites [270]. Thus, the addition of collagen type I to 
synthetic or other natural polymers likely would enhance the biocompatibility of those polymers 
while preserving the mechanical strength, therefore, combining the advantages of the two types 
of materials [119,270]. Multiple approaches have been used to introduce proteins into fibrous 
structures including coating, grafting and blending [113,119,245,270]. He et al. [119,245] 
determined that the spreading, viability and attachment of human coronary artery endothelial 
cells was enhanced on collagen-coated or blended poly (L-lactic acid)-co-poly(ɛ-caprolactone) 
nanofiber electrospun scaffolds. Noh et al. [271] demonstrated that coating chitin matrices with 
type I collagen significantly promoted the attachment of proliferating normal human oral 
keratinocytes, normal human epidermal keratinocytes, and normal human gingival fibroblasts 
compared to either uncoated or BSA-coated chitin matrices. Electrospinning is a simple 
technique that when performed using a blended mixture of proteins allows their combination 
both on the surface and throughout the resulting scaffold [219].  
Here, we determine the effects of collagen type I on the physical and mechanical 
characteristics of electrospun scaffolds generated using various ratios of 7% collagen type I 
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blended with 7% SF solutions. We also present the human mammary epithelial, MCF10A, cell 
adhesion, viability, and infiltration onto these electrospun scaffolds in order to model their 
compatibility with SF biomaterials and their potential use in 3D modeling of the mammary 
gland. 
4.3. Materials & Methods 
4.3.1. Silk Extraction 
Bombyx mori SF was extracted from silk cocoons (Bombyx mori silk cocoons, B quality, The 
Yarn Tree, Asheville, NC, USA) as described by Rockwood et al. [207]. Briefly, after discarding 
the silk worms, 5 grams of cocoons were cut and boiled for 30 minutes in 2 liters of 0.02 Na2CO3 
(Sigma, Saint Louis, MO, USA) aqueous solution then rinsed 3 times (20 minutes each) in 
deionized water to remove the sericins. Silk fibers were left to dry overnight then dissolved in 
9.3M LiBr (Fisher Scientific, Fair Lawn, NJ, USA), 12% (w/v), overnight (in 60ºC for the first 4 
hours). Silk solution was then dialyzed against deionized water for 48 hours using 3500 MWCO 
dialysis tubes (Fisher Scientific) with repeated water changes after 1, 4, 6, 12, 12, and 12 hours. 
The regenerated dry silk fibroin sponge was collected by freezing extracted silk solution in -80°C 
followed by lyophilization (SP Scientific, Gardiner, NY, USA). 
4.3.2. Collagen Type I  
Collagen type I, in powder form, used to prepare collagen solution for electrospining was 
obtained by lyophilizing 3.0 mg/ml collagen type I solubilized in 0.01N HCL (Advanced 
BioMatrix, San Diego, CA, USA). 
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4.3.3. Electrospinning 
The air-flow impedance electrospinning technique on a perforated mandrel described by 
McClure et al. [221] was used. In this technique the stainless steel perforated mandrel (Beverlin 
Manufacturing Company, Grand Rapids, MI, USA) was connected to the air line and pressurized 
air traveled through the lumen of this mandrel and exited through the pores impeding fiber 
deposition [58,221]. The air-flow impedance electrospinning method results in formation of 
highly porous regions (perforation regions), which allow cell infiltration, and dense fiber regions 
(flat regions), which provide structural stability [58,221]. The perforated mandrel is a hollow 
mandrel and 6 mm in diameter. It contains 0.75 mm holes spaced 2.0 mm center to center, 
laterally. The center-to-center longitudinal distance was 1.5 mm. A lure lock (Becton Dickinson, 
Franklin Lakes, NJ, USA) was fitted and taped to one end of the perforated mandrel using Tartan 
electric tape (3M Company, St. Paul, MN, USA). A 3mm diameter solid mandrel was inserted 
into the opposite end of the perforated mandrel and secured in place using electric tape (3M 
Company) [58,221]. The perforated mandrel was subjected to an applied air pressure of 100 kPa. 
 Extracted SF or collagen type I (in powder form, anhydrous) were dissolved in 1,1,1,3,3,3 
hexafluoro-2-propanol (HFIP) (TCI America, Portland, OR, USA) at a concentration of 7%. The 
7% SF solution was blended with 7% type I collagen solution at ratios of 95:5, 90:10, and 85:15 
(SF:C type I, v/v). Pure silk and the blended solutions were loaded into Becton Dickinson 
syringes with an 18 gauge blunt tip needle. The needle was subjected to +25 kV with an air-gap 
distance of 13 cm between the needle and the mandrel. A volume of 1.5 ml of the SF-C solution 
was dispensed at a rate of 5ml/h and electrospun on the perforated mandrel. The average 
thickness of the resulting dry scaffolds was 296 ± 7.87 µm. 
 
 85 
4.3.4. Scaffold Characterization 
Scanning Electron Microscopy (SEM) was performed using a JEOL LV-5610 SEM (JEOL 
Ltd., Tokyo, Japan). Inner surface measurements were taken randomly within the site of 
perforation.  Average fiber diameter and pore size of the electrospun structures were measured 
using 60 random locations on each SEM image using ImageTool 3.0 software (Shareware 
provided by UTHSCSA, San Antonio, TX, USA).  
4.3.5. Mechanical Testing 
Uniaxial tensile testing was performed using Tinius Olsen H10KT universal testing machine 
(Horsham, PA, USA). Three sets of ‘dog bone’ shape scaffold samples for each silk:collagen 
ratio were tested in their dry or hydrated form. The purification process used in extraction of SF 
from the B. mori silk cocoons disrupts the β-sheet crystalline domains of SF increasing its water 
solubility.[208]. In contrast, treatments with organic solvents such as methanol, ethanol, or 
alcohol lead to conformational change and self-organization of random coils into natural β-sheet 
structures [139,142,171,187,193,208]. Thus, the scaffold samples for mechanical testing were 
soaked in 99.98% ethyl alcohol (PHARMCO-AAPER) for 1 hour and then washed three times 
(10-minute each) in Phosphate-Buffered Saline (PBS) (Cellgro, Manassas, VA, USA). All 
mechanical testing was performed at room temperature.  
4.3.6. Protein Coating 
Pure SF electrospun scaffolds were soaked in 99.98% ethyl alcohol for 1 hour followed by 
three 10-minute washes in PBS in order to disinfect scaffolds as well as promotion of self-
organization of random coils into natural β-sheet structures [139,142,171,187,193,208] . The 
disinfected scaffolds were coated with 3.0 mg/ml collagen type I solubilized in 0.01N HCL 
overnight in 4ºC.   
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4.3.7. Cell Culture 
Immortalized human mammary epithelial cells, MCF10A (ATCC, Manassas, VA, USA) 
were cultured in growth media containing DMEM/F12 supplemented with 5% horse serum (both 
from Invitrogen; Invitrogen Life Technologies, Grand Island, NY, USA), 1% Penicillin (10,000 
units/ml) and Streptomycin (10,000 g/ml) (Cellgro), 20 ng/ml Epidermal Growth Factor (EGF) 
(BD Biosciences, San Jose, CA), 0.5 g/ml Hydrocortisone, 100 ng/ml Cholera Toxin, and 10 
g/ml Insulin (all from Sigma) [51]. Half of the media volume was changed every 2 days. 
Electrospun scaffolds were disinfected through soaking in 99.98% ethyl alcohol for 1 hour 
followed by three 10-minute washes in PBS. MCF10A cells were seeded at 40×10
3 
cells per 10-
mm diameter biopsy punches of electrospun SF, SF-collagen type I blends, and collagen-coated 
SF scaffolds and maintained for up to 14 days at 37
°
C and 5% CO2.  
4.3.8. Cell Adhesion Analyses 
Tissue culture well-plates were coated with 7.5% poly(2-hydrohyethyl methacrylate) 
(PHEMA) (Sigma) to prevent cells from attaching to cell culture vessels [258,259]. Ten 
millimeter silk scaffold disks were disinfected through soaking in 99.98% ethyl alcohol for 1 
hour followed by three 10-minute washes in PBS. The SF, SF-C blends, and SF-C coated 
scaffolds were coated with 1% bovine serum albumin (BSA) (Gemini Bio-Products, West 
Sacramento, CA, USA) solution for 30 minutes, to reduce the adhesion of serum proteins to the 
scaffolds, followed by three 5-minute washes in PBS. One 10 mm disinfected and BSA coated 
scaffold disk was used per well. MCF10A cells (4×10
4 
cells / scaffold) were seeded on these 
scaffold disks and incubated for 40 minutes before addition of further media to allow for better 
cell entrapment and attachment. After 1 or 2 hours in culture the plates were gently shaken, each 
scaffold was taken out and dipped in media-containing wells 5 times to remove the non-attached 
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cells. The number of non-attached cells suspended in each well was counted and the percentage 
of attached cells on each scaffold disk determined based on the total number of cells used and the 
number of non-adherent cells recorded. 
4.3.9. Cell Viability Analyses 
MCF10A cells (1×10
4 
cells / scaffold) were seeded on 6-mm diameter disinfected SF, SF-C 
blended, and coated scaffold disks and cell viability was determined on day 14. Cell viability 
(number of living cells) was assessed using MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt] assays (CellTiter 96 ® 
Aqueous Non-Radioactive Cell Proliferation Assays, Promega, Madison, WI, USA), as 
described by the manufacturer. The number of viable cells was calculated based on a standard 
curve defining the relationship between absorbance and cell number.  
4.3.10. Cell Infiltration Measurements  
Following cell culture on electrospun scaffolds, scaffolds and cells were fixed in 4% 
formaldehyde for 20 minutes then rinsed in PBS at room temperature. Samples were 
permeabilized in 1:1000 Triton (MP Biomedicals) and equilibrated briefly in 2X saline sodium 
citrate (SSC) (0.3 M NaCl, 0.03 M sodium citrate, pH 7.0; Kirkegard and Perry Laboratories, 
Gaithersburg, MD, USA) then treated with 100 g/ml DNAse-free RNAse (ABgene, Surrey, 
U.K.) in 2X SSC for 20 minutes at 37°C. Samples were then incubated for 5 minutes with the 
fluorochrome base-intercalator propidium iodide (500nM; MP Biomedicals), which dyes the 
nuclei, then rinsed in 2X SSC. 
Fixed and stained scaffold-cell samples were soaked in 30% sucrose solution for 2 hours at 
4
°
C. The samples were then embedded in Tissue-Tek® Optimal Cutting Temperature (O.C.T) 
compound (Ted Pella, Redding, CA, USA) and stored at -80
°
C. Frozen samples were cross-
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sectioned (20 m thick sections) using a cryostat (MICROM GmbH, Walldorf, Germany). For 
each sample, ten cross-sections were imaged using Olympus IX71 fluorescent microscope 
equipped with a DP70 digital camera, using the 10X objective (Olympus, Tokyo, Japan). The 
distance from the surface of the scaffold to the center of sixteen nuclei was measured at evenly 
spaced points (totaling 160 points per sample) using ImageTool 3.0 software (Shareware 
provided by UTHSCSA, San Antonio, TX). 
4.3.11. Statistical Analyses 
All parameters are expressed as mean ± standard error of the mean (SEM). One-way analysis 
of variance (ANOVA) followed by the post-hoc Newman-Keuls Multiple Comparison Test were 
used to assess the differences in cell infiltration, cell attachment, cell viability, fiber diameter 
pore size and mechanical strength between the electrospun SF-C blended scaffolds. A priori, p 
values below 0.05 were defined as significant.   
4.4. Results 
4.4.1. Physical Characteristics of Electrospun SF-C Blended Scaffolds  
SF was blended with ratios of collagen type I (up to 15%) to improve biocompatibility 
without compromising mechanical strength. Both fiber diameters and pore sizes of the inner 
surface of the SF-C blended electrospun scaffolds were characterized at multiple randomly 
selected locations within the perforation regions (highly porous regions) of the perforated 
mandrel subjected to AP of 100 kPa (Figures 4.1 A and 4.B, respectively). Uniaxial tensile 
testing was performed on both dry and hydrated SF-C electrospun scaffolds (Figure 4.2). 
Electrospun scaffolds generated from blends of SF and collagen type I were characterized (Table 
4.1).          
Figure 2. Fiber diameter 
measurements. *, ^, and 
+ indicate a significant 
difference from 50, 300,  
and 400 kPa respectively 
(*p<0.001, ^p<0.05, and 
+p<0.01). # indicates a 
significant difference from 
all other conditions 
(#p<0.001).    
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4.4.2. Blending of Collagen Type I with SF Decreased the Fiber Diameters and Pore Sizes 
of SF-C Electrospun Scaffolds.  
As shown in Figures 4.1A and B, fiber diameter and pore size associated with addition of 
collagen to SF decreased (p < 0.001 and p < 0.001 and 0.05, respectively). There was a 
significant correlation between the amount of collagen (up to 10%) present in the solution and 
fiber diameter and pore size (r
2 
= 0.9998, p < 0.01, and r
2 
= 0.9987, p < 0.05, respectively, Figure 
4.1). However, this correlation was not significant as the amount of collagen was increased from 
10 to 15% (r
2 
= 0.8335, p > 0.05, and r
2 
= 0.8671, p > 0.05, respectively, Figure 4.1). 
Electrospun scaffolds prepared from pure SF (silk:no collagen) exhibited the largest fiber 
diameter and pore size (2.15 ± 0.13 µm, and 137.86 ± 22.55 µm, respectively). The fiber 
diameter of pure SF scaffolds was significantly higher than of those in SF-C blended scaffolds at 
all ratios tested (p < 0.001, Figure 4.2A). The pore size of pure SF scaffolds was significantly 
higher than of those in scaffolds prepared by addition of 5, 10, or 15% collagen to SF (p < 0.05, 
p < 0.001, and p < 0.001, respectively, Figure 4.1B).  Increasing the collagen content from 5% to 
10 or 15 % resulted in a significant decrease in fiber diameter and pore size (p < 0.001 and p < 
0.05, respectively). Although fiber diameters and pore sizes were not significantly different 
between 90:10 and 85:15 SF-C blended scaffolds (Figures 4.1A and B), fiber diameters and pore 
sizes were significantly lower in those blends compared to 95:5 and 100:0 (p<0.05, Table 4.1 and 
Figure 4.1).  
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Table 4.1. Scanning electron micrographs of silk and SF-C blended electrospun scaffolds spun using a 
perforated mandrel subjected to an air pressure of 100 kPa. 
SF:C Ratio (v/v) Scanning Electron 
Microphotographs of the 
Perforation Region 
Average Fiber 
Diameter ± SEM (µm) 
Average Pore Size ± 
SEM (µm
2
) 
100:0  
 
2.15 ± 0.13
a 
 
 
 
 
137.86 ± 22.55
c 
95:5  
 
1.52 ± 0.08
b 
90.61 ± 15.99
d 
90:10  
 
0.93 ± 0.06 37.11 ± 3.44 
85:15 
 
1.03 ± 0.04 42.06 ± 4.39 
a 
Significantly
 
> all SF-C blended scaffolds; p < 0.001. 
b
 Significantly > 90:10 and 85:15 SF-C blended scaffolds; p < 0.001.
 
c
 Significantly > 95:5, 90:10 and 85:15 SF-C scaffolds; p < 0.05, p < 0.001, and p < 0.001.
 
d
 Significantly > 90:10 and 85:15 SF-C blended scaffolds; p < 0.05. 
 
4.4.3. Mechanical Strength of Electrospun SF-C Blended Scaffolds.  
 Uniaxial tensile testing was performed on dry and hydrated SF-C blended electrospun 
scaffolds. Within the dry samples, there were no significant differences between the modulus of 
elasticity of pure SF scaffolds and the 95:5, 90:10, and 85:15 SF-C blends (ns, Figure 4.2). 
However, the elastic moduli of 95:5 and 90:10 SF-C scaffolds were significantly higher than the 
elastic modulus of 85:15 SF-C blends (p < 0.01 and p < 0.05, respectively, Figure 4.2). No 
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significant correlation between the collagen amount and the elastic modulus was recorded (p > 
0.05, r
2 
= 0.9286). Following hydration, the moduli of elasticity of SF-C blended electrospun 
scaffold samples were not significantly different (Figure 4.2).  
  
Figure 4.1. Average fiber diameters and pore sizes of pure SF and SF-C blended electrospun 
scafolds. A) Average fiber diameters. *** indicates significant difference from all SF-C blended 
scaffolds (p < 0.001). # indicates a significant difference from 90:10 and 85:15 SF-C blended scaffolds (p 
< 0.001). B) Average pore sizes. * indicates significant difference from 95:5 SF-C blended scaffolds (p < 
0.05). *** indicates a significant difference form 90:10 and 85:15 SF-C blended scaffolds (p < 0.001). + 
indicates a significant difference from 90:10 and 85:15 SF-C blended scaffolds (p < 0.05). 
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Figure 4.2. Moduli of elasticity of SF-C blended electrospun scaffolds. A) Dry samples. * indicates 
significant difference in the elastic modulus compared to 100:0 and 90:10 SF-C blended electrospun 
scaffolds (*p < 0.05). ** indicates significant difference in the elastic modulus compared to 95:11 SF-C 
blended electrospun scaffolds (**p < 0.01). B) Hydrated samples. No significant differenced were 
observed between elastic moduli regardless of the SF-C blend electrospun scaffold tested.   
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4.4.4. MCF10A Cell Adhesion and Viability on Electrospun SF-C Blended Scaffolds  
MCF10A cell adhesion on 85:15 SF-C blended scaffolds was significantly higher than of that 
on pure SF scaffolds after a one-hour incubation period (p < 0.05, Figure 4.3A). At that time 
point, cell adhesion was not significantly different amongst the SF-C blended scaffolds (ns, 
Figure 4.3A). Following a one-hour incubation period, MCF10A cell adhesion to SF-C coated 
scaffolds was not significantly different from adhesion to pure SF or the SF-C blends (ns, Figure 
4.3A).  
Moreover, MCF10A cell adhesion to all SF-C blended electrospun scaffolds and SF-C coated 
scaffolds was significantly higher than MCF10A cell adhesion to pure SF electrospun scaffolds 
following a two-hour incubation period (p < 0.01, Figure 4.3B). Overall, there was no significant 
correlation between the final collagen concentration (Table 4.2) present in the SF-C blended or 
coated electrospun scaffolds and cell adhesion after either 1 or 2-hour incubation (r
2 
= 0.6021, p 
> 0.05 and r
2 
= 0.7028, p > 0.05, respectively, Figure 4.3A and B).   
 
Table 4.2. Amount of collagen present in each scaffold condition
a
 
Method Scaffold Collagen type 
I Solution 
Concentration, 
(mg/ml) 
Final Collagen type 
I Concentration, 
(mg/ml) 
Blended 100:0 (SF:C) 0 0 
95:5   (SF:C) 70 3.5 
90:10 (SF:C) 70 7 
85:15 (SF:C) 70 10.5 
Coated SF-C Coated  3 ≤ 3 
a 
Final Collagen type I concentrations in the blended scaffolds were calculated based on the initial 
concentration (70 mg/ml) and the ratio of collagen in each blended solution (i.e., in 95:5 there is 5% 
collagen/ml, therefore, 70 mg/ml * 0.05= 3.5 mg/ml). The collagen type I concentration used to coat SF 
scaffolds was 3 mg/ml, therefore 3mg/ml or less was adsorbed onto the SF scaffolds. 
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There was a significant increase in MCF10A cell viability on  SF-C coated scaffolds 
compared to pure SF scaffolds and 95:5, 90:10, and 85:15 SF-C blended scaffolds after 14 days 
in culture (p < 0.01, p < 0.001, p < 0.001, and 0.01, respectively, Figure 4.4).  
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Figure 4.3. Percentage of MCF10A cell adherence to SF-C blended electrospun scaffolds. A) After 
1-Hour incubation. * indicates a significant difference from 100:0 (p < 0.05). B) After 2-Hour 
incubation. ** indicates a significant difference from 100:0 (p < 0.01). 
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Figure 4.4. MCF10A cell viability onto SF-C blended and SF-C coated electrospun scaffolds. ** 
indicates significant difference from 100:0 and 85:15 SF-C blended electrospun scaffolds (p < 0.01). *** 
indicates significant difference from 95:5, and 90:10 SF-C blended electrospun scaffolds (p < 0.001).  
 
 
4.4.5. SF-C Electrospun Scaffolds Limit the Infiltration of MCF10A Cells  
Static cultures of MCF10A cells were maintained for up to 14 days onto SF-C blended and 
coated electrospun scaffolds and the ability of MCF10A cells to infiltrate and colonize the 
scaffolds was assessed by the depth reached by MCF10 cells. 
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The deepest MCF10A cell infiltration was observed onto SF-C coated electrospun scaffolds. 
Cell infiltration through these scaffolds was significantly higher than infiltration through pure SF 
and SF-C blended scaffolds (p < 0.01 and p < 0.001, respectively, Figure 4.5). MCF10A cell 
infiltration onto pure SF scaffolds was significantly higher than onto 95:5, 90:10, and 85:15 SF-
C blended scaffolds (p < 0.01, Figure 4.5). There was a decrease in cell infiltration as the amount 
of collagen increased within the scaffolds. However, MCF10A cell infiltration onto 95:5, 90:10, 
and 85:15 SF-C blended scaffolds was not significantly different. The depth of MCF10A cell 
infiltration was significantly correlated with pore size of electrospun scaffolds (r
2
 = 0.9388, p < 
0.05, Figure 4.5). 
      
Figure 4.5. MCF10A cell infiltration through SF-C electrospun scaffolds after 14 days in culture. ** 
indicates significant difference from 100:0 SF-C blended scaffolds (p < 0.01). *** indicates significant 
difference from 95:5, 90:10 and 85:15 SF-C blended scaffolds (p < 0.001). # indicates significant 
difference from 95:5, 90:10 and 85:15 SF-C blended scaffolds (p < 0.01).   
 
 
4.5. Discussion 
The mechanical properties and biocompatibility of SF-based biomaterials offer significant 
advantages in tissue engineering applications [56,145,146]. SF-derived biomaterials from the 
domestic silkworm B. mori have been examined to develop 3D models of breast tissues [55,58]. 
However, in contrast with SF produced by A. pernyi, the wild-type silkworm, the cell attachment 
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to B. mori SF remains limited [146]. As cell adhesion to the ECM is essential for cell-ECM 
interactions and tissue specificity [6], cell adhesion to the SF can be enhanced by incorporating 
either the specific RGD peptide or ECM protein such as laminin, fibronectin, and collagen into 
SF through coating or blending [41,143,186,203,204]. Thus, here we investigated the 
characteristics of blended SF-C electrospun scaffolds. Our results indicate that although the 
blending of SF and collagen lead to significant changes in mechanical properties of the 
electrospun scaffolds, the tensile strength of the blended SF-C electrospun scaffolds remained 
similar. Furthermore, the biocompatibility of these blended electrospun scaffolds was improved.   
Our results using blended 7% SF and 7% collagen type I solutions at ratios of 100:0, 95:5, 
90:10, and 85:15 (SF:collagen type I v/v) electrospun scaffolds indicate that blending SF with 
collagen type I altered the physical characteristics of these fibrous structures. Specifically, the 
blending of SF and collagen type I led to a significant decrease in the average pore size and fiber 
diameters of the electrospun scaffolds. At the concentrations and ratios tested, the blended SF-C 
scaffolds showed no changes in their mechanical strength in their hydrated state, however, their 
tensile strength in their dry state decreased with high SF-C ratio (85:15). 
Furthermore, our data demonstrates that increasing the collagen content in the SF-C blended 
electrospun scaffolds led to a significant decrease in fiber diameter and pore size. Particularly, 
the 90:10 and 85:15 SF-C blended scaffolds had significantly smaller fiber diameter and pore 
size than the 95:5 SF-C blended scaffolds. This decrease in the fiber diameter confirmed the 
decrease of the fiber diameter of nano-fibrous electrospun scaffolds prepared from blends of 
polydioxanone (PDO) and type I collagen compared to pure PDO scaffolds [220].  
Interestingly, the uniaxial tensile testing results revealed no significant changes in the 
mechanical strength of the hydrated scaffolds when SF was blended with collagen type I in the 
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ratios tested (SF-C 100:0 to 85:15). Similar mechanical properties were demonstrated for 
hydrated PDO:collagen blended electrospun scaffolds [220]. However, in their dry state the 
tensile strength of SF electrospun scaffolds when blended with collagen at a ratio of 85:15 SF-C 
was significantly lower than that of scaffolds generated using SF-C blends with higher SF 
content. These observations were consistent with observations by He et al. [119] that 
demonstrated a significant decrease in tensile strength in collagen-blended poly(L-lactic acid)-
co-poly(ɛ-caprolactone) [P(LLA-CL), 70:30] fibrous scaffolds at a ratio of 50:50 compared to 
the tensile strength in non-blended P(LLA-CL) scaffolds. 
Furthermore, the infiltration of MCF10A epithelial cells through SF-C blended scaffolds 
significantly decreased as the pore size within these scaffolds decreased. In contrast, the 
MCF10A cell infiltration onto SF-C coated scaffolds was significantly deeper.  Our results also 
highlight that the infiltration of MCF10A epithelial cells through SF-C blended scaffolds was 
significantly reduced compared to cell infiltration through pure SF scaffolds. This reduced 
infiltration is mainly associated with the significantly smaller pores generated within the SF-C I 
blended scaffolds. Furthermore, the smallest cell infiltration was associated with the highest 
collagen type I ratio to SF, i.e., 85:15 SF-C blended scaffolds, which exhibited the smallest pore 
size compared to all other conditions. These results confirm our and others previous studies 
[58,221,268]. In a previous study, a deeper MCF10A cell infiltration through SF electrospun 
scaffolds was associated with higher pore sizes generated following electrospinning SF at an air 
pressure of 100 kPa than all the other conditions [58]. The electrospinning conditions used here 
were similar excepted for the blending of SF with collagen highlighting the key importance of 
the biomaterial mix used in both the generation of scaffolds with various pore size and adhesion 
properties [119,151,268].  
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Although the MCF10A cell infiltration into SF-C blended scaffolds was reduced in part 
because of reduced pore size, our data demonstrate that cell infiltration through SF-C coated 
electrospun scaffolds increased in part because of the larger pore size and the presence of 
collagen type I cell binding sites [221,268,272]. These data confirm previous observations 
demonstrating increased cell infiltration through collagen-glycosaminoglycan porous scaffolds as 
the pore size was increased [268]. Further, McClure et al. [221] demonstrated increased human 
dermal fibroblast cell infiltration through poly(ɛ-caprolactone) (PCL) scaffolds, prepared by air-
flow electrospinning, with larger pore sizes than scaffolds with smaller pores. Moreover, our data 
agree with Zhang et al.’s observations that demonstrated significantly higher infiltration of bone 
marrow mesenchymal stem cells in gelatin/PCL blended scaffolds compared to pure PCL 
scaffolds [272]. 
Our results also demonstrate that both collagen type I blending and coating onto fibrous SF 
scaffolds significantly altered the adhesion and viability of MCF10A epithelial cells. Indeed, the 
adhesion of epithelial cells to electrospun fibrous scaffolds was significantly increased when SF 
was blended or coated with collagen type I. This result is consistent with previous observations 
demonstrating that 3D sponge-like porous scaffolds prepared from blends of SF and collagen 
promoted higher chondrocyte attachment than sponge-like porous scaffolds prepared from pure 
SF [273,274]. Furthermore, the limited MCF10A cell attachment to pure SF scaffolds and the 
improved attachment to the collagen-blended scaffolds observed here are in keeping with the 
attachment of Saos-2 osteoblast-like cells to B. mori pure SF and RGD-modified SF films 
demonstrated by Sofia et al. [151].  
The increase in MCF10A cell viability cultured onto SF-C coated scaffolds is associated with 
both the presence of cell binding site from collagen type I and the larger pores. Higher cell 
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viability associated with larger pores confirms previous observations demonstrating increased 
cell viability through scaffolds with larger pores [58,268]. In a previous study, we demonstrated 
significantly increased MCF10A cell viability onto 7% SF electrospun scaffolds with larger 
average pore size in comparison to 7% SF electrospun scaffolds with smaller pore sizes [58]. 
These observations also confirmed increased cell viability through collagen-glycosaminoglycan 
porous scaffolds as the pore size was increased [268]. Similarly, higher cell viability associated 
with the presence of cell binding site from collagen type I confirms previous observations 
demonstrating higher number of viable cells on collagen blended or collagen coated P(LLA-CL) 
nanofibers [119,245]. 
Taken together, the blended SF-C electrospun scaffolds maintained the SF tensile strength, 
and despite different fiber and pore size allowed an improved MCF10A cell adhesion, viability, 
and infiltration. The SF-C coated scaffolds also promoted enhanced MCF10A cell adhesion, 
viability, and infiltration. Thus, electrospun SF and collagen type I blended or coated scaffolds 
provide an improved in vitro approach to mimicking the mammary epithelial microenvironment.  
4.6. Conclusion 
These results provide evidence that blended or coated SF-C electrospun scaffolds support 
mammary epithelial cell viability and adhesion. Specifically, modifications of the SF chemical 
properties through the addition of the ECM protein collagen type I using coating or blending 
approaches promoted significant increases in the initial MCF10A cell adhesion on these 
biomaterials. Although, this ECM protein did not provide the cells with adequate chemical cues 
and integrin mediated cell-ECM interactions required for formation of epithelial structures, these 
results demonstrate the ability to modify the microenvironment of the SF electrospun scaffolds to 
modulate and enhance cell-ECM interactions.   
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CHAPTER 5: LAMININ-COATING OF ELECTROSPUN SILK FIBROIN 
DERIVED SCAFFOLDS IN THREE-DIMENSIONAL CULTURES OF 
MAMMARY EPITHELIAL CELLS 
 
5.1. Abstract 
Cell-ECM interactions are essential to many aspects of cell behavior including adhesion, 
morphology, motility, and differentiation in both in vitro and in vivo. ECM proteins such as 
laminin, fibronectin, and collagens enhance cell adhesion and support cell-ECM interactions 
through ECM protein-integrin bindings. Further, laminin specifically promotes epithelial cell 
morphological and functional differentiation in three-dimensional (3D) culture systems. Here, we 
investigated the effects of laminin coating on the engineered silk fibroin (SF)-derived 
electrospun scaffolds on the attachment, survival, and morphological differentiation of the 
mammary epithelial cell MCF10A cultured onto those scaffolds under various conditions. 
Although MCF10A cell survival remained unchanged regardless of the conditions tested, 
MCF10A cell attachment significantly increased on laminin-coated electrospun SF- derived 
scaffolds compared to the non-laminin coated electrospun SF- derived scaffolds (p < 0.05). 
Further, MCF10A cells cultured on electrospun SF-derived scaffolds coated with 15 µg/ml of 
laminin in the presence of lactogenic hormones formed epithelial structures. These data 
highlights the potential of electrospun SF-derived scaffolds coated with the ECM protein laminin 
in the generation of 3D mammary structures in vitro. 
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5.2. Introduction 
Engineered in vitro 3D models of the mammary tissue have contributed greatly to the study 
and understanding of breast development and cancer initiation 
[50,51,54,56,83,84,106,110,122,123,125-127,275]. Notably, the importance of cell-cell, cell-
stroma, and cell-extracellular matrix (ECM) interactions, in the generation of functional breast 
tissue structures have been established [50,84,106,124,128]. Indeed, using 3D scaffolds to 
generate a microenvironment that closely mimics the structural and physiological features of 
breast tissue was associated with the engineering of functional mammary models and potential 
breast implants [10]. Previously 3D mammary models have mostly utilized gel scaffolds, such as 
Matrigel
®
 and collagen to simulate the mammary tissue microenvironment 
[50,51,54,56,83,84,106,110,122,123,125-127,275]. Matrigel
®
 has been especially useful in in 
vitro 3D modeling, however, the concentrations of growth factors within Matrigel
®
 in long-term 
studies and in vivo use, may be associated with alterations of cellular activities [133,134]. 
Moreover, Matrigel
®
 is derived from a mouse sarcoma, limiting its biocompatibility and use in 
human [133,134]. Also tested, were hydogels including specific type I collagen gels that 
demonstrated rapid gel contraction and low stability [276]. More recently, Wang et al. [55] 
demonstrated that mammary epithelial cells co-cultured with stromal cells (pre-differentiated 
adipocytes and fibroblasts) within a collagen/Matrigel
®
 mixture and maintained on 3D silk 
sponges formed ductal and acinar structures. Those 3D sponges were formed of a reticulated 
network with pore walls that measure several microns thick and as such were structurally 
differed from the more fibrillar structure of the mammary ECM [277]. Indeed, the ECM mainly 
composed of structural proteins collagens types I, II, and III, which have diameters varying from 
50 to 500 nm forms a nano-fibrous structure [115,219,220]. These ECM fibrous proteins are one 
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to two orders of magnitude smaller than the cells allowing cell interactions with multiple fibers 
simultaneously and participating in the cell 3D polarity, migration and morphology [221]. 
Electrospinning is a unique and versatile technique that enables the development of nanofibers, 
in the nano to a few micrometer range, from a variety of polymers [131,141,142,223]. Given 
their similar properties with the fibrous components to the ECM, electrospun polymer-derived 
scaffolds have been used for tissue engineering and regenerative medicine [8,142,171]. The 
electrospinning process permits tailoring and control of several aspects of ECM-like scaffolds 
including the thickness, composition, diameters and porosity of the nano-fibers [8,141,224,225].  
Furthermore, the surface area and porosity of electrospun nanofiber scaffolds also favor cell 
interactions [8]. The structural properties of scaffolds derived from electrospun nanofibers mimic 
ECM structural features and thus provides an excellent micro/nano environment for cell growth 
and function [8,171].  
Silk fibroin (SF), the major component of a large subset of non-bio-absorbable biomedical 
sutures, has been used extensively in medical applications [114,139]. Silk-derived biomaterials 
are also investigated given their excellent mechanical properties [141], biocompatibility, slow 
controllable degradation rate [139,143,144], hemostatic properties, and low antigenicity 
[142,145], high oxygen permeability, high drug permeability, resistance against enzymatic 
cleavage [146], and thermal stability over a wide range of temperatures up to about 250 °C 
without loss of functional integrity [142]. SF-derived biomaterials have been generated in 
various forms such as films [143,145], membranes [143,145], gels [145,147], sponges [143,145], 
powders, scaffolds [145,147], fibers, nets, meshes, yarn [143], and nano-particles [147].  
Earlier we provided evidence of the biocompatibility of SF nano-fibrous electrospun 
scaffolds with mammary epithelial cells [58]. However, in the conditions tested despite high cell 
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adhesion (unpublished data), viability and infiltration, no mammary acinar structure was 
observed. Aggeler et al. (1988) and Bissell et al. (1989), demonstrated remarkable 
morphological alterations and formation of many large cell aggregates with hollow lumens, as 
well as, increased synthesis of β-casein mRNA when cultures of mammary epithelial cells were 
maintained on 3D gels compared to two-dimensional (2D) cultures maintained on flat cell 
culture plastic [84,120]. Although in 2D culture conditions of epithelial cells formed a 
monolayer, those cells expressed elevated levels of β-casein mRNA when they were cultured in 
2D culture conditions coated with the basement membrane protein laminin [84,120]. These 
observations suggests that multiple levels of regulation are involved in mammary-specific gene 
expression and cooperative interactions between ECM molecules and cells as well as cell-cell 
contact formation and the establishment of epithelial polarity positively modulate β-casein 
expression and are necessary for functional differentiation in culture [84,106]. Further, laminin 
gels supported the formation of multicellular structures by mouse mammary epithelial cells 
similar to those formed on Engelbreth-Holm-Swarm (EHS) basement membrane matrix (i.e., 
Matrigel
®
) [137]. Incubation of mouse mammary epithelial cells in the presence of lactogenic 
hormones onto laminin gels induced synthesis of the milk protein β-casein [137]. Thus, laminin 
along with lactogenic hormones promote the morphological and functional differentiation of 
mammary epithelial cells [137]. It has been demonstrated that β1-integrin-cell interactions 
mediated by ECM protein laminin are crucial in differentiation of mammary epithelial cells and 
secretion of milk protein, β-casein, by these cells [106]. Inhibiting these β1-integrin-cell 
interactions results in disruption of theses polarized and differentiated structures [106]. Further, 
the polarized structures resulting from interactions with laminin, but not other ECM proteins 
such as collagen I, are resistant to apoptosis through β4 integrin interactions [138]. Interactions 
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of β4 integrin with laminin initiate signals for cell growth, viability, and functional 
differentiation. These interactions direct tissue polarity and promote resistance to apoptosis in 
both nonmalignant and malignant breast epithelial structures as well [138].  
 Here, we hypothesized that the coating of the SF nanofibrous electrospun scaffolds with the 
ECM protein laminin would promote the polarized cellular organization and acinar formation 
and functional differentiation of MCF10A cells. Therefore, we determined the effects of laminin 
on the MCF10A cell adhesion, viability, and organization when cultured on laminin-coated 
electrospun SF derived scaffolds.    
5.3. Materials and Methods 
5.3.1. Silk Extraction 
Bombyx mori SF was extracted from silk cocoons (Bombyx mori silk cocoons, B quality, The 
Yarn Tree, Asheville, NC, USA) as described by Rockwood et al. [207]. Briefly, after discarding 
the silk worms, 5 grams of cocoons were cut and boiled for 30 minutes in 2 liters of 0.02 Na2CO3 
(Sigma, Saint Louis, MO, USA) aqueous solution then rinsed 3 times (20 minutes each) in 
deionized water to remove the sericins. Silk fibers were left to dry overnight then dissolved in 
9.3M LiBr (Fisher Scientific, Fair Lawn, NJ, USA), 12% (w/v), in 60ºC for 4 hours. Silk 
solution was then dialyzed against deionized water for 48 hours using 3500 MWCO dialysis 
tubes (Fisher Scientific) with repeated water changes after 1, 4, 6, 12, 12, and 12 hours. The 
regenerated dry silk fibroin sponge was collected by freezing extracted silk solution in -80°C 
followed by lyophilization (SP Scientific, Gardiner, NY, USA). 
5.3.2. Electrospinning 
The air-flow impedance electrospinning technique on a perforated mandrel was used 
[58,221]. In this technique the stainless steel perforated mandrel (Beverlin Manufacturing 
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Company, Grand Rapids, MI, USA) was connected to the air line and pressurized air traveled 
through the lumen of this mandrel and exited through the pores impeding fiber deposition 
[58,221]. The air-flow impedance electrospinning method results in formation of highly porous 
regions (perforation regions), which allow cell infiltration, and dense fiber regions (flat regions), 
which provide structural stability [58,221]. The perforated mandrel is a hollow mandrel and 6 
mm in diameter. It contains 0.75 mm holes spaced 2.0 mm center to center, laterally. The center-
to-center longitudinal distance was 1.5 mm. A lure lock (Becton Dickinson, Franklin Lakes, NJ, 
USA) was fitted and taped to one end of the perforated mandrel using Tartan electric tape (3M 
Company, St. Paul, MN, USA). A 3mm diameter solid mandrel was inserted into the opposite 
end of the perforated mandrel and secured in place using electric tape (3M Company) [58,221]. 
The perforated mandrel was subjected to an applied air pressure of 100 kPa. 
 Extracted SF (in dry form, anhydrous) was dissolved in 1,1,1,3,3,3 hexafluoro-2-propanol 
(HFIP) (TCI America, Portland, OR, USA) at a concentration of 7%. The 7% SF solution was 
loaded into Becton Dickinson syringes with an 18 gauge blunt tip needle. The needle was 
subjected to +25 kV with an air-gap distance of 13 cm between the needle and the mandrel. A 
volume of 1.5 ml of the SF solution was dispensed at a rate of 5ml/h and electrospun on the 
perforated mandrel. The average thickness of the resulting dry scaffolds was 266.7 ± 13.6 µm.  
5.3.3. Scaffold Characterization 
Scanning Electron Microscopy (SEM) was performed using a JEOL LV-5610 SEM (JEOL 
Ltd., Tokyo, Japan). Inner surface measurements were taken randomly within the site of 
perforation.  Average fiber diameter and pore size of the electrospun structures were measured 
using 60 random locations on each SEM image using ImageTool 3.0 software (Shareware 
provided by UTHSCSA, San Antonio, TX, USA).  
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5.3.4. Laminin Coating 
Pure SF electrospun scaffolds were soaked in 99.98% ethyl alcohol for 1 hour followed by 
three 10-minute washes in PBS in order to disinfect scaffolds as well as promote self-
organization of random coils into natural β-sheet structures [139,142,171,187,193,208] . The 
disinfected scaffolds and cell culture vessels were coated with 0, 1, 5, 10, 15, and 20 µg/ml of 
Laminin 1 from Engelbreth-Holm-Swarm murine sarcoma (basement membrane) (Sigma), 
solubilized in sterile deionized water, overnight in 4ºC. SF scaffolds and cell culture vessels were 
coated with the same amount of laminin by calculating the total available surface area of the 
scaffolds as described by Boland et al. [278] and the surface area of cell culture vessels.   
5.3.5. Cell Culture 
Immortalized human mammary epithelial cells, MCF10A (ATCC, Manassas, VA, USA) 
were cultured in growth media containing DMEM/F12 supplemented with 5% horse serum (both 
from Invitrogen, Carlsbad, CA, USA), 1% Penicillin (10,000 units/ml) and Streptomycin (10,000 
g/ml) (Cellgro), 20 ng/ml Epidermal Growth Factor (EGF) (BD Biosciences, San Jose, CA, 
USA), 0.5 g/ml Hydrocortisone, 100 ng/ml Cholera Toxin, and 10 g/ml Insulin (all from 
Sigma) [51]. Half of the media volume was changed every 2 days. 1×10
5
 MCF10A cells were 
seeded per 10-mm diameter disinfected and laminin coated and non-coated SF electrospun 
scaffold disks and maintained in culture for up to 14 days at 37
°
C and 5% CO2. After 3 days in 
culture the media, some cultures were supplemented with a lactogenic cocktail (0.8 mM insulin, 
0.2 mM prolactin, 1 mM Dexamethasone (Sigma) [279]. 
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5.3.6. Cell Adhesion Analyses 
Tissue culture well-plates were coated with 7.5% poly(2-hydrohyethyl methacrylate) 
(PHEMA) (Sigma) to prevent cells from attaching to cell culture vessels [258,259]. Ten 
millimeter disinfected and laminin coated and non-coated SF scaffold disks were further coated 
with 1% bovine serum albumin (BSA) (Gemini Bio-Products, West Sacramento, CA, USA) 
solution for 30 minutes, to reduce the adhesion of serum proteins to the scaffolds, followed by 
three 5-minute washes in PBS. One 10 mm disinfected laminin and BSA coated scaffold disk 
was used per well. MCF10A cells (4×10
4 
cells / scaffold) were seeded on these scaffold disks 
and incubated for 40 minutes before addition of further media to allow for better cell entrapment 
and attachment. After 1 or 2 hours in culture the plates were gently shaken, each scaffold was 
taken out and dipped in media-containing wells 5 times to remove the non-attached cells. The 
number of non-attached cells suspended in each well was counted and the percentage of attached 
cells on each scaffold disk was determined based on the total number of cells used and the 
number of non-adherent cells recorded. 
5.3.7. Cell Viability Analyses 
MCF10A cells (1×10
4 
cells / scaffold) were seeded on 10-mm diameter disinfected and 
laminin coated and non-coated SF scaffold disks as well as laminin coated and non-coated cell 
culture vessels and cell viability was determined on day 14. Cell viability (number of living 
cells) was assessed using MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt] assays (CellTiter 96 ® Aqueous Non-Radioactive Cell 
Proliferation Assay; Promega, Madison, WI, USA), as described by the manufacturer. The 
metabolically active cells react with a tetrazolium salt in the MTS reagent to produce a soluble 
formazan dye with an absorption that can be measured at 490 nm. For each condition, the 
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numbers of cells were calculated based on standard curves and normalized to the percentages of 
attached cells.  
5.3.8. Immunofluorescence Staining and Structure Formation Analyses 
Following cell culture on laminin coated and non-coated electrospun silk scaffolds after 14 
days, cell containing scaffolds were fixed in 4% formaldehyde for 20 minutes then rinsed in PBS 
at room temperature. The fixed samples were then blocked in Odyssey Blocking Buffer (LI-
COR, Lincoln, NE) including 0.2% Tween 20 (Sigma). After 60 minutes at room temperature the 
blocking buffer was aspirated and Alexa Fluor
®
 555 Anti-GM130 antibody (BD Biosciences, 
San Jose, CA, USA) was added at 1:10 concentration and samples were incubated for 60 minutes 
at room temperature. Samples were then rinsed three times in PBS for 5 minutes each and treated 
with sterile Vybrant
®
 DiD cell labeling solution phospholipid dye (Invitrogen) for 30 minutes at 
room temperature. After three 5-minute PBS rinses samples were treated with 0.1 µg/ml DAPI 
nucleic acid stain (Invitrogen). Formation of acinar structures was visualized using a confocal 
microscope (Olympus FV1000). 
5.3.9. Statistical Analyses 
All parameters are expressed as mean ± standard error of the mean (SEM). Two-way analysis 
of variance (ANOVA) followed by the post-hoc Bonferroni Multiple Comparison Test were used 
to assess the differences in cell attachment and cell viability between the electrospun laminin 
coated SF scaffolds and laminin coated cell culture vessels . A priori, p values below 0.05 were 
defined as significant.   
 
 
Figure 2. Fiber diameter 
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and 400 kPa respectively 
(*p<0.001, ^p<0.05, and 
Figure 2. Fiber diameter 
measurements. *, ^, and 
+ indicate a significant 
difference from 50, 300,  
and 400 kPa respectively 
(*p<0.001, ^p<0.05, and 
+p<0.01). # indicates a 
significant difference from 
all other conditions 
(#p<0.001).    
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5.4. Results 
5.4.1. Physical Characteristics of Electrospun SF Scaffolds  
Both fiber diameters and pore sizes of the inner surface of the SF electrospun scaffolds were 
characterized at multiple randomly selected locations within the perforation regions (highly 
porous regions) of the perforated mandrel subjected to AP of 100 kPa. The average fiber 
diameter was measured at 2.15 ± 0.13 µm. The average pore size was measured at 137.86 ± 
22.55 µm
2
.        
5.4.2. MCF10A Cell Adhesion on Laminin Coated SF Electrospun Scaffolds 
MCF10A cell adhesion after 1 and 2 hours in culture was assessed on laminin coated and 
non-coated SF scaffolds (SFS) (3D cultures) and laminin coated and non-coated cell culture 
vessels (CCV) (2D cultures). After a one-hour incubation, MCF10A cell adhesion onto SF 
scaffolds coated with 5 (p < 0.05, Figure 5.1A), 15 or 20 µg/ml (p < 0.01, Figure 5.1A) laminin 
was significantly higher than MCF10A cell adhesion onto non-coated (0 µg/ml) and 10 µg/ml 
laminin coated SF scaffolds. After a one-hour incubation, MCF10A cell adhesion onto 
electrospun SF-derived scaffolds coated laminin solutions of increasing concentrations (1-20 
µg/ml) remained similar (ns, Figure 5.1A). In similar incubation conditions, 2D cultured 
MCF10A cell adhesion onto laminin-coated vessels was significantly higher than on non-coated 
vessels regardless of the concentration of laminin used for coating (1 and 5 µg/ml (p < 0.01) and 
10, 15, and 20 µg/ml (p < 0.001, Figure 5.1A). Vessels coated with 20 µg/ml laminin promoted 
higher 2D MCF10A cell attachment than vessels coated with lower laminin concentrations (1 or 
5 µg/ml; p < 0.01 and p < 0.05, respectively, Figure 5.1A). MCF10Acell adhesion on 3D and 2D 
cultures were similar regardless of the coating and conditions tested excepted within the non-
coated SF scaffolds and non-coated cell culture vessels after one-hour incubation (p < 0.01, 
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Figure 5.1A). Overall, within the first hour both laminin concentrations (p < 0.001) and culture 
conditions (p < 0.01) markedly altered MCF10A cell adhesion. 
After a longer incubation period (2 hours), MCF10A cell adhesion to all the laminin coated 
SF scaffolds was significantly higher than MCF10A cell adhesion to non-coated SF electrospun 
scaffolds (1, 5, and 10 µg/ml (p < 0.05), 15 µg/ml (p < 0.001), and 20 µg/ml (p < 0.01), Figure 
5.1B). No significant correlation between the laminin concentration and MCF10A cell adhesion 
regardless of the incubation time tested was observed (r
2 
= 0.4065, p > 0.05 and r
2 
= 0.6314, p > 
0.05, respectively, Figure 5.1A and B).  Overall, after a two-hour incubation, the laminin 
concentration had a significant effect on MCF10A cell adhesion regardless of the culture 
conditions (p < 0.001, Figure 5.1B).   
 
Figure 5.1. MCF10A cell adhesion on laminin-coated vessels and electrospun SF-derived scaffolds. 
A) After 1-hour incubation. # indicates a significant difference between adhesion on non-coated 3D and 
2D cultures (p < 0.01). * indicates a significant difference from laminin coating of 5 µg/ml (p < 0.05). ^ 
indicates a significant difference form laminin coating of 15 and 20 µg/ml (p < 0.01). ** Indicates 
significant difference from laminin coating of 1 and 5 µg/ml (p < 0.01). *** indicates significant 
difference from 10, 15, and 20 µg/ml (p < 0.001). + and ++ indicate significant differences from 20 µg/ml 
(+ p < 0.01 and ++ p < 0.05). a and b indicate significant difference from 5, 15, and 20 µg/ml (a p < 0.05 
and b p < 0.01). B) After 2-hour incubation. *, **, and *** indicate significant differences between 
laminin coated and non-coated 3D cultures (* p < 0.05, ** p < 0.01, and *** p < 0.001). # indicates 
significant difference between laminin coated and non-coated 2D cultures (p < 0.001).  
 
 
 
0 1 5 10 15 20
0
50
100
a,b*
,^ +
A
**,***
Laminin Concentration, g/ml
A
tt
a
c
h
e
d
 C
e
ll
s
 (
%
)
++
#
0 1 5 10 15 20
0
50
100
SFS
CCV
B
#
Laminin Concentration, g/ml
A
tt
a
c
h
e
d
 C
e
ll
s
 (
%
)
*
******* #
# # #
 110 
5.4.3. MCF10A Cell Viability on Laminin Coated Electrospun SF-derived Scaffolds 
MCF10A cell viability was assessed on laminin-coated and non-coated electrospun SF-
derived scaffolds and vessels following a 14-day incubation in cell culture conditions. Overall, 
more MCF10A cells were recorded in cell culture vessels (2D conditions) than 3D culture 
condition (electrospun SF-derived scaffolds) (p < 0.001; 2-way ANOVA). This difference was 
mainly associated with significant difference in the numbers of MCF10A cells present in 
laminin-coated vessels (20 µg/ml) and scaffolds coated with the same laminin concentration (p < 
0.05, Figure 5.2).  
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Figure 5.2. MCF10A cell viability on laminin-coated and non-coated vessels and scaffolds. * 
indicates significantly higher number of cells in vessels coated with laminin (20 µg/ml) (p < 0.05). 
 
5.4.4. Acinar Structures on Laminin Coated Electrospun SF-derived Scaffolds. 
The presence of MCF10A derived acinar structures was assessed in both vessels coated with 
increasing laminin concentrations and electrospun SF-derived scaffolds after a 14-day incubation 
in culture with or without lactogenic hormones by confocal microscopy. No acinar structure was 
observed in vessels coated or not with laminin (0-20 µg/ml, data not shown). On electrospun SF-
derived scaffolds in the absence of lactogenic hormones or at low concentrations of laminin (1, 
5, 10 µg/ml) no structure were detected (Figure 5.3A). However, in the presence of lactogenic 
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hormones MCF10A acinar structures were observed onto electrospun SF-derived scaffolds 
coated with 15 and 20 µg/ml of laminin (Figure 5.3B and Table 5.1). 
 
Figure 5.3. MCF10A Cell morphology in 3D laminin coated SF-derived scaffolds. A) Absence of 
acinar structures. B) Polarized acinar structure on SF scaffolds coated with 15 µg/ml of laminin. MCF10A 
acini were immunostained with antibodies to the Golgi protein, GM130 (green), which illustrated the 
apical orientation of the Golgi apparatus toward the hollow lumen of acini. Cell nuclei were stained with 
DAPI nucleic stain (blue). Cell membranes were stained with Vybrant DiD phospholipid stain (red). Silk 
fibers are shown in blue.  
 
Table 5.1. Formation of acinar-like structures under different conditions 
Laminin 
Concentration, 
µg/ml 
Lactogenic Hormones 
Acinus-like Structure 
Formation 
0 Yes No 
1 Yes No 
5 Yes No 
10 Yes No 
15 Yes Yes 
20 Yes Yes 
 
5.5. Discussion  
In engineering 3D in vitro mammary models, mammary epithelial cells form acinar and 
ductal structures [50,51,54,56,83,84,122,125-127]. Bissell et al. [84] Aggeler et al. [120] 
demonstrated that cultures of mammary epithelial cells onto laminin coated tissue culture vessels 
or laminin coated floating collagen gels lead to increased expression of β-casein mRNA. Further, 
mammary epithelial cells cultured on laminin gels formed structures with hollow lumens and 
induced the synthesis of β-casein in the presence of lactogenic hormones [137]. Earlier, we noted 
that MCF10A mammary epithelial cells on SF-derived electrospun scaffolds did not generate any 
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acinus-like structures (unpublished data). Here, the electrospun SF-derived scaffolds were coated 
with laminin, a basement membrane protein that improve cell-ECM interactions and promote 
epithelial differentiation [137]. Our results indicate that the laminin coating of electrospun SF-
derived scaffolds enhanced MCF10A cell attachment and in the presence of lactogenic hormones 
the formation of organized MCF10A cell acinus-like structures was detected.  
As expected, our data indicate significantly higher MCF10A cell attachment on laminin-
coated electrospun SF-derived scaffolds and tissue culture vessels than attachment on non-coated 
scaffolds and vessels. These observations further confirm the significantly higher cell attachment 
demonstrated for rat islet cells onto laminin-coated tissue culture vessels [280]. Our data indicate 
lower numbers of viable MCF10A cells on laminin-coated SF scaffolds, in particular using 20 
µg/ml laminin concentration, compared to laminin coated cell culture vessels. This observation 
demonstrates the slow proliferation rate of MCF10A cells in 3D cultures and formation of 
growth-arrested acinaus-like structures as demonstrated in Matrigel
®
 cultures [51].  
Our results demonstrate that MCF10A cultured on electrospun SF-derived scaffolds coated 
with laminin at concentrations of 15 and 20 µg/ml and the presence of lactogenic hormones 
formed acinar structures, although different in both number and size compared to structures 
formed onto Matrigel
® 
(data not shown). The absence of acinar structures observed here when 
MCF10A cells were cultured on SF scaffolds without lactogenic hormones confirm observations 
by Streuli et al. [137] demonstrating that laminin and lactogenic hormones, together,  promote 
the morphological and functional differentiation of mammary epithelial cells. Indeed, MCF10A 
cells formed acinar structures when culture onto Matrigel
®
, an ECM composed mainly of 
laminin in 3D culture conditions [137]. Furthermore, the use of 3D laminin gels lead to the 
generation of similar 3D acinar –like structures [137]. The structures formed onto our 
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electrospun SF-derived laminin-coated scaffolds may be associated with the intensity of laminin-
coating and the presence of lactogenic hormones. 
5.6. Conclusion 
Our results demonstrate that the presence of laminin provided cell-ECM interaction sites, 
possibly through β1 and β4 integrins, which are crucial in the differentiation and formation of 
polarized growth-arrested structures of mammary epithelial cells. Here, we further demonstrated 
the flexibility of SF-derived electrospun scaffolds, which allow modification and control over the 
structural features as well as chemical features of the engineered microenvironment. This control 
allows testing of various factors involved in the function of the breast tissue either individually 
and/or as a group.    
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CHAPTER 6: CONCLUSION AND FUTURE DIRECTIONS 
 
 
Three-dimensional (3D) modeling of tissues and organs in vitro has proven a useful tool to 
study organ development and function in both healthy and diseased states. In vitro breast 
epithelial cell models further our understanding of the complex interactions between mammary 
epithelial cells and the stromal components during normal breast development and breast cancer 
initiation, progression, and development. In modeling of breast tissue, mimicking the structural 
properties of the ECM is essential as the ECM plays a key role in the organization and function 
of the tissue. It is also critical to provide mammary epithelial cells with an environment including 
physiochemical and mechanical cues essential to the maintenance and regulation of cell behavior 
and tissue function mimicking those provided by the breast tissue microenvironment. Multiple 
scaffold approaches mimicking the ECM have been tested. However, only limited work has been 
conducted using fiber-based scaffolds to mimic breast tissue ECM nano-fibrous composition and 
structure.  
Tissue-like scaffolds that closely resemble the fibrous structure of ECM can be produced 
through electrospinning of biologically-derived or synthetic polymers. Those nano-fiber 
scaffolds closely mimic the structure of collagen fibers in the tissue’s ECM and also promote cell 
adhesion and survival. In particular, SF-derived scaffolds have mechanical properties and a 
biocompatibility suitable for the generation of long-term 3D cultures and tissue like-structures 
that can serve as in vitro 3D breast tissue models and for tissue repair, respectively. 
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The studies detailed in the present work address the overall goal of developing electrospun 
SF-derived scaffolds that promote mammary cell growth and the formation of mammary like 
structures depending on the composition and/or coating of the scaffolds with ECM proteins. 
Specifically, the studies presented investigated (1) the effects of various concentrations of SF 
along with different electrospinning techniques on the mechanical and physical properties of 
electrospun SF-derived scaffolds and (2) whether those scaffolds provide suitable 
microenvironments for mammary epithelial cells as determined by MCF10A cell attachment, 
viability, and structure formation. Further, we determined (3) the effects of blending or coat 
electrospun SF-derived scaffolds with either collagen I and laminin, two key ECM proteins, on 
the attachment, viability and structure formation associated with normal human mammary 
epithelial cells.   
Our results highlight the effects of SF concentration on the mechanical and physical 
properties of the SF-derived scaffolds and demonstrate that low polymer concentrations led to 
the formation of fibers with diameters closer to those of ECM fibers. Our results also 
demonstrate significant effects of air-flow pressure used during electrospinning on the formation 
of larger pores within scaffolds. Both of these features, i.e., small fiber diameters and large 
pores, are important parameters in mimicking breast ECM substitutes. Indeed, cells have been 
shown to develop increased attachment and organization around fibers with diameters smaller 
than the diameters of the cells [267]. Furthermore, cells infiltrated more deeply through scaffolds 
with pores large enough for the cells to migrate through and colonize the scaffolds [221]. The 
advantages of these electrospun scaffolds are that their physical, mechanical, and chemical 
properties can be modified to generate a variety of different matrices. There are, however, 
limitations in generations of these scaffolds using the air-flow electrospinning technique. 1) The 
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flow of air out of the pores of the perforated mandrel is not uniform and 2) deposition and 
collection of fibers on this perforated mandrel further affects the air flow distribution.     
Our observations further demonstrate improved cell adhesion and viability on SF-derived 
scaffolds that were blended and/or coated with collagen I or laminin. Our results demonstrate 
that collagen type I did not provide the cells with adequate chemical cues and integrin mediated 
cell-ECM interactions required for formation of epithelial structures. On the other hand, the 
presence of laminin provided cell-ECM interaction sites, possibly through β1 and β4 integrins, 
which are crucial in the differentiation and formation of polarized growth-arrested structures of 
mammary epithelial cells. Moreover, in the presence of lactogenic hormones, MCF10A 
mammary epithelial cells cultured onto laminin-coated SF-derived scaffolds promoted cell 
differentiation and formation of acinus-like structures. However, the number and complexity of 
these structures contrasted with the number of complex structures formed in Matrigel
®
. The low 
rate of cell proliferation on these electrospun scaffolds in comparison with cell cultures 
maintained in 2D highlight the growth-arrest of the epithelial cells once they form acinus-like 
structures. The developed microenvironment generated through electrospinning of SF is depicted 
in Figure 6.1.   
 
Figure 6.1. Silk fibroin microenvironment developed through electrospinning  
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Taken these results, we demonstrated the mechanical integrity of SF-derived scaffolds in 
culture and the flexibility of these electrospun scaffolds, which allow modification and control 
over the structural features as well as chemical features of the engineered microenvironment. 
This control allows testing of various factors involved in the function of the breast tissue either 
individually and/or as a group. The biocompatibility of these protein nanofibers demonstrated by 
MCF10A cell attachment, survival, and evidence of organized structures supports the use of 
these SF-derived scaffolds in modeling 3D breast tissues in vitro. Our data addressing the use of 
electrospun SF-derived scaffold in the modeling and/or tissue repair of the mammary gland 
parallel observations highlighting the engineering of ligament [42], adipose-like tissue [150], and 
skin [171] using nano-fibrous SF-derived scaffolds. Further, they underline that to better 
recapitulate the histological complexity of the normal breast and breast cancers, and to better fill 
the gap between animal models and 2D cell cultures, it is essential to develop more intricate 3D 
models than those currently available.     
Unlike other organs, the majority of the breast tissue development occurs after birth, during 
puberty, and pregnancy and requires dynamic and reciprocal signaling between cells and their 
surrounding microenvironment [86]. To delineate the mechanisms by which the tissue 
microenvironment modulates tissue function and cancer growth and development this 
dynamically changing cellular microenvironment must be adequately mimicked. To that end, the 
engineering and generation of dynamic microenvironments that respond to feedback from the 
tissue / cell during long culture periods will allow the analysis of cellular responses to this 
dynamically changing environment in both normal and cancerous tissue.  
Most breast tissue studies have utilized monotypic cell culture systems, where epithelial cells 
have been grown in isolation within 3D scaffolds. However, both normal and cancerous breast 
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tissues contain several heterotypic cell types. Indeed, the ducts and lobules of the normal breast 
are comprised of a bilayer structure of inner luminal epithelial cells and outer myoepithelial cells 
[86]. In order to generate heterotypic breast models, the addition of myoepithelial cells to 
epithelial cultures must be considered. The addition of at least one type of stromal cells such as 
adipocytes and/or fibroblasts influenced the epithelial cell cultures [50,53-
55,83,106,125,126,281]. Thus, the generation of heterotypic culture systems with a combination 
of multiple cell types such as adipocytes, fibroblasts, immune cells, and endothelial cells that can 
mimic the histological complexity of the tissue in vivo should be investigated. Challenges 
associated with heterotypic cell cultures include the different metabolic and nutritional needs of 
these various cell types and the signaling cascades among the different cell types. Culture 
conditions should be defined to meet both the growth and differentiation requirements and the 
signaling needs of the different cell types in culture. 
Furthermore, the development of normal breast tissue, as well as, cancer initiation and 
progression is regulated by various hormones and breast stroma and the basement membrane 
consisting of ECM proteins such as collagens type I, II, III, and IV, laminin, fibronectin, 
proteoglycans, and glycoproteins [86,87]. Those proteins and hormones critically modulate the 
fate of epithelial cells especially during cell differentiation and functional activities of the breast 
and also during breast cancer progression. Therefore, the blending and/or coating scaffolds with 
multiple ECM proteins and their effects on cellular behavior should be further investigated. Also, 
the incorporation of various hormones and their effects on breast tissue maintenance, activation 
or cancer progression should be investigated in in vitro 3D models.     
In addition to biochemical cues, cell mechanics and mechanical properties of the matrix play 
crucial roles in breast tissue function and cancer biology. Cell mechanics can be separated in 
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three different subfields: 1) cellular mechanical properties, which allow understanding of cell 
deformity and migration in cancer; 2) mechanotransduction, which is the cellular response to 
imposed forces on cells by the external environment. Importantly these mechanical forces 
influence tumor growth and metastasis; and 3) cell-generated forces that will allow a better 
understanding of how cells sense their microenvironment [130,282]. Further investigation of 
these mechanical forces will contribute to generation of more relevant 3D models. Also, 
mechanical properties of the matrix have been shown to play an important role in the formation 
of polarized acinar-like structures. Indeed, increased matrix density is associated with disruption 
of organized and polarized growth-arrested structures formed by epithelial cells [129]. Therefore, 
further mechanical testing of the electrospun scaffolds, as a whole, through compression testing, 
and as individual fibers will shed light on the cellular behavior within these scaffolds.   
Further, the mechanical testing of the breast tissues have demonstrated the heterogeneity of 
this tissue with various densities within the fatty regions and the fibroglandular regions [88-91].  
Therefore, the development of scaffolds with heterogeneous and controlled regions with variable 
fiber diameters and pore sizes will allow the formation of more biologically relevant matrices 
and 3D breast tissue models.   
One major challenge in tissue engineering is complete cellularization of the entire scaffold. 
Many studies have investigated electrospun scaffolds for a range of tissue engineering 
applications, however, generation of materials that permit complete cell integration and 
infiltration have not been successful and often, cellular population and tissue formation occur 
only at the scaffold periphery [283].    
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Figure 6.2. Gradient electrospinning setup. Adapted from [283] 
 
In an effort to promote further cell infiltration through electrospun scaffolds, in a recently 
developed method (as depicted in Figure 6.2), two polymer solutions in two separate syringes are 
used, e.g., SF which does not contain adhesion sites (polymer 1) and collagen with cell binding 
sites (polymer 2). The polymers meet at the T-junction and are mixed through a mixing channel. 
The flow rate of the two polymers, before mixing, is altered during the electrospinning period 
resulting in the formation of scaffolds with primarily Polymer 2 at the bottom and primarily 
Polymer 1 at the surface [283]. This increasing gradient of adhesion sites towards the bottom of 
the scaffold will promote cell migration and infiltration from the surface of the scaffolds into the 
inside and bottom of scaffolds [283]. Therefore, the fabrication of matrices that can direct cell 
migration and promote colonization of the entire matrix, gradient electrospinning method should 
also be investigated. 
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